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Abstract 
 
The primary purpose of this study is to evaluate the potential of FTIR and Confocal Raman 
micro spectroscopy (CRM) in elucidating the biochemical changes occurring in different 
layers of the cervical epithelium including basal, superficial and the underlying connective 
tissue known as stroma during the progression of Cervical Intraepithelial Neoplasia (CIN) 
to cancer. Initially the two techniques were compared and Raman was chosen based on its 
higher spatial and spectral resolution. The sample preparation and spectral measurement 
procedures were optimised and all samples were formalin fixed paraffin processed, 
dewaxed using xylene, and measured on calcium fluoride windows. Raman spectra were 
recorded using a source wavelength of 785nm and a X100 dry objective lens. Raman micro 
spectroscopy was able to differentiate the normal region of the cervical tissue sample into 
three layers including stroma, basal/para-basal and superficial layers on the basis of the 
spectral features of the collagen, DNA bases and glycogen as well as discrimination of the 
diseased areas from the normal areas. In particular Raman spectroscopy could describe the 
biochemical changes in the diseased samples in detail. On moving from normal to abnormal 
regions of the cervical tissue sample, the characteristic Raman features of the basal layer 
were observed in the superficial layer and in the stroma. Notably, the normal region of a 
CIN III sample was found to have biochemical information similar to the abnormal region. 
This has been indicated by the absence of the collagen Raman spectral bands in the stromal 
layer as well as absence or minute presence of the glycogen bands in the superficial layer. 
A comparison of the Principal Components Analysis (PCA) loadings of the HPV negative 
and positive cell lines (C33A and CaSki), with those of the basal layers of normal and 
abnormal tissue samples showed no strongly matching Raman signatures which could lead 
to the identification of signatures of HPV infection in the cervical cancer tissue samples. 
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However, a feature associated with the amide-III beta sheet (1222 cm-1) was found to be 
consistently present in the PCA loadings contributed by the basal layers of the intermediate 
and abnormal samples. This was much reduced in intensity in the most extreme abnormal 
sample and the carcinoma in situ samples. This feature may be considered as an early 
marker of disease progression, but further investigation is needed to confirm this finding. 
KMCA indicated the possibility of the migration of basal cells into the superficial and 
stromal layers and subsequent PCA led to the conclusion that basal cells indicated by high 
DNA content and lack of glycogen are progressing to the superficial layer due to the 
progression of the disease. In the case of stroma, the basal like characteristics are actually 
associated with the biochemical changes in the stromal cells and there is no migration of 
these cells into the stroma. In addition, during cervical cancer progression, relative to the 
DNA, collagen has a diminished contribution at some points in the Raman map of the 
stroma and KMCA recognised the greater similarities with the DNA rich cells of the basal 
layer. This has been supported by the enhanced expression of p16 protein in the basal and 
superficial layers rather than in the stroma. 
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Chapter 1 
 
Introduction 
 
Cervical cancer is the third most common cancer in women worldwide, 85% of cases 
arising in the developing world (Jemal et al., 2011). Mortality associated with cervical 
cancer can however be significantly reduced if the disease is detected at the early stages of 
its development or at the pre-malignant state (cervical intraepithelial neoplasia, CIN) 
(Parkin et al., 2005). 
Current methods for identifying neoplastic cells and differentiating them from their normal 
counterparts are often nonspecific, slow, invasive, or a combination thereof (Chan et al., 
2006). The primary screening tool for cervical neoplasia is the Papanicolaou (Pap) smear 
test, which involves the microscopic examination of exfoliated cells for morphological 
abnormalities (Papanicolaou and Traut, 1941). The colposcopy is a widely used tool, which 
usually follows an abnormal Pap smear. The incidences of the disease and associated 
mortality have been falling in developed countries, where these screening methods are 
widely practiced. However, these methods have several shortcomings, including high false 
negative/positive results that could be due to the subjective interpretations of the 
cytologist/pathologist diagnosing the disease based on morphological abnormalities. There 
are difficulties in separation of normal, basal cell hyperplasia, immature squamous 
metaplasia and inflammation associated changes from true koilocytes, which are indicative 
of low grade squamous metaplasia (McCluggage et al., 1998). There are also difficulties in 
differentiating low grade squamous intraepithelial lesions from immature metaplastic 
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squamous with atypia, mild abnormality, resulting in inter- and intra- observer difference of 
opinion (McCluggage et al., 1998).  
It is estimated that 90% of deaths can be prevented by early diagnosis, however (Bazant-
Hegemark et al., 2008), which emphasizes the need for effective screening methods. 
Optical methods such as Confocal Microscopy and Optical Coherence Tomography are 
potential techniques that can be used to visualise the neoplastic changes more sensitively. 
These tools are emerging as non-destructive, real-time imaging modalities for early 
diagnosis of precancerous lesions of the cervix (Bazant-Hegemark et al., 2008). Potentially 
offering higher sensitivity and specificity based on biomolecular analyses, spectroscopic 
methods such as IR absorption and Raman scattering are attracting increased attention. The 
suitability of these techniques, particularly Raman spectroscopy, for rapid noninvasive 
screening of cervical biopsies will be explored in this work. 
1.1 Cervix 
 
The cervix is the lower fiberomuscular portion of the uterus.  The upper portion adjoining 
the uterus is known as the endocervix and the lower end adjoining the vagina is known as 
the exo cervix. The lining of the endocervix is covered by a single layer of tall columnar 
cells with dark staining nuclei forming the columnar epithelium (Figure 1.1). The 
exocervix, on the other hand, is covered by stratified, glycogen containing squamous 
epithelium. The point where the two epithelial layers meet is known as the transformation 
zone (Sellors and Sankaranarayanan, 2003/4). Initially, the epithelium at the transformation 
zone is comprised of a single layer of mucus secreting columnar epithelium, but the 
hormonal changes at the onset of puberty make the environment for the exposed epithelium 
more acidic, causing it to change from a single layer epithelium to a more protective, 
stratified squamous epithelium. 
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Figure 1.1 Diagrammatical representation of human cervix. 
(http://www.gynalternatives.com/structur.htm) 
 
1.2 Cervical Cancer 
Cervical cancer is the major cause of gynaecologic-related death worldwide, but is 
absolutely avoidable with regular cytological screening (Shepherd and Bryson, 2008 Nov). 
Cervical cancer impacts the lives of women worldwide. Recent reports on cervical cancer 
indicate that 275,100 women died of cervical cancer in 2008 and 85% of these deaths 
occurred in developing countries (Jemal et al., 2011). Cervical cancer is only the eleventh 
most common cancer among women in developed countries, however, due to existing 
screening practices. In the absence of such established screening procedures, it becomes the 
second most common cancer (Peto et al., 2004). Most of the precancerous and cancerous 
lesions arise in the transformation zone, which is the area where metaplasia occurs at the 
onset of puberty (Cuzick et al., 2008). 
1.2.1 Types of cervical cancer 
Cervical cancer can be divided into the following types: 
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1.2.1.1 Squamous cell carcinoma 
Squamous cell carcinoma is the most common carcinoma of the cervix (about 90%) and it 
originates from the squamous epithelium of the exocervix. It is sub divided into three 
classes: 
1. Large cell keratinising tumours 
2. Large cell non keratinising tumours 
3. Small cell non keratinising tumours  
 
1.2.1.2 Adenocarcinoma 
Adenocarcinoma is a type of cancer which arises from the glandular epithelium. Although it is 
rarely found in the cervix, it develops in the endocervix. It accounts for 10% of cervical cancers 
and primarily affects women over the age of 60 years (Mera, 1997). Different reports suggest 
that there has been a recent increase of up to 15% in its occurrence, especially in young women 
who take oral contraceptives (Quinn, 1998). 
Mixed adenosquamous tumours are rare (about 5%). Other malignant tumours such as 
lymphomas, melanoma, and sarcomas can be diagnosed but are rare (Mera, 1997).   
 
1.3 Risk factors 
The risk factors for cervical cancer according to epidemiological studies are discussed in 
detail below: 
 
1.3.1 Sexual activity 
The risk relates to the number of sexual partners for either the woman or her partner. The 
greater the number of sexual contacts, the greater can be the risk involved (Mera, 1997). 
 29 
The age of first sexual intercourse is not a risk factor in itself, other than the likelihood that 
initiation at an earlier age may result in the accumulation of more sexual partners. Most of 
the other risk factors are associated with this factor.  
 
1.3.2 Infection with Human papilloma virus (HPV) 
Infection with the human papilloma virus is the most commonly cited cause of cervical 
cancer, occurring in 99.7% cases, especially with types 16 and 18 of the virus (Bosch et al., 
1995, Walboomers et al., 1999). Over 100 types of human papilloma virus have been 
identified, of which 40 are known to infect the genital tract. Some of them, such as type 6 
and 11, cause only warts and are known as low risk strains, while others such as type 16 
and 18 can lead to cervical precancerous states and are thus classed as high risk strains. 
Type 16 followed by 18 are the most frequently detected types of HPV at the time of 
diagnosis of squamous cell carcinoma (SCC) (Woodman et al., 2007). Other high risk HPV 
types include 31,33,35,39,45,51,52,56,58,59,68,73 and 82 and the low risk types include 
6,11,40,42,4344,54,61,70,72 and 81 (Villa and Denny, 2006).The integration rate of the 
HPV 16 genome with that of the infected basal cells increases with severity of cervical 
neoplasia. However, in some women with invasive disease, only episomal forms, genetic 
material existing as a free autonomously replicating DNA, are identified (Woodman et al., 
2007). On the other hand, HPV 18 is found in an integrated form in most of the cases with 
high grade cervical intraepithelial neoplasia or invasive disease (Woodman et al., 2007). 
Infection with HPV 18 is considered to be the cause of adenocarcinoma, which is only 10% 
of cervical cancer (Woodman et al., 2007).  
Pathological examination of cervix cone biopsies reveals that, in many cases, more than one 
grade of cancer can co-exist in the same sample and this is considered to be due to the 
infection of the cervix by different strains of HPV and not due to the different stages of 
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evolution in a continuing process that is caused by a single viral type infection (Agorastos 
et al., 2005). 
 
1.3.3 Irregular cervical cytological screening 
Women who do not undergo regular cervical cytological screening may have four times 
more risk of developing cervical cancer than those who are regularly screened (Mera, 
1997). 
 
1.3.4 Cigarette smoking  
Cigarette smokers have higher risk of developing cervical cancer than non smokers (Mera, 
1997). The metabolites of tobacco smoke have been found in the cervical mucus of 
smokers. The presence of constituents of tobacco smoke in the cervix may favour infection 
by the human papilloma virus.(HPV) The DNA of the cells in the cervix forms adducts 
with some metabolites of tobacco and can act as a tumour promoter after infection with 
HPV (Collins et al., 2010). 
 
1.3.5 Use of oral contraceptives 
The use of oral contraceptives increases the risk of cervical cancer, whereas use of barrier 
methods of contraception are associated with decreased risk and the reason for these 
methods being safe is that they do not allow seminal fluid to come in contact with the 
cervix (Mera, 1997). Prolonged use of oral contraceptives increases the risk of cervical 
cancer in HPV positive women (Smith et al., 2003). 
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1.4 Classification system 
Cervical cancer arises after progressing through a long phase of pre-invasive disease. This 
is characterised microscopically as a sequence of events progressing from cellular atypia to 
various grades of dysplasia or cervical intraepithelial neoplasia (CIN) before progression to 
invasive cancer (Richart, 1968).  It has been observed that some cases of dysplasia regress, 
while some persist, some progressing to carcinoma in situ (CIS). The concept of cervical 
cancer precursors dates back to the late nineteenth century, when non invasive atypical 
changes were found in tissue specimens adjoining invasive cancer (Sellors and 
Sankaranarayanan, 2003/4). The term carcinoma in situ was developed in 1932 to represent 
those lesions which had undifferentiated carcinoma cells in the full thickness of the 
epithelium without disturbing the basement membrane (Sellors and Sankaranarayanan, 
2003/4). A relationship between CIS and invasive cervical cancer was subsequently 
reported (Reagan et al., 1953). In late 1950, the term Dysplasia was coined, to indicate 
cervical epithelial atypia, a missing step between normal epithelium and CIS (Reagan et al., 
1953). Dysplasia was further classified into three groups, mild, moderate and severe, 
depending on the levels of atypical cells in the epithelium. As a result, cervical 
precancerous lesions were described using the categories of dysplasia and CIS for many 
years. A system that separates the classification of dysplasia from CIS was increasingly 
accepted on the basis of findings from a number of follow up studies involving women with 
such lesions (Sellors and Sankaranarayanan, 2003/4). A direct relationship between 
progression of disease and histological grade of tissue led to the concept of a single 
continuous disease process (Sellors and Sankaranarayanan, 2003/4). This continuous 
process leads the normal epithelium through various grades of dysplasia into invasive 
cancer. On this basis, the term cervical intraepithelial neoplasia (CIN) was developed by 
Richart in 1968 for cellular atypia confined to the epithelium (Richart, 1968). It classified 
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mild dysplasia as CIN I, moderate as CIN II, with CIN III describing severe dysplasia to 
carcinoma in situ.  
HPV was recognised, in 1980, as an infectious agent responsible for pathological changes 
such as koilocytic atypia (Richart, 1990), which means cells with irregular cytoplasm or a 
halo; koilocytes are cells with a luminous circle in the cytoplasm (Sellors and 
Sankaranarayanan, 2003/4).  
The hypothesis that cervical cancer may arise from infections with HPV was made by 
Hausen (Hausen et al., 1974a, Hausen et al., 1974b, Zurhausen, 1976). The isolation of 
HPV 16 and later HPV 18 and characterisation as infectious agents responsible for cervical 
cancer  (Boshart et al., 1984, Durst et al., 1983) and a detailed study of cervical dysplasia 
suggesting that its development is not a continuous event, as only 5% of CIN II and less 
than 12% of CIN III progress to invasive cancer if left untreated (Pinto and Crum, 2000), 
paved the way for a creation of the Bethesda system of classification. The Bethesda system 
(TBS) of classification was created in 1988 and revised in 1991 in a workshop organised by 
the US National Cancer Institute (Jastreboff and Cymet, 2002). This system classifies 
cervical intraepithelial neoplasia according to the following categories: atypical squamous 
cells of undetermined significance (ASCUS) refers to squamous atypia, low grade 
squamous intraepithelial lesion (LSIL) applies to lesions with condylomatous (a skin 
tumour near the anus or genital organs) atypia, mild dysplasia or CIN I and high grade 
squamous intraepithelial lesion (HSIL) applies to lesions with moderate to severe or CIN II 
and CIN III lesions and CIS (Moscicki, 1999, Kaufman and Adam, 1999, Sigurdsson, 
1999). TBS was re-evaluated and revised in a 2001 workshop organized by the US National 
Cancer Institute, at which more than 20 countries were represented (Solomon et al., 2002). 
The revisons of the 2001 TBS included specific statements about specimen adequacy, 
general categorization, and interpretation and results. In the adequacy category, 
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“satisfactory” and “unsatisfactory” are retained, but “satisfactory but limited by” is 
eliminated. The new category of “atypical squamous cells” (ASC) is replaced by the 
category of “atypical squamous cells of undetermined significance” (ASCUS) while 
dividing it into qualifiers of (a) ASC of “undetermined significance” (ASC-US) and (b) 
“cannot exclude high-grade squamous intraepithelial lesion (HSIL),” or (ASC-H). The 
categories of ASCUS, “favor reactive” and “favor neoplasia” were eliminated. The 
terminology for low-grade squamous intraepithelial lesions (LSILs) and HSILs remained 
the same as previous. The category of “atypical glandular cells of undetermined 
significance” (AGUS) is eliminated to avoid confusion with ASCUS and replaced by the 
term “atypical glandular cells” (AGC), in an effort to identify whether the origin of the cells 
was endometrial, endocervical, or unqualified. “Endocervical adenocarcinoma in situ” and 
“AGC, favor neoplastic” were included as separate AGC categories (Apgar et al., 2003). 
 
1.5 Precancerous stages 
The normal squamous stratified epithelium in an adult cervical transformation zone has 
three different types of cell layers, including a single layer of basal cells at the bottom, 
several layers of round polygonal cells forming an intermediate layer and the flattened 
epithelium at the surface. A haematoxylin and eosin (H&E) stained tissue section of normal 
cervical epithelium is shown in Figure 1.2. 
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Figure 1.2 Hematoxylin and Eosin (H&E) stained normal stratified squamous epithelium 
basal and parabasal cell layer. The bracket and arrow show parabasal and basal cell layers 
respectively. 
 
(http://www.mtmlabs.com/us/index.php?option=com_content&view=article&id=107&Item
id=29) 
 
1.6 Cytological Abnormalities 
For the past 50 years, the primary method used for the screening for pre-cancerous lesions 
in asymptomatic women in the general female population has been the Papanicolaou test 
(Pap smear). The method was developed by George Papanicolaou, before HPV was 
implicated in cervical cancer, and boasts a specificity of 95-98% but a sensitivity of lower 
than 50% (Nanda et al., 2000). In another study where a comparison between the HIV-
infected and HIV-uninfected women was made for the diagnostic characteristics of Pap 
testing, the sensitivity was found to be 86.7% in the HIV-infected group and 94.4% in the 
HIV-uninfected group (P= 0.70). The specificity was 65.8% versus 88.3% (P= 0.01) 
respectively (Anderson et al., 2006). The Pap smear is the microscopic examination of the 
exfoliated cells of the cervix for morphological abnormalities (Ronco et al., 2006). 
Abnormal Pap smears are normally followed by colposcopy or histological tests, but the 
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decision still remains in the hands of a pathologist, rendering the interpretation subjective 
(Papanicolaou and Traut, 1997).  
Cellular changes, symptomatic of disease, can be detected in such cytological smears. 
Cytological smears are classified on the basis of shape and size of the cell with special 
emphasis on shape and size and staining properties of the cell nucleus. The changes in the 
structure of nuclei are labelled as dyskaryosis. Dyskaryosis may be classified as mild, 
moderate and severe, corresponding, as mentioned previously, to CIN I, CIN II and CIN III 
respectively. Cytology also has the ability to identify invasive cancer and any minute 
change in the cells termed as borderline changes. Smears do not, however, allow an 
estimate of the extent of epithelial involvement and the state of the underlying stromal 
tissue. Overall, cytology tends to underestimate the severity of abnormality (Mera, 1997). 
 
1.7 Histological abnormalities during dysplasia 
While progressing towards invasive cancer, a chain of morphological changes can be seen 
in the epithelium of the cervix (Figure 1.3). These changes involve individual cells and the 
thickness of the abnormal epithelium. The dysplastic changes or grades of CIN are the 
terms used to define these changes. These changes involve the cell development and 
maturation and can be seen as atypical maturation of different epithelial cell layers, 
abnormal keratinisation and nuclear and cytoplasmic changes (Mera, 1997).  
An expansion in the layers of epithelium due to the relatively undifferentiated cells in the 
basal and parabasal cell layers occurs so that they constitute the major portion of the 
epithelium. The precancerous conditions of the cervix are always confined to the epithelium 
of the cervix and cause no harm to the underlying stroma (Mera, 1997). The three grade 
CIN system can be used to describe effects on cell differentiation and the thickness of 
epithelium affected.  
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1.7.1 CIN I  
In this grade of cervical pre-cancer, the cells in the basal layer of the epithelium have larger 
nuclei than their normal counter parts. There is an increase in nucleus to cytoplasm ratio 
and the nuclei are pleomorphic (exhibit a variety of shapes). These types of cells occupy 
one third of the epithelial layer and the upper two thirds remains as normal stratified 
squamous epithelium. 
 
1.7.2 CIN II   
In the CIN II grade, the abnormal cells occupy the lower half of the epithelium. The upper 
half still shows normal stratification and maturation. A H&E stained CIN II cervical 
epithelium is shown in Figure 1.3. 
 
Figure 1.3 Hematoxylin and Eosin (H&E) stained CIN II cervical epithelium. 
 
(http://www.mtmlabs.com/us/index.php?option=com_content&view=article&id=107&Item
id=29) 
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1.7.3 CIN III 
 
In the CIN III grade, the whole epithelium is covered by abnormal cells, leaving only the 
upper one or two layers as normal epithelium. In this grade, the cells contain large dark 
staining nuclei. These are the most severe changes possible before invasive carcinoma. A 
H&E stained CIN III cervical epithelium is shown in Figure 1.4. 
 
 
Figure 1.4 Hematoxylin and Eosin (H&E) stained CIN III cervical epithelium. 
(http://www.mtmlabs.com/us/index.php?option=com_content&view=article&id=107&Item
id=29) 
 
A schematic diagram of these layers of a normal cervical epithelium along with the changes 
which occur during the progression of cervical intraepithelial neoplasia (CIN) is presented 
in Figure 1.5. 
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Figure 1.5 Schematic representation of the progression of normal epithelium towards 
invasive cervical cancer. 
(www.medscape.com) 
 
 
1.8 Progression to invasive cancer 
Early dysplastic changes may persist without progression to the next stage and may revert 
or may progress to invasive cancer. Currently, it is not possible to predict the cases which 
are going to progress or revert. The degree of regression depends on the severity of the 
lesion. Most of the CIN I lesions revert to normal, only 1% progressing to invasive 
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carcinoma (Pinto and Crum, 2000) and this is why the treatment of a CIN I lesion is 
considered unnecessary (Mera, 1997). 
Other risk factors can determine progression, including infection with HPV types 16 or 18. 
Treatments exist to prevent progression, but they are not given until lesions progress to CIN 
II or CIN III. 
 
1.9 Malignant stages 
Cervical cancer is locally invasive, spreading upward in the corpus uteri, downward into 
the vaginal walls, forward in the bladder and backwards to cover the rectum and sacral 
plexus. Fistulas can be produced by the involvement of the rectum or bladder. Lymphatic 
spread is usually along the paracervical lymph toward the external iliac lymph nodes. 
Cervical cancer can metastasise to the liver, lungs and bone but this occurs only at very late 
stages (Mera, 1997). 
On the basis of the degree of invasion and involvement of lymph nodes, malignancy is 
classified into following stages: 
(a) Stage 0 Only few cancerous cells in the epithelium of cervix. They can persist there 
for several years. 
(b) Stage I Cancerous cell spread to the underlying basement membrane, but still 
limited to the cervix. It is further divided into following sub classes. IA: Cancerous cells 
invade the connective tissue but there is no involvement of blood and the lymphatic system. 
Thickness of the tumour is not more than 3mm. IB: Thickness of tumour is more than 3mm 
and there is involvement of the blood and lymphatic system.    
(c) Stage II Tumour spread beyond the cervix into the upper wall of vagina. 
(d) Stage III  Pelvic wall and lower third of vaginal wall are covered by tumour cells. 
(e) Stage IV  There is involvement of rectum and bladder. 
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The survival rate depends on the prognosis of the tumour. Stage 0 tumour is entirely 
treatable. The 5 year survival rate is 94% for Stage IA but this falls to 30% for Stage III and 
IV. 
 
1.10 Detection and assessment of cervical lesions 
 
The assessment of cervical lesions is usually done by visual inspection, bimanual pelvic 
examination, colposcopy and histological examination after the appearance of the 
symptoms or finding of abnormalities by employing the routinely used Pap smear 
examination. No useful information is obtained by the visual examination or bimanual 
inspection if the tumour is in the initial stages, especially if it lies inside the cervical canal. 
It appears as an inflammable outgrowth of the external opening of the lower part of the 
cervix in the vagina. As it penetrates the cervix, it becomes a hard, barrel shaped mass. It is 
important to mention that the cervix is supported by the ligament which connects it to the 
bony pelvis which means that the cervix is not originally fixed at its position but is caused 
to be by the development of the tumour (Mera, 1997). The penetration of the tumour into 
the vaginal fornix, which is an arch shaped depression in the upper vagina, results in the 
fixation of the cervix at its place. The tumour growth is fragile and bleeds on touching. 
Cervicitis and infected benign mucous polyps can produce the same symptoms, however 
(Mera, 1997). 
Histological confirmation of the malignancy opens the pathway to several tests to confirm 
the stage of disease e.g. cystoscopy, proctosigmoidoscopy or barium enema to determine 
the involvement the bladder or rectum, chest radiography, intravenous pyelogram. The 
findings of the staging investigation should be confirmed by surgical exploration and 
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histological examination of the excised tissue, unless radiotherapy alone is the treatment of 
choice (Mera, 1997). 
Several different techniques have been used for the diagnosis of cervical cancer. A brief 
overview of these techniques is presented in this chapter and they are discussed in more 
detail in chapter 2. For the preliminary diagnosis of cervical cancer, the Pap smear test is 
commonly used. It involves the microscopic examination of the exfoliated cells of the 
cervix and detects cytological abnormalities (Ronco et al., 2006). The Pap smear test has 
low sensitivity and, to overcome this, HPV-DNA/RNA based techniques were introduced 
for the investigation of atypical squamous cells of undetermined significance (ASCUS) and 
low grade squamous intraepithelial lesions (LSIL) (Cuzick et al., 2008), as infection with 
Human Papilloma Virus (HPV) is considered an established reason for these pathological 
changes (Richart, 1990). HPV DNA/RNA testing is usually performed with commercially 
available tests, eg. Hybrid Capture II (HC II), Amplicor, Cobas4800, PreTectHPV-Proofer, 
APTIMA and Linear Array test (Ovestad et al., 2011, Clad et al., 2011). It is followed by 
the evaluation of the cervix with a low power light microscope (colposcope) for changes in 
the tissue reflectance, a marker for precancerous lesions (Thekkek and Richards-Kortum, 
2008). It should be noted that due to the low specificity of such a visual examination, the 
ultimate diagnosis is recognized to be the histopathological examination of a punch biopsy 
or excised specimen (Mitchell Md et al., 1998). 
In order to use the Pap smear test effectively, a proper infrastructure of laboratory for 
screening purposes, trained staff and most importantly facilities for recalling a patient for 
repeated examination are needed, which make this an expensive option in resource poor 
settings. 
On the other hand, although they are more sensitive, interpretation of the results of 
colposcopy of the cervix and histopathological examination of the cervical tissue sections 
 42 
are in the hands of colposcopist and pathologist, respectively, and can vary according to the 
expertise of the examiner, giving rise to considerable intra- and inter- observer variability 
and false positive and negative results, hence making the techniques subjective. Moreover, 
these techniques are based on the observation of the morphological changes which become 
evident later than the biochemical changes (Hutchings et al., 2009, Kendall et al., 2009) 
taking place as a result of the progression of disease and cannot reliably be detected by 
histopathological techniques (Haggitt, 1994). 
In order to provide the opportunity of cervical screening to women in resource poor settings 
and to increase specificity and sensitivity of diagnosis, new screening techniques are 
required. 
Simple visual approaches such as visual inspection with acetic acid (VIA) have also been 
evaluated to facilitate cervical cancer screening in developing countries as an alternative to 
the the Pap smear and colposcopy (Ekalaksananan et al., 2010, Murillo et al., 2010, 
Aggarwal et al., 2010, Cremer et al., 2010, Ngoma et al., 2010, Nessa et al., 2010, 
Muwonge et al., 2010, Sankaranarayanan et al., 1998, Sankaranarayanan et al., 2007). More 
sophisticated optical techniques are being considered as a viable alternative for the early 
diagnosis of the cervical cancer. These are currently in use for research purposes and a lot 
of effort is being made to establish them for the detection and diagnosis of cervical cancer. 
They include confocal microscopy, optical coherence tomography and fluorescence 
spectroscopy, as discussed in detail in chapter 2. 
Most techniques, and indeed classification systems, are based on the morphological 
changes associated with disease. These are a result of and become evident later than the 
biochemical changes taking place as a result of the progression of disease (Hutchings et al., 
2009, Kendall et al., 2009). Ultimately, new techniques should be based on detection of the 
biochemical changes. Vibrational spectroscopic techniques, including FTIR absorption and 
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Raman scattering hold such potential and promise disease diagnosis at its earliest stage 
(Kendall et al., 2009). 
Raman spectroscopy is an analytical technique that enables chemical characterisation of 
molecules within a sample. It is based on the inelastic scattering of photons upon 
interaction with material vibrations and provides a chemical signature of the material. It has 
been recognised to hold great potential in tracing the events of biochemical changes 
involved in the progression of normal tissue toward invasive carcinoma (Chan et al., 2006). 
Prominent features of malignant cells with respect to normal cells are increased levels of 
DNA and amino acids and decreased levels of glycogen in epithelial layers (Krishna et al., 
2006, Utzinger et al., 2001). Raman spectroscopy has been shown to be capable of 
discriminating between normal keratinocytes, and cervical cancer cell lines with a 
sensitivity of 70-100% and specificity of 70-90% and was also able to differentiate between 
normal and HPV infected keratinocytes (Jess et al., 2007). In vivo probe systems that can 
probe for biochemical changes have been used for Raman spectroscopy (Krafft and Sergo, 
2006). The cervical tissue studies to date have been confined to differentiation of normal 
cervical tissue from high grade or cancerous tissue. Investigation of 150 cervical tissue 
biopsies by Raman spectroscopy was carried out and normal cervical tissues were separated 
from malignant tissues with a sensitivity and specificity of 99.5% (Krishna et al., 2006). 
(Lyng et al., 2007) reported differentiation of 40 histological samples into normal cervical 
epithelium, invasive carcinoma and cervical intraepithelial neoplasia with nearly 100% 
sensitivity and specificity. An in vivo study on 66 patients showed that Raman spectroscopy 
has 89% sensitivity and 81% specificity to distinguish high grade dysplasia from benign 
tissue (Robichaux-Viehoever et al., 2007). The reported results are higher than colposcopy, 
which has a sensitivity of 87% and specificity of 72%. 
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1.11 Aim of the study 
 
The aim of the present study is to evaluate the potential of Raman micro spectroscopy for 
early stage diagnosis of disease of the cervix as well as to elucidate the biochemical origin 
of the spectral markers associated with the onset and progression of the disease. The initial 
stages will establish the biochemical signatures of different layers of the cervical 
epithelium. It is expected that these signatures will be distinct, as the biochemistry of each 
layer is different. These differences in the biochemistry of each layer in the form of Raman 
spectral markers may be helpful for the better classification of cervical intraepithelial 
neoplasia (CIN). This would lead to the classification of cervical cancer on the basis of the 
biochemical changes occurring during the progression of the disease instead of 
morphological changes. 
Raman micro spectroscopy will then be used to monitor the complete progression of 
cervical cancer from normal through to the various grades of CIN including CIN I, CIN II, 
CIN III and invasive carcinoma on the basis of spectral differences obtained from 
respective tissue samples. 
Raman mapping will be carried out to differentiate between different layers of cervical 
epithelium such as basal, parabasal, intermediate and superficial, in formalin fixed and 
paraffin preserved (FFPP) normal cervical tissue sections. The next step will be the 
recording of Raman maps from pathologically diagnosed CIN I, CIN II, CIN III and tumour 
tissue sections from areas of normal and abnormal morphology.  
The Raman spectra of cervical tissues are characterized by strongly overlapping spectral 
features so it can be difficult to interpret by visual inspection. Hence sophisticated 
mathematical and statistical data analysis techniques and algorithms are required for the 
extraction of useful information from these spectra. In recognition of this, multivariate data 
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analysis such as principal component analysis (PCA), K means cluster analysis (KMCA), 
independent component analysis (ICA) and nonlinear negatively constrained least squares 
analysis (NNCLSA) will be used as standard protocols for spectroscopic data analyses in an 
attempt to elucidate the pattern of progression from normal to invasive carcinoma. 
Complementary techniques such as FTIR imaging and immunohistochemistry will also be 
carried out in parallel. 
 
1.12 Overview of the thesis 
 
In chapter 2, the different techniques which are currently in use for cervical cancer 
screening and diagnosis are discussed in greater detail. These techniques include the Pap 
smear test, HPV DNA/RNA based screening methods, visual inspection with acetic acid 
(VIA), colposcopy, histopathology. Moreover, techniques based on optical methods 
including confocal microscopy, optical coherence tomography, fluorescence spectroscopy, 
FTIR and Raman micro spectroscopy are also discussed along with the advantages and 
disadvantages of each technique with respect to their application for the screening of 
cervical cancer. As the techniques of choice for the current study are FTIR and Raman 
micro spectroscopy, these two techniques are compared for the acquired spectral features 
from the same cervical tissue samples. As Raman micro spectroscopy provides better 
spectral and spatial resolution, this technique has been selected for the further studies. 
In chapter 3, for Raman spectral studies, different parameters which need to be optimized 
for sample preparation and measurement are discussed. In the case of formalin fixed and 
paraffin processed (FFPP) tissue sections, which are used for all the experiments for Raman 
spectral measurements, parameters such as the dewaxing solvent, the thickness of the 
section cut from the block, the substrate for the adhesion of the tissue sections, the laser 
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wavelength and the objective lens to focus the laser and collect the Raman signals are 
optimised. 
Having optimised these parameters for the current study, different cervical tissue samples 
from CIN II and CIN III patients are analysed with Raman micro spectroscopy. In chapter 
4, the results of the Raman spectral mapping performed on the cervical tissue samples are 
presented. The results are analysed in the context of their morphological classification, and 
trends in biochemical changes are explored. The “Raman based classification” is compared 
to that of histopathology which suggests Raman micro spectroscopy as an alternative to 
histopathology.  
In order to further elucidate the biochemical basis of the development of the cervical 
cancer, principal component analysis (PCA) has been performed on the Raman spectral 
data and presented in the chapter 5. The PCA of different regions of the tissue samples, 
normal and diseased, as identified by KMCA in the previous chapter, may be helpful to 
describe the biochemical differences between them. The changes occurring in the basal 
layer can be associated to the infection of the HPV virus and to identify these spectral 
changes, PCA results of the Raman spectral data of the cervical cell lines with different 
copy number of HPV will be compared with the PCA of the of the basal layers of the true 
normal and normal side of the CIN II sample. Further, PCA have been employed to 
differentiate between the basal layers of the normal, intermediate and abnormal, as 
mentioned in the chapter 4, to answer the question that was put by the results of the KMCA 
that either the basal layer proliferates into the stromal and superficial layers or there are the 
cells of these layers which undergo some biochemical changes during the development and 
progression of the disease. 
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To further confirm the information acquired from the PCA, in chapter 5, regarding the 
answer to the question “whether the cells of the basal layer proliferates into the superficial 
stromal layers or there are the cells of these layers which undergo some biochemical 
changes during the development and progression of the disease” immunohistochemical 
staining for the evaluation of the expression of p16 protein is performed and presented in 
chapter 6. The expression of p16 is a biomarker for the presence of HPV and is expected to 
be enhanced in the basal and superficial cells/layers rather than in the stroma/stromal cells. 
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Chapter 2 
Techniques for cervical cancer screening and diagnosis 
2.1 Introduction 
The molecular and biochemical changes that ultimately lead to the occurrence of cancer 
include the disturbance of the basic organisation of nucleic acids, proteins, lipids, and 
carbohydrates (Ooi et al., 2008) and these changes can be used as diagnostic markers of 
cancer. Historically, many techniques have targeted the above mentioned biomolecules and 
sub-cellular structures, nucleus to cytoplasm ratio or cellular morphology for diagnosis as 
well as for the prognosis of cancer. However, changes at this level are detectable only after 
they have already caused considerable gross morphological changes in the tissue. Due to 
technological advances, more opportunities have arisen to investigate the bio-molecular 
components in tissue samples and to examine malignant abnormalities on this basis. As a 
result, the mutations/ biochemical changes in bio-molecules appearing before manifestation 
of disease on a cellular level can be detected earlier, facilitating timely and precise 
diagnosis, leading to increased patient survival and quality of life (Ooi et al., 2008). 
 
2.2 Techniques Currently Used 
Currently, screening for cervical cancer is preliminarily done by the microscopic 
examination of the exfoliated cells of the cervix for cytological abnormalities (Ronco et al., 
2006) and the technique is commonly known as the Papaniculaou test or Pap smear test 
(Papanicolaou and Traut, 1941). An abnormal Pap smear test is followed by the assessment 
of the cervix with a low power light microscope (colposcope) for localised variations in the 
tissue reflectance, a marker for precancerous lesions (Thekkek and Richards-Kortum, 
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2008). Simple agents such as acetic acid and Lugol’s iodine, together with the use of a 
green illumination filter, can enhance the contrast of suspicious regions. Due to the low 
specificity of such a visual examination, the ultimate diagnosis is established by the 
histopathological examination of a punch biopsy or excised specimen (Mitchell et al., 
1998). Infection with the Human Papilloma Virus (HPV) is accepted as a root cause of such 
pathological changes (Richart, 1990). Thus, the identification of abnormalities in exfoliated 
cells (smears) may be followed by screening using the HPV DNA or RNA detection test 
(Cuzick et al., 2008). Currently, HPV testing is being introduced as a primary screening 
tool and an adjunct to cervical cytology for women over 30 years as recommended by 
American society for Colposcopy and Cervical pathology (Wright et al., 2007). The 
recommendations have been updated to address the age-appropriate screening strategies, 
including the use of cytology and HPV testing, follow-up of women after screening which 
includes management of screen positives and screening interval for screen negatives, age at 
which to exit screening, future considerations regarding HPV testing alone as a primary 
screening approach, and screening strategies for women vaccinated against HPV16/18 
infections (Saslow et al., 2012). 
2.2.1 Pap smear test 
In order to determine cytological abnormalities in the cells of the cervix, the Pap smear is 
the test that is used for the preliminary screening of cervical cancer. This is done by the 
microscopic examination of the exfoliated cells of the cervix (Ronco et al., 2006).  
The collection of cells from the squamocolumnar junction and outer opening of the cervix 
of the uterus is done by the use of a cyto brush. The cells are then stained by the 
Papanicolaou technique and are examined under a microscope to look for abnormalities in 
the nucleus and cytoplasm, such as nuclear to cytoplasm size ratio. Increased ratio is linked 
with a severe degree of CIN. Symptomatic changes to the nucleus include (a) increase of 
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nuclear size with difference in shape (common feature of all dysplastic cells), (b) intense 
staining pattern of nucleus, (c) irregular chromatin distribution, (d) uncommon mitotic 
figures and visible nucleoli. 
The proportion of the thickness of the epithelium with mature and differentiated cells is 
used for grading CIN. More severe degrees of CIN may have greater proportion of the 
thickness of epithelium (Sankaranarayanan, 2004). 
 
2.2.1.1 Advantages 
1. The sensitivity and specificity of Papanicolaou test are reported to be 11 to 99 
and 14 to 97% respectively (Boyko, 1996). 
2. The technique is relatively non-invasive. 
2.2.1.2 Disadvantages 
1. Sampling errors may occur and consistent and reliable sampling cannot be 
guaranteed 
2. The technique is subjective and may lead to wrong interpretation.  
 
2.2.2 Human Papillomavirus (HPV) based screening 
A large amount of epidemiology and laboratory based research indicates that infection with 
oncogenic HPV, especially with types 16 and 18, is frequently associated with squamous 
cell carcinoma in the cervix (Woodman et al., January 2007). This link between infection 
with high risk HPV in the lower genital tract and cervical cancer has resulted in the 
development of a HPV DNA or RNA detection system for cervical cancer screening and of 
vaccines against high risk HPV types. There are currently two vaccines available on the 
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market; Gardasil (Merck and Co.) and Cervarix (GlaxoSmithKline). Gardasil provides 
immunity against the two high risk HPV types, 16 and 18, which are associated with the 
development of cervical cancer and two low risk HPV types, 6 and 11, responsible for the 
majority of genital warts and recurrent respiratory papillomatosis. Cervarix claims to 
provide immunity against the two high risk HPV types, 16 and 18 (Madrid-Marina et al., 
2009). 
 
2.2.2.1 DNA based techniques 
Currently, two DNA based tests for HPV detection are approved by the US Food and Drug 
Administration (FDA); Hybrid Capture II (HC II) (Qiagen Gaithersburg, Inc. MD USA) 
and the Hologic Cervista high risk HPV DNA test (Hologic Incorporated, Bedford, MA) 
(Clad et al., 2011). Other DNA based tests available include Roche Amplicor, Roche Linear 
Array and Cobas 4800 (Ovestad et al., 2011). 
Hybrid capture-II has a sensitivity of 93.1% and 95.5% for detecting CIN II and CIN III 
respectively (Dufresne et al., 2011). The detection of a virus in women with transient stages 
of infection may increase the burden of screening of the HPV positive woman, as detection 
of HPV DNA prompts immediate treatment of the lesions, although follow up of these 
lesions suggest that 45.7% of CIN I and 21% of CIN II lesions regress (Insinga et al., 
2009). The technique can be used as a follow up test for women treated for high grade 
lesions with localized treatment such as ablation or excision therapy to identify women who 
have been or have not been cured by their treatment (Cuzick et al., 2008). This technique is 
able to distinguish between high risk and low risk HPV types on the basis of nucleic acid 
hybridization of the bases of the E-1 gene but does not allow the identification of specific 
genotype. 
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Amplicor® is another DNA based HPV test which can target and detect DNA from 13 high 
risk genotypes. This test allows simultaneous PCR amplification of the target DNA from 13 
high risk HPV genotypes (16, 18, 31, 33 35, 39, 45, 51, 52, 56, 58, 59 and 68) and from β-
globin DNA as a cellular control. After PCR amplification, the oligonucleotide probes are 
used to hybridize to the amplified products and they are detected by colorimetric 
determination (Ovestad et al., 2010). 
In the Roche Linear Array test, the biotinylated primers are used to define an approximately 
450-bp sequence within the L1 region of the HPV genome. A pool of primers is used to 
amplify the HPV DNA targets from 37 HPV genotypes (6, 11, 16, 18, 26, 31, 33, 35, 39, 
40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73, 81, 82, 
83, 84, 89 and IS39 (subtype of 82)). It should be noted that the group of 16 high-risk 
genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, 82 and IS39) includes the 
13 genotypes targeted by the Amplicor test. Moreover, groups of possible high-risk (26, 53 
and 66), unclassified (55, 62, 64, 67, 69, 71, 83, 84 and 89) and low-risk (6, 11, 40, 42, 54, 
61, 70, 72 and 81) genotypes can also be detected. The β-globin DNA can be used as a 
cellular control (Ovestad et al., 2010). 
The Cobas 4800 system, another DNA based test for HPV detection, (Roche Molecular 
Diagnostics, Pleasanton, CA, USA) provides fully automated sample preparation combined 
with real-time PCR technology which can amplify and simultaneous detect 14 high risk 
HPV genotypes, identification of HPV 16 and 18 and β-globin used as an internal control 
for sample validity (Ovestad et al., 2011). 
The Hologic Cervista high risk HPV DNA and Cervista HPV 16/18 tests (Third Wave 
Technologies, Madison, WI; now owned by Hologic, Bedford, MA) were approved by the 
US FDA in March 12, 2009. Cervista HPV HR (high risk), for use in cervical cancer 
screening, is a DNA test for 14 carcinogenic HPV genotypes. Cervista HPV 16/18 is 
 53 
approved for the DNA detection of HPV-16 and HPV-18, the 2 most carcinogenic HPV 
types (Kinney et al., 2010). 
 
2.2.2.2 RNA based techniques 
The progression of cervical cancer is dependent on the continuous expression of the E6/E7 
genes of HPV, essential for successful transformation and maintenance of the neoplastic 
phenotypes in cervical carcinoma cells. To detect these genes, on the basis of their mRNA, 
two techniques are available; PreTect HPV Proofer and APTIMA (Clad et al., 2011). 
The PreTect HPV Proofer test is a real time multiplex assay for full length amplification of 
the mRNA of 5 high risk HPV types and is carried out by extraction of the total RNA from 
the samples. 
The APTIMA HPV messenger RNA assay works on the target capture transcription 
mediated amplification of E6/E7 mRNA from 14 high risk HPV types and is able to 
differentiate between these types and identify which HPV type is present as well as which 
are more likely to persist. 
 
2.2.2.2.1 Advantages 
1. HPV DNA detection can be used as a primary screening tool. 
2. It is an adjunctive test to cytology; can be used as a classification tool for the 
management of women with atypical squamous cells abnormalities of undetermined 
significance. 
3. HPV DNA genotyping can be used for the identification of the different types of 
HPV. 
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4. Sensitivity and specificity for detection of high-risk HPV are found to be >92% and 
99% for the APTIMA HPV Assay and 93% and 82% for the HC2 test (Dockter et al., 
2009). 
 
2.2.2.2.2 Disadvantages 
1. HPV testing identifies transient infections which are common in women under 30 
years and hence no important information is provided below this age. 
2. None of these techniques can predict regression of CIN-II and CIN-III. 
 
2.2.3 Colposcopy 
Colposcopy is a technique of visualizing abnormalities in the tissue using light microscopy. 
Contrasting agents such as 3-5% dilute acetic acid, resulting in so-called aceto whitening, 
are used as contrast agents to help differentiate abnormal areas of the tissue from normal. 
Aceto whitening is due to the reversible coagulation of intracellular proteins. An increase in 
intracellular proteins during neoplasia results in a dense white spot (Gaffikin et al., 2003). 
Recognition of well defined areas near to the squamocolumnar junction indicates a positive 
test. The colposcopist extracts biopsies from any abnormal area found and sends them to 
the pathologist for further examination. 
2.2.3.1 Advantages 
1. This is a relatively non-invasive technique. 
2. Detailed and careful examination is possible as the technique provides good 
magnification. 
3. It has sensitivity greater than 90% (Mitchell, 1994). 
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2.2.3.2 Disadvantages 
1. The technique/instrumentation is expensive. 
2. Minor signs may be over interpreted and may lead to wrong decisions. 
3. It has poor specificity (greater than 50%) (Mitchell, 1994). 
4. It is subjective 
2.2.4 Visual inspection with acetic acid (VIA) 
In addition to more advanced techniques, simple visualisation approaches have also been 
investigated to facilitate cervical cancer screening in resource poor settings. For example, 
the use of visual inspection with acetic acid (VIA) is also under study as an alternative to 
the Pap smear and colposcopy in many developing countries (Ekalaksananan et al., 2010, 
Murillo et al., 2010, Aggarwal et al., 2010, Cremer et al., 2010, Ngoma et al., 2010, Nessa 
et al., 2010, Muwonge et al., 2010, Sankaranarayanan et al., 1998, Sankaranarayanan et al., 
2007). VIA involves the examination of the cervix with the naked eye with the help of a 
bright light source after one minute application of contrasting agents such as 3-5% acetic 
acid. A recent review of the performance of VIA in twenty six studies reported 80% 
sensitivity and 92% specificity (Sauvaget et al., 2011).  
2.2.4.1 Advantages 
1. VIA requires minimum support infrastructure. 
2. The patient can be referred immediately for testing. 
2.2.4.2 Disadvantages 
1. It is a subjective technique. 
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2. There is a need to define consistent criteria for the suspicious lesions and to train the 
provider.   
2.2.5 Histopathology 
The examination of the processed tissue samples by a pathologist for diagnosis is called 
histopathology. The processing of the tissue samples includes a series of steps which 
preserves the anatomy of the tissue samples as close as possible to their structure in vivo. 
After taking a biopsy, the tissue samples are passed through different processes which 
include fixation, dehydration, clearing, embedding, section cutting and staining. Tissue 
processing can be done manually or can be automated. After the final step, staining, the 
tissue sections on slides are examined by the pathologist. The diagnosis and grading of CIN 
by a pathologist is done on the basis of histological features including differentiation, 
maturation and stratification of the cells as well as nuclear abnormalities. The samples with 
more severe degrees of CIN are expected to have a higher proportion of the thickness of the 
epithelium composed of undifferentiated cells with only a thin layer of mature, 
differentiated cells on the surface. Nuclear abnormalities, including enlarged nuclei, 
increased nucleus to cytoplasm ratio, increased intensity of stained nuclei as well as 
variation in the size of nuclei are also taken into account (Sellors and Sankaranarayanan, 
2003/4). 
2.2.5.1 Advantages 
1. Exact diagnosis of the severity of the cancer is possible. 
2. The margin line of diseased area can be determined. 
2.2.5.2 Disadvantages 
1. False negative and false positive results may be possible, especially in the case of 
CIN or atypical cells. 
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2. The technique is subjective and interpretation of the results is in the hands of the 
pathologist. 
2.3 New techniques based on optical methods 
There has been a tremendous increase in the development of more complex optical methods 
for the detection and diagnosis of cervical cancer and they are now considered as 
techniques of choice for early detection, because these are fast, can be automated and 
objective with the help of statistical analysis techniques (Chidananda et al., 2006). The 
optical techniques currently under development include confocal microscopy, optical 
coherence tomography, and fluorescence spectroscopy. In the next sections of this chapter, 
these techniques are discussed in detail with a particular focus on the use of these 
techniques in studies related to the detection of cervical cancer along with advantages and 
disadvantages of each technique. 
2.3.1 Confocal Microscopy 
A confocal microscope works on the principle of optical sectioning and is generally 
described as a microscope that collects light coming only from the focal plane. Adjusting 
the focal plane provides different slices for 3D stacks. It allows non-invasive high 
resolution imaging at the cellular level at varying depths of the cervical epithelium. The 
light for detection is created by either fluorescence or reflection. Confocal fluorescence 
microscopy, by probing for fluorophoric metabolites (NADH, FAD), can differentiate 
fluorescence from the cytoplasm and peripheral membrane of the cell. It can also be 
employed to differentiate between different layers of the tissue samples, including basal 
cells from parabasal, intermediate and superficial cells (Pavlova et al., 2003).  
Confocal microscopy, while working on the basis of the reflectance, can visualise the 
indicators of cancer onset and progression, such as morphological changes, nuclear to 
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cytoplasm ratio or irregularity of cell spacing (Carlson et al., 2005, Bazant-Hegemark et al., 
2008). The confocal technique has been applied in vivo to acquire images of the cervical 
epithelium with sub-cellular resolution by using a fibre-bundle confocal reflectance 
microscope (Carlson et al., 2005) in order to differentiate between normal and cervical 
precancers. 
The technique has the following advantages and disadvantages: 
2.3.1.1 Advantages: 
1. It can provide an axial resolution of ≤1µm. 
2. The light for detection is created by either reflection or fluorescence, providing 
double selectivity of target volume. Simple chemicals such as acetic acid can be 
used as contrast agents. 
3. The technique has high sensitivity (100%) and specificity (91%) (Bazant-Hegemark 
et al., 2008). 
2.3.1.2 Disadvantages: 
1. Contrast agents can make the focussing complicated by causing the tissue to swell. 
2. The field of inspection is of the order of a few hundred micrometers. 
3. The penetration depth of modern probes is ~250 µm but can be impaired by the 
presence of scatterers in the overlying tissue (Bazant-Hegemark et al., 2008). 
2.3.2 Optical coherence tomography (OCT) 
Optical coherence tomography (OCT) is an imaging tool which uses the scattering of the 
incident light by the tissue to obtain quantitative information of the microstructural changes 
in the tissue sample. The technique is based on low coherence interferometery which is 
obtained by using typically a near infrared light source and an interferometer and usually its 
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working principal is explained by analogy to ultrasound. The changes in the refractive 
index determine the contrast for the structural features (Bazant-Hegemark et al., 2008). The 
higher resolution of OCT compared to ultrasound is due to the use of light, rather than 
sound or radio waves. The light beam is focussed on the tissue, and a tiny portion of this 
light which is reflected from sub-surface features is collected. It should be noted that most 
light is not reflected but, rather, scatters and loses its original direction and does not 
contribute to forming an image but rather contributes to glare. By using the OCT technique, 
scattered light is filtered out with the help of an interferometer to completely remove the 
glare. Even the very tiny proportion of reflected light that is not scattered can then be 
detected and used to form the image.  
The diagnostic potential of the technique has been shown by different researchers, assessing 
normal and abnormal cancerous tissues (Boppart et al., 1998, Clark et al., 2004, Maitland et 
al., 2008). Endoscopic OCT was used for the first time for the evaluation of cervical 
malignancy (Feldchtein et al., 1998, Sergeev et al., 1997). The intactness of the basement 
membrane has been determined to be a marker for a healthy epithelium, by the evaluation 
of cervical tissue samples from the genital tract of the female, 21 healthy and 11 CIN III 
samples, using OCT (Pitris et al., 1999). In another study of samples including CIN I, CIN 
II/III, it was reported that the thickness of the squamous epithelium varies for healthy 
samples and a healthy epithelium can be used as a marker for an intact basement membrane 
(Escobar et al., 2004, Escobar et al., 2005). 
The technique has following advantages and disadvantages: 
2.3.2.1 Advantages 
1. The technique can show diagnostic capability at a tissue depth of 2-3 mm because it 
uses near IR where tissue is more transparent. 
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2. The technique is non-invasive, as it makes use of near infrared light sources in the 
range of 800-1500nm, at powers that are harmless to skin (Fujimoto et al., 2000). 
3. The interferometric detection is not disturbed by ambient light. 
2.3.2.2 Disadvantages 
1. Although it has sensitivity of 95%, it has a specificity of only 46% for the 
differentiation of precancerous lesions from cancerous lesions of cervical epithelium 
(Gallwas et al., 2010) 
2. The choice of the wavelength of light is limited by the strong absorbers in tissue 
samples, namely melanin (visible range) and water (infrared range). 
3. The light sources to be used need to fulfil the stringent criteria in respect to partial 
coherence, for the interferometric detection. 
4. Low contrast of the technique  
5. Poor spatial resolution and sub-cellular structures or even single cells cannot be 
resolved. 
 
2.3.3 Spectroscopy 
Spectroscopy is defined as the interaction of light with matter in terms of wavelength (λ). 
The three main types of spectroscopy are absorption, emission and scattering spectroscopy. 
Absorption spectroscopy usually entails ultra violet, visible and/or infrared absorption. It 
measures the spectrum of light that a substance absorbs to get information about its 
structure. Emission spectroscopy measures the spectrum of light that a substance emits 
upon excitation e.g. fluorescence and phosphorescence spectroscopy. Scattering 
 61 
spectroscopy is similar to emission spectroscopy but it detects and measures all the 
wavelengths that a substance scatters upon excitation e.g. Raman spectroscopy (Latimer, 
1967). 
2.3.3.1 Fluorescence spectroscopy 
This technique is a form of electromagnetic spectroscopy and utilizes light, usually in the 
UV region of the spectrum, to excite electrons in molecules of specific compounds 
resulting in the emission of light of a lower energy than the incident light, called 
fluorescence, which is measured for the analysis of the samples. 
Fluorescence spectroscopy has been employed to demonstrate the potential of the technique 
for detection of pre-cancers in the cervix (Georgakoudi et al., 2002, Ramanujam et al., 
1996, Zlatkov, 2009). The fluorescence spectra of normal and cancerous tissue samples 
have been studied (Zuluaga et al., 1999, Hubmann et al., 1990, Brookner et al., 1999, 
Grossman et al., 2001, Agrawal et al., 1999, Ramanujam et al., 2001, Ramanujam et al., 
1994) in an effort to establish an optical pathology method for the early detection of cancer. 
By acquiring the laser induced fluorescence spectra from normal and cancerous stage III B 
cervical tissue samples and employing Principal Component Analysis (PCA), (Chidananda 
et al., 2006) have concluded that fluorescence spectroscopy can be used as a technique to 
predict the pathology of samples with high sensitivity and specificity, by performing 
comparisons with the calibration sets of different stages of cervical cancer. 
2.3.3.1.1 Advantages 
1. The technique can provide very specific information as specific molecules will give 
fluorescence at a specific excitation wavelength. 
2. The technique has great sensitivity to changes in the structural and dynamic 
properties of bio molecules. 
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3. The technique has made it possible to identify cellular components with a high 
degree of specificity. 
 
2.3.3.1.2 Disadvantages 
1. Consumables like the fluorescent tags may be required for the samples to be 
studied, which are expensive. 
2. As it uses UV or visible light, Confocal fluorescence spectroscopy has a penetration 
depth of only ~0.1mm. 
 
2.3.4 Vibrational spectroscopy 
During the vibration of a molecule, movements of the bonded atoms towards and away 
from each other occur at a characteristic frequency. By taking the example of a diatomic 
molecule as two spheres of mass m1 and m2 connected by a spring (Hollas, 2004), the 
energy of the system can be related to how much the spring is stretched or compressed. 
According to a classical mechanics approach, the spring obeys Hooke’s law, for which the 
force, F, required to extend the spring is proportional to the displacement from equilibrium 
∆x,  
 
F K X= − ∆                                                        (Equation 2.1) 
 
The proportionality constant is known as the force constant, K.  
The potential energy, E, of the system depends on the square of the displacement from 
equilibrium and is given by: 
( )21
2
E K x= ∆                                     (Equation 2.2) 
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The characteristic frequency is given by: 
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Where, the reduced mass, µ= m1.m2/m1+m2 
 
The frequency of the vibration is proportional to the square root of the ratio of the spring 
force constant to the reduced mass on the spring. The lighter the mass on the spring or 
stronger the spring, the higher the vibrational frequency will be. Similarly, vibrational 
frequencies for stretching bonds in molecules can be related to the strength of the chemical 
bonds and the masses of the bonded atoms. 
It should be noted that the molecules differ from sets of spheres-and-springs in that the 
vibrational frequencies are quantized. That is, only certain energies for the system are 
allowed, and only photons with certain energies can excite molecular vibrations. Moreover, 
the symmetry of the molecule will also decide whether a photon can be absorbed. 
2.3.4.1 Infrared spectroscopy  
Infrared radiation belongs to that part of electromagnetic spectrum that lies between visible 
and microwave region. The infrared region is divided into three regions (near, mid and far 
infrared) according to its distance from the visible region in the electromagnetic spectrum, 
as illustrated in Table 2.1. 
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Region Wavelength 
range(λ,µm) 
Wavenumber 
range(λ, cm-1) 
Energy (E) 
(Kcal/mol) 
Near                                     0.78-3                  12820-4000                  10-37 
Middle                                 3-30                     4000-400                      1-10 
Far                                       30-300                 400-33                          0.1-1 
 
Table 2.1 Regions of the IR spectrum in commonly employed units. 
 
Frequency (ν) is defined as the number of wave cycles that pass through a point in one 
second. The unit for the frequency is Hz. 1 Hz = 1 cycle/second. The length of one wave 
cycle is defined as the wavelength (λ) and is measured in microns (µm). Wavelength and 
frequency are inversely related:  
 
ν=c/λ                                                                                (Equation 2.4) 
 
Infrared (IR) spectroscopy is based on the absorption of infrared radiation by the sample 
under study and the fact that molecules absorb specific frequencies of the incident light 
which are characteristic of their structure.  
IR spectroscopy optically probes the molecular vibrations that depend on the composition 
and structure of the material under study. Infrared light is used to irradiate the sample and 
changes in the vibration induced are recorded. Disease and other pathological conditions 
lead to changes in structure and chemical composition. These changes produce alterations 
in the vibrational spectra that can be used as sensitive phenotypic marker of disease  (Krafft 
et al., 2008b). Near or mid infra red light sources give the best contrast for medical 
applications.  
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There may be many vibrations in a molecule, for molecules with N atoms, linear molecules 
have 3N–5 degrees of vibrational modes, whereas nonlinear molecules have 3N–6 degrees 
of vibrational modes. A vibration can be "IR active," only if it is associated with changes in 
the permanent dipole. 
FTIR (Fourier Transform Infra red) spectroscopy is a measurement technique for the 
acquisition of infrared spectra. Frequency differentiation is performed with an 
interferometer. After passing through the sample, the measured signal is the interferogram. 
The mathematical Fourier Transform of this signal produces a spectrum similar to that from 
conventional (dispersive) infrared spectroscopy (Gremlich and Yan, 2001). 
The use of FTIR spectroscopy for cervical cancer diagnosis has been demonstrated by 
studying the exfoliated cells from 156 samples from female patients (Wong et al., 1991) 
and differentiating them into normal, dysplastic and malignant. The cancerous progression 
and normal proliferation has been associated with glycogen reduction, increased hydrogen 
bonding from phosphodiester groups and reduced hydrogen bonding in alcoholic groups of 
the amino acids. 
Analysis of FT-IR spectra of over 2,000 individual cells from 10 normal females, 7 females 
with dysplasia, and 5 females with squamous cell carcinoma has revealed that the spectra of 
normal-appearing intermediate and superficial cells of the cervix obtained from women 
with either dysplasia or cancer are different from those of normal women. It is reported that 
the structural changes underlying the spectroscopic variations may be more representative 
of the state of the disease than the morphological changes (Cohenford and Rigas, 1998). 
This information strongly supports the potential of FTIR spectroscopy for the diagnosis of 
cervical cancer. As cervical cells mature from basal to parabasal, intermediate, and then 
superficial cells, an increase of glycogen content is reported (Koss, 1992). This normal 
progression is disrupted in diseased tissue and hence can be used as a diagnostic marker for 
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cervical cancer by FTIR spectroscopy. Moreover, changes in the levels of biomolecules 
including RNA, DNA can also be helpful for diagnostic purposes (Mordechai et al., 2004). 
The infrared spectroscopy has been employed for the analysis of Pap smear cells and an 
algorithm is developed called the PapMap to process the imaging data which is reported to 
lead towards the automation of the screening process (Schubert et al., 2010). 
 
2.3.4.1.1 Advantages 
 
1. Larger sample area can be scanned in less time as compared to Raman spectroscopy 
(see section 2.3.2.3.5). 
2. Spatial resolution is ≥ 10 µm. 
3. Possibility to measure the secondary structure of protein non- invasively in a native 
environment. 
4. Same samples can be used for further studies. 
5. No interference from fluorescence of biological sample during measurements. 
 
2.3.4.1.2 Disadvantages  
 
1. The interference from water at 1640cm-1 overlaps IR absorbance of protein. Modern 
FT-IR instrument and software can overcome this problem to a great extent. 
2. There is strong interference from glass. There is need for alternative materials that 
do not interfere during IR spectroscopy to be used as substrates for biological 
samples. 
3. It needs good data analysis techniques to acquire useful and meaningful information 
from the spectral data. 
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2.3.4.2 Raman Spectroscopy 
The working principal of Raman spectroscopy is based on a scattering phenomenon. 
Scattering results from the interaction between the photons and materials, such as 
molecules. As shown schematically in Figure 2.1, most photons colliding with molecules 
do not change their energy after collision. These collisions are called elastic collisions and 
the result of these collisions is elastic scattering called Rayleigh scattering. Rayleigh 
scattering is a two photon process as a result of which there may be a change in direction of 
light but no net change in frequency. 
 
Figure 2.1 Schematic presentation of Rayleigh and Raman scattering of incident light. 
(http://en.wikipedia.org/wiki/Raman_spectroscopy) 
 
On the other hand, inelastic collisions, after which the incident photons change their 
energy, lead to inelastic scattering during which exchange of vibrational energy occurs. The 
process is defined as Raman scattering. Raman scattering is also a two photon process by 
which a change in the energy of the colliding photon occurs from hνo to hνo ± hνs where νo  
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is the incident photon frequency, νs is the frequency of the scattering vibration and h is 
Planck’s constant. 
For a molecular vibration to be Raman active, the net molecular polarizability must be 
changed. The polarizability (α) represents the ability of an applied electric field, E, to 
induce a dipole moment, µ0, in an atom or molecule. This process is represented 
mathematically by the equations below (Ball, 2001): 
o Eµ α=                                                                         (Equation 2.5) 
 
At the molecule’s equilibrium nuclear geometry, the polarizability has a value, α0. At some 
displacement, ∆r, away from the molecule’s equilibrium geometry, the instantaneous 
polarization α is given by: 
o r
r
α
α α
∂ 
= + ∆ ∂ 
                                                         (Equation 2.6) 
 
where the derivative 
r
α∂ 
 ∂ 
 represents the change in polarizability as a function of 
displacement. If the molecule is vibrating in a sinusoidal fashion, ∆r can be written as some 
sinusoidal (that is, sine- or cosine-based) function in terms of the frequency of the 
vibration, νs, and the time, t: 
 
max cos(2 )sr r tpiυ=                                                          (Equation 2.7) 
 
where rmax is the maximum vibrational amplitude. Light that has a particular frequency, νo, 
has an associated electric field, E, that also has sinusoidal behavior: 
 
( )max 0cos 2E E v tpi=                (Equation 2.8) 
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Here, Emax is the maximum electric field frequency. Equations 2.6, 2.7 and 2.8 can be 
substituted for α, ∆r and E, respectively, into equation 2.5 to get: 
 
0 0 max 0 max max 0cos(2 ) cos(2 )cos(2 )s
dE t E r t t
dr
αµ α piυ piυ piυ = +  
 
                 (Equation 2.9) 
 
To get a relationship for a product of two cosines, which is what the second term in 
equation 2.9, is: 
( ) ( ) ( ) ( )1cos cos cos cos
2
a b a b a b × = + + −                             (Equation 2.10) 
 
In comparing equations 2.9 and 2.10, it can be seen that a is 2piνot and b is 2piνst. 
Substituting for the product of the two cosines in equation 2.10, gives the following: 
( ) ( )( ) ( )( )max maxmax cos 2 cos 2 cos 22o o o o s o s
E rE v t t v v t v v
r
αµ α pi pi pi∂ = + + + − ∂ 
           
(Equation 2.11) 
 
The oscillating polarization reradiates light at the same frequency and thus the scattered 
light has components of the frequencies represented in Equation 2.10. By analyzing the 
terms in equation 2.10, it can be seen what they imply. The first term contains the variable 
νin, which is the frequency of the incoming light. This term relates to the outgoing, scattered 
photon that has the same frequency as the incoming photon. That is, this term ultimately 
explains Rayleigh scattering. The second term contains two cosines. One contains the 
variable νin+ν, which relates to an outgoing, scattered photon that has increased in 
frequency by some amount, ν, which is the frequency of the molecular vibration. The 
associated increase in energy is the result of the annihilation of a quantum of vibration of 
energy hν. The last cosine term contains the variable νin-ν, which relates to a scattered 
photon that has decreased its frequency by the same amount, ν. The decrease in energy is 
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the result of the creation of a quantum of vibration of energy hν. These two terms 
ultimately explain Raman scattering. The two terms show that incoming photons will shift 
their frequencies, up and down, by amounts equal to the vibrational frequencies of the 
molecule. This is the basis of Raman spectroscopy. 
At ambient temperature, most of the molecules are in their vibrational ground state. 
According to Boltzman, a much smaller number of molecules are in a vibrationally excited 
state. Therefore, the chances for a Raman interaction which transfer vibrational energy to a 
molecule and leave a quantum of lower energy hνo–hνs are much higher than an interaction 
which leaves a quantum of higher energy hνo+hνs. In 1852, while studying fluorescence 
spectra, Stokes postulated that the wavelength of light produced by phosphorescence or 
fluorescence is always longer than that of the exciting light. By association, Raman 
scattering processes are referred to as Stokes, resulting in quanta of lower energy, or anti-
Stokes resulting in quanta of higher energy (Ball, 2001, Schrader, 1995). At room 
temperature, as most of the molecules are generally in the ground vibrational state, Stokes 
Raman scattering most commonly occurs and is usually measured. 
 
The Raman shift of the photon energy is a measure of the energy of vibration of the 
molecule. A complex molecule will have many vibrational modes, and the intensity of the 
scattered radiation versus Raman shift gives a Raman spectrum which is characteristic for 
each individual substance and for this reason, Raman spectral features can be the 
identification markers of a substance and can be used to analyse its structure (Sasic, 2008). 
 
Studies ranging from pure biological molecules in isolation to all aspects of the human 
body have been a matter of strong interest in the field of spectroscopy of bio-molecules. 
FTIR Spectroscopy was used to study human and animal tissues (Blout and Mellors, 1949) 
 71 
and Woernely, 1952. Due to the lack of well established instrumentation at that time, 
researchers who attempted to record the Raman spectra of such samples were facing 
problems of overwhelming fluorescence from biological molecules, long integration times 
and high power density requirements. Important developments in the field of diode lasers 
and charged coupled device (CCD) cameras in 1969 (Boyle and Smith, 1970) finally made 
it possible to record high quality Raman spectra of biological samples in 1970s (Lord and 
Yu, 1970). Vibrational Spectroscopy has emerged as a major tool for biochemical 
applications as it is able to provide direct information regarding the molecular constituents 
of tissue samples at the cellular level. 
 
There has been extensive use of Raman spectroscopy for various applications including 
studies made on biological tissue. These include bone (Rehman et al., 1995), cornea (Kachi 
et al., 2000), epithelial tissue including the larynx, tonsil, oesophagus, stomach, bladder and 
prostate (Stone et al., 2002, Stone et al., 2004, Keller et al., 2008), lung (Notingher et al., 
2003, Huang et al., 2003a, Huang et al., 2003b, Kaminaka et al., 2001, Min et al., 2005, 
Krafft et al., 2008a, Liu et al., 2005, Qian et al., 2008, Short et al., 2008, Bonnier et al., 
2010a). The technique has also been applied to study the composition of lymphocytes 
(Puppels et al., 1993), human red blood cells (Deng et al., 2005) as well as to differentiate 
between different types of cells including mixed cancer cells (Krishna et al., 2005), human 
living cells (Kuhnert and Thumser, 2004), individual cells (Chan et al., 2006). In addition, 
it has been employed to study different biological/macromolecules including DNA (Ruiz-
Chica et al., 2004), bodily fluids such as saliva (Farquharson et al., 2005b, Farquharson et 
al., 2005a), tissue processing (O Faolain et al., 2005), and raft cultures (Viehoever et al., 
2003).  
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The use of Raman spectroscopy to distinguish cervical cancer from normal tissue was first 
reported in 1992 (Liu et al., 1992). Three significant peaks at 1262 ,1445 and 1657 cm-1 
were consistently observed in all gynaecologic tissues studied using FTIR and Raman 
spectroscopy and it was observed that the intensity ratio of 1445/1657 cm-1 could be used to 
differentiate between normal and malignant cervical tissue samples. The intensity ratio of 
1445 and 1657 cm-1 was found to be higher in normal tissue samples (Liu et al., 1992). 
Resonance Raman spectroscopy, using a 254 nm laser, was used to differentiate between 
malignant and normal cells of the cervix and the breast (Yazdi et al., 1999). Differentiation 
was possible due to changes detected in the peak ratios of different nucleic acid contents in 
normal and tumour cells. Changes in the vibrational structure of nucleic acids associated 
with the malignant phenotype of the cell were also detected. The peak ratio 1480/1614 cm-1 
was found to have a higher value in malignant samples and lower for normal samples 
(Yazdi et al., 1999). 
Spectra obtained from human cervical tissue in vitro, using a NIR Raman spectroscopic 
probe could differentiate between normal and precancerous tissues with a sensitivity of 
82% and specificity of 92% (Mahadevan-Jansen et al., 1998). An increase in ratio of 
intensities at 1454 to 1656 cm-1 and decrease in ratio of intensities at 1330 to 1454 cm-1 was 
used to separate the cervical dysplasia from normal tissue types in vivo (Utzinger et al., 
2001). DNA, phospholipids and collagen were identified as diagnostically significant 
(Utzinger et al., 2001). The analysis of distinctive peaks and fingerprint region agrees with 
the portrait provided by infrared spectroscopy i.e. basal cells have characteristic bands of 
DNA, epithelial cells show high level of glycogen in normal cells (Wong et al., 1991). A 
statistical method that combines the method of maximum representation and discrimination 
feature (MRDF) and sparse multinomial logistic regression (SMLR) was developed for 
multiclass analysis of Raman spectra. Application of this method and incorporation of 
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patient hormonal status increased the sensitivity to 98%, specificity to 96% and accuracy to 
94% (Kanter et al., 2009a, Kanter et al., 2009b). Four different cell lines, HPV negative 
C33A, HPV 18 positive HeLa which has 20-50 integrated copies of HPV per cell, HPV 16 
positive SiHa with 1-2 HPV copies per cell and CaSki with 60 -600 integrated copies of 
HPV per cell, were studied using Raman and FTIR spectroscopy. Principal component 
analysis (PCA) clearly differentiated the C33A, SiHa group from HeLa and CaSki group 
(Ostrowska et al., 2010). A recent study of de-paraffinized cervical tissue with Raman 
mapping and hierarchical cluster analysis (HCA) was able to differentiate between normal 
squamous epithelium and cervical intraepithelial neoplasia (Tan et al., 2011).  
In the next section, FTIR and Raman mapping of tissue sections from cervical tissue 
biopsies is described.  
 
2.3.4.2.1 Advantages of the technique 
 
1. This is non-destructive technique; the sample is not damaged during the analysis by 
this technique and can be used again. 
2. The technique is fast, about 1 min. per acquisition is required. 
3. It is non-invasive method. 
4. There is minimal interference from water and CO2. 
5. No labelling is required during the use of this technique. 
6. In vivo and real time measurement from the biological systems are possible. 
 
2.3.4.2.2 Disadvantages of the technique 
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1. High laser intensities are required because the Raman scattering is a relatively 
weak phenomenon and thus the equipment cost can be quite high depending on 
their applications. 
2. The technique, generally, is less sensitive for quantitative analysis as compared 
to chromatographic techniques like HPLC. 
3. It needs good data analysis techniques to acquire useful and meaningful 
information from the Raman spectra. 
 
2.4 Conclusion 
 
Different techniques currently in use for research or clinical purposes for the screening of 
cervical cancer have been introduced in this chapter. These techniques, Pap smear, 
colposcopy, HPV DNA/RNA based techniques, VIA, histological examination, confocal 
microscopy, optical coherence tomography and vibrational spectroscopy are discussed 
along with their advantages and disadvantages, with particular focus on vibrational 
spectroscopy. 
 
In the next chapter, the use of the FTIR and Raman micro spectroscopy is initially 
demonstrated and the spectral data acquired by using these techniques is compared to 
choose the best technique for further analysis. Moreover, the optimisation of different 
parameters, for the chosen technique to perform the spectral mapping, including dewaxing 
agent, laser line selection, substrate, objective lens and thickness of the cervical tissue 
sections is presented. 
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Chapter 3 
Optimisation of vibrational spectroscopy for cervical tissue Imaging 
 
As described in Chapter 2, one of the several advantages of FTIR and Raman spectroscopy 
is the ability of the techniques to provide information about the biochemical composition of 
biological specimens with little or no sample preparation. In the current study, both 
techniques have been demonstrated for the imaging of cervical tissue section and compared 
to choose the best one for further analysis.  
 
3.1 Comparison of FTIR and Raman spectral mapping of cervical tissue sections 
 
For this study, two parallel tissue sections from a FFPP cervical tissue block were cut, one 
used for H&E staining and other for FTIR and Raman spectral mapping. 
For H&E staining, first of all the tissue section was dewaxed using xylene and then stained 
in Harris’ haematoxylin for five minutes, and then washed in running tap water for three 
minutes. After washing, the sample was differentiated in 1% acid alcohol for 1 or 2 
seconds. The cellular nuclei should be blue and the background should be clear when 
observed under the light microscope. This was followed by staining in 1% Eosin for one 
minute and then rinsing well in tap water. The sample was dehydrated by dipping three 
times in methylated spirit followed two baths of absolute alcohol for three and two minutes 
respectively and then two baths of histoclear for four and five minutes respectively. Finally, 
the stained tissue section was mounted with glass cover slip using DPX mounting medium. 
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The stained tissue section was used as a morphological standard to identify abnormal and 
normal epithelium against the unstained tissue sections. 
 
3.1.1 FTIR Data acquisition 
FTIR images were recorded using a Perkin Elmer Spotlight 400N FTIR imaging system, 
incorporating a liquid nitrogen cooled mercury cadmium telluride 16x1, 6.25µm pixel array 
detector, and were acquired by the Spectral Image software . The FTIR image from 
dewaxed cervical tissue section mounted on a CaF2 slide was recorded over the range 4000-
800 cm-1 in transmittance mode with a resolution of 4 cm-1 and interferometer speed of 
1.0cm-1/second at continuously varying magnification. The scans per pixel for back ground 
were 120 and, for images, 16 per pixel respectively. 
3.1.2 Raman Data acquisition 
Raman maps were recorded using a HORIBA Jobin Yvon HR 800 Raman microscope 
(LabSpec V5.58) with a 785 nm laser as source. The X100 dry objective was used to focus 
on the sample and collect the Raman scattered light in a backscattering geometry. Raman 
scattering was collected through a 100 µm confocal hole onto a Synapse air-cooled CCD 
detector for the range of 400-1800 cm-1 using a 300 Gr/mm diffraction grating. The 
instrument was calibrated using the 520.7 cm-1 peak of silicon. Raman spectral mapping 
was done using 15 seconds x2 acquisition with a step size of 18µm. 
 
3.1.3 Data pre-processing of FTIR and Raman maps  
 
For the FTIR spectra, the correction to atmospheric CO2 absorption bands in the spectra 
was done by a built in function of Perkin Elmer Spotlight software. All data processing 
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(FTIR and Raman spectral data) was done directly on the spectral image using MatLab 7.2 
and the protocols which have been established in the Dublin Institute of Technology (DIT) 
based on the internationally recognized methods (Kniefe, 2010). Data pre-processing 
included smoothing, baseline correction and normalization. All spectra, including 
calibration and substrate backgrounds, were vector normalized and smoothed using a 
Savitzky Golay smoothing method. A rubber band correction for baseline removal for all 
the spectra was carried out and the substrate spectra were subtracted from each spectrum. 
This has been demonstrated by presenting the raw Raman spectral data and the processed 
data in Figure 3.1 and 3.2 respectively. 
 
Figure 3.1 Raw Raman spectral data of basal-true normal cervical tissue sample. 
 
All the data sets have been processed by using the same protocols and there is no 
manipulation of the data done which could potentially contribute to the changes in the 
Raman spectra and into the results of the PCA loading and KMCA. For example, the vector 
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normalisation of the spectra, in fact removes the intensity variation of different peaks (if it 
exists) and all the data would reflect only the changes associated with the changes 
occurring as a result of the disease progression. 
 
 
 
Figure 3.2 Processed Raman spectral data of basal-true normal cervical tissue sample. 
 
 
3.1.4 Data analysis 
 
K-means cluster analysis (KMCA) and Principal Component analysis (PCA) were used to 
analyse the spectral data sets obtained from the FTIR and Raman maps. The results of the 
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KMCA for the initial study are presented in the current chapter and some detailed analysis 
in chapter 4 and those of the PCA in the chapter 5. 
KMCA is an unsupervised non hierarchical method of clustering the cases randomly into 
user predefined clusters and cycles until a local minimum is found by using the Euclidean 
sum of squares as a descriptor (Wang and Mizaikoff, 2008). The false colour map 
generated then shows the clusters with similar spectral and hence biological properties. 
 
Principal component analysis (PCA) consists of a mathematical procedure involving the 
transformation of possibly correlated variables into a smaller number of uncorrelated 
variables known as principal components (PC). The first principal component accounts for 
as much variability in the data as possible, and each succeeding principal component 
accounts for as much of the remaining variability as possible. The loadings of the PC can 
describe the biochemical differences which are used by the PCA to determine the 
variability in the Raman spectral data and hence separation of different groups of spectra. 
PCA was developed in 1901 by Karl Pearson (Pearson, 1901). Now it is mostly used as a 
tool in exploratory data analysis and for making predictive models. PCA involves the 
calculation of the eigenvalue decomposition of a data matrix, usually after mean centering 
the data for each attribute. The results of a PCA are usually discussed in terms of 
component scores and loadings (Martens and Naes, 1994). The PCA results are presented 
as loadings and the scatter plot. The first principal component accounts for as much 
variability in the data as possible, and each succeeding principal component accounts for as 
much of the remaining variability as possible. A PCA scatter plot is used to group and 
differentiate datasets according to their similarities and differences, based on the identified 
principle components. The weightings, or “loadings”, of the principle components represent 
the spectral profile which is responsible for the grouping and differentiation of the datasets. 
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The loadings of the PC can therefore describe the biochemical differences which are used 
by the PCA to determine the variability in the Raman spectral data and hence separation of 
different groups of spectra. 
 
3.1.5 Results of FTIR and Raman spectral mapping of cervical tissue sections 
Figure 3.3 a, shows a H&E stained cervical tissue section, the red box indicating the area 
from where Raman and FTIR maps are acquired. The tissue region has been diagnosed as 
normal by the histopathology department of the Coombe Women and Children’s Hospital, 
Dublin. Figure 3.3 b and 3.3 d show the optical images of the parallel unstained tissue 
section as viewed by the FTIR and Raman micro spectrometer. KMCA of the FTIR and 
Raman maps of the same sample are shown in Figure 3.3 c and Figure 3.3 e, respectively. 
KMCA of the FTIR image divides the map into four parts, indicated by blue and brown and 
orange clusters representing stroma, basal and substrate respectively while green and mid 
blue, both associated to the superficial layer. 
 
 
 
 
 
 
 
 
 
Figure 3.3 H&E stained cervical epithelium (a) unstained tissue under FTIR spectroscope 
(b) Five cluster KMCA map generated from the FTIR map (c) unstained tissue under 
Raman spectroscope (d) Five cluster KMCA map generated from the Raman map (e). 
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Figure 3.4 shows the mean spectra for the five K-means clusters in the FTIR map. The 
specific vibrational modes are labelled with solid lines. The bands at 1028, 1080 and 1152 
cm-1 are assigned to glycogen and are only observed in the superficial layer (green and mid 
blue). These bands are absent in the stroma (blue). This is understandable, as no glycogen is 
expected in this layer (Chowdhury and Chowdhury, 1981). The FTIR feature at 1236 cm-1 
can be assigned to the asymmetric stretching of the O-P-O of DNA/RNA in the basal layer 
(brown) and for collagen proteins in the stroma (blue) (Andrus and Strickland, 1998). This 
FTIR band is present in both these layers. The stromal layer is mainly composed of 
fibroblasts that are rich in collagen and the basal layer contains more dividing cells which 
leads to a greater concentration of DNA and hence this band is more prominent in these 
layers. 
The bands at 1402 and 1454 cm-1 can be assigned to the CH deformation
 
modes of 
carbohydrates (glycogen) (Dovbeshko et al., 2000, Wood et al., 1998). These FTIR bands 
are dominant in the squamous epithelium (green and mid blue spectra) as expected. The 
difference between green and mid blue is only in the intensity/concentration of glycogen, 
but otherwise they give the same biochemical information. 
The features of the FTIR spectra at 1654 cm-1 (amide-I) and 1546 cm-1 (amide-II), both 
assigned to proteins, are present in all three layers, but their intensity seems to decrease 
from epithelial, to stroma and to superficial layers respectively. In the epithelial layer, these 
bands are probably due to the proteins which are also present inside the nucleus where 
required for folding of the DNA and are almost always seen in any spectra taken from the 
cells and tissues. The band at 2300 cm-1 cannot be assigned to any biological feature and is 
probably due to the incomplete atmospheric correction, therefore assumed to be spectral 
artefacts. The sharp FTIR bands at 2848, 2916 and 2956 cm-1 are due to the lipids (Fabian 
et al., 1995, Huleihel et al., 2002). 
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The KMCA of the FTIR map shows the separation of cervical epithelium into three distinct 
layers, but the analysis of the mean representative spectrum of each cluster does not 
elucidate the biological differences underlying this separation. As the FTIR marker bands 
for DNA (basal layer) and collagen (stromal layer) at ~ 1236 cm-1 are not resolved, so there 
is no band to differentiate between these two layers. 
 
KMCA of the Raman map is shown in Figure 3.3 e. The mid blue cluster corresponds to 
the substrate. The KMCA Raman map differentiates the tissue section into stroma (blue), 
with characteristic Raman bands of collagen including 849 cm-1, 921 cm-1, 938 cm-1 and 
1245 cm-1, basal (green) with Raman bands for DNA bases, thymine (755 cm-1), adenine 
(722cm-1) and cytosine (782 cm-1) and superficial layers (orange and brown) with Raman 
bands of glycogen at 480, 849 and 938 cm-1, as shown in Figure 3.5.  
The layer differentiating bands for the mean spectra of FTIR map were limited to those at 
1028, 1080 and 1152 cm-1, related to glycogen, and 1236 cm-1 related to asymmetric 
stretching of the O-P-O of DNA/RNA and amide III mainly due to collagen. However, in 
the case of Raman spectroscopy, there are distinctly resolved bands for collagen, DNA 
bases and glycogen. It should be noted that these bands related to DNA were not observed 
in the FTIR spectra of this sample. Thus, a comparison of Figure 3.4 and Figure 3.5 
indicates the rationale for preference of Raman micro spectroscopy over FTIR for the 
current studies. Moreover, the spatial resolution of Raman spectroscopy is less than 1µm 
while FTIR is~5-10 µm, offering the prospect of investigations at sub cellular level. 
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Figure 3.4 K-means cluster spectra for the FTIR map, blue cluster corresponding to stroma, 
brown to basal layer, green and mid blue colours to superficial epithelium and orange 
representing substrate of region in figure 3.3 c. 
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Figure 3.5 Mean Raman spectra from KMCA of Raman map, blue cluster corresponding to 
stroma, green to basal layer, brown and orange colours to superficial epithelium from 
region in figure 3.3 e. 
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Regarding the sample preparation and measurement conditions, there are certain parameters 
that need to be optimized, however. In the case of FFPP tissue sections, these include the 
dewaxing protocol, the thickness of the section cut from the block, the substrate for the 
adhesion of the tissue sections, the laser wavelength and the objective lens used to focus the 
laser and collect the Raman signals. 
 
3.2 Optimisation of the parameters for Raman spectral Imaging 
3.2.1 Introduction 
Vibrational spectroscopy is a very sensitive technique and so precise sample preparation is 
a pre-requisite in order to acquire reproducible results and for standardisation between 
laboratories. The major advantage of this technique is that of minimal sample preparation. 
However, depending on the experimental set-up and the origin of the tissue, sample 
processing is often required. For the Raman analysis of ex-vivo specimens, the samples can 
be either snap frozen, transferred to an optimal cutting temperature (OCT) medium or 
formalin fixed and embedded in paraffin, in order to maintain the biochemical state of the 
tissue samples (Salzer and Siesler, 2009). Formalin helps to preserve the sample and 
paraffin serves as a support medium to cut thin tissue sections using a microtome. For the 
optical pre evaluation and selection of the sampling area, a parallel section can be prepared 
on a standard glass slide, H&E stained and analysed. Samples must be fixed and 
dehydrated, before embedding in paraffin, followed by cutting the sections. After 
sectioning, the paraffin must be removed by the use of an organic solvent such as xylene, 
hexane or cyclohexane for H&E staining, and for spectroscopic investigation, the paraffin 
itself can give strong spectroscopic signatures (Faolain et al., 2005, Salzer and Siesler, 
2009). 
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The above mentioned sample processing steps may affect the biochemical composition of 
the tissue samples, e.g. lipids of the sample may dissolve in the organic solvents used for 
dewaxing, or protein can be denatured due to the high temperatures of 45ºC and 60ºC 
during section cutting or embedding. However, variations in the effects, if any, of the 
processing to the Raman spectral profiles can be minimised by keeping the heating 
temperature and time constant, and adopting a standardised processing protocol throughout 
the study (Salzer and Siesler, 2009). 
Although, it has already been demonstrated that dewaxing in hexane for 18 hours is the 
most efficient procedure for removal of the paraffin from tissue sections (O Faolain et al., 
2004), it was required during the present study to compare this protocol with the standard 
histopathology laboratory procedure for dewaxing in xylene. It was considered important 
for this study to be consistent with procedures used by the pathologist in the hospital. 
3.2.2 Raman Spectral acquisition  
The details of the Raman spectral acquisition have already been provided in (section 3.1.2). 
It should be noted that, for fresh tissue sections, Raman spectral acquisition was done by 
using an X50 long working distance objective lens. Spectral quality was monitored by 
observing the amide I peak and comparing it with spectral features of pure paraffin wax and 
solvents used to remove the wax. 
3.2.3 Raman spectra of the wax and marking ink 
Although, wax is expected to be removed completely after dewaxing the tissue samples 
with the suitable dewaxing agent, there may remain some residual wax which can 
contribute to the tissue spectra. The ink which is used by the pathologist to mark the tissue 
samples can also contribute to the Raman spectra of the sample of interest. The Raman 
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spectra of pure wax and marking ink are presented in Figure 3.6 and Figure 3.7, 
respectively, for reference. 
 
Figure 3.6 Raman spectrum of pure wax. 
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Figure 3.7 Raman spectrum of pure marking ink. 
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3.2.4 Selection of suitable tissue for optimisation study 
Initially, Raman spectra were acquired from fresh liver, oesophagus and skin tissues of rat, 
to determine the tissue section that would be most suitable for the optimisation studies i.e. 
producing Raman spectra with low fluorescence / scattering or background noise and 
matching with the spectra of cervix. Raman spectra from the fresh tissue of rat kidney, liver 
oesophagus and skin are compared with a Raman spectrum from dewaxed cervical tissue in 
Figure 3.8. Skin was found to be the optimal tissue as it produced good quality spectra in 
terms of low background and similarity to the spectrum of cervical tissue. The dewaxing 
protocol was therefore examined using rat skin as the experimental specimen. The selection 
of the dewaxing agent can be done on the basis of the general rule which is “like dissolves 
like” (Burke, 1984). As wax is non-polar, so the solvent required for its removal from the 
tissue samples should be non-polar. Xylene and histolene are commonly employed in 
hospitals and for consistency with hospital protocols, for the current study, these two agents 
were included in addition to hexane, cyclohexane, ether and dishwashing liquid. With the 
exception of the dishwashing liquid, all these compounds are non polar and therefore 
should show very good solubility for paraffin wax, although they vary in performance. 
Their ability to dissolve the wax can be related to the Hildbrand solubility parameter value 
of the solvent (Barton, 1983). This value increases in the sequence hexane, ether, 
cyclohexane, xylene to histolene. It should be noted that hexane has already been proven to 
be very useful for such application (O Faolain et al., 2004) and xylene is in use in hospitals. 
On considering the solvency behaviour of these two, the other compounds including ether 
and cyclohexane lie between the above mentioned already in use dewaxing agents and the 
rationale for their selection for the current study is that they could also potentially behave as 
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dewaxing agents as their Hildebrand solubility parameter values lie between the hexane and 
xylene. Moreover, dishwashing liquid was selected because of its degreasing ability.  
 
Figure 3.8 The Raman spectra of different organs of the rat compared with one from the 
cervical tissue section. 
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3.2.5 Sample preparation-fixation, waxing and section cutting, 
The rat skin tissue was fixed in formalin, dehydrated through various grades of alcohol and 
embedded in paraffin using in house facilities. A microtome (Leica RM 2135) was used to 
cut the sections and these were mounted onto quartz slides. These sections were dewaxed 
using (a) ether; (b) cyclohexane; (c) xylene; (d) histolene; (e) hexane; (f) 1.7% solution of 
dishwashing liquid. The tissue sections were immersed in two baths of dewaxing solvent 
for 5 and 4 minutes followed by two baths of ethyl alcohol for 3 and 2 minutes and one bath 
of methylated sprit. Dewaxing solvents were used to immerse the tissue sections for a 
further 18 hours to remove any remaining wax. In the case of the dishwashing liquid 
solution, tissues were washed in two baths of soap solution at 90ºC for one minute each and 
then twice washed in distilled water at 90ºC and once at 45ºC for 30 seconds. After soaking 
in distilled water at room temperature, the tissue sections were oven dried for 5 minutes at 
60ºC. Raman spectra were acquired from formalin fixed and paraffin preserved (FFPP) 
fresh rat skin tissue samples dewaxed in the above mentioned solvents.  
3.2.6 Results and Discussion 
Figure 3.9 shows the spectra from a fresh tissue section and from a piece of bulk tissue 
from the rat skin. The most prominent Raman bands are labelled and include phenylalanine 
(1005 cm-1), lipids (1451 cm-1) and amide-I (1670 cm-1), amide-III (1273 cm-1). The Raman 
spectra from the fresh piece of skin are noisy due to the scattering of the laser from the 
uneven surface of the tissue (Bonnier et al., 2011). The Raman spectrum from the fresh 
tissue section has more defined Amide I, phenylalanine and lipid bands. Due to this reason, 
the fresh rat skin “section” was selected for the comparison to dewaxed skin tissue sections 
in this chapter. 
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Figure 3.9 Raman spectra of rat skin tissue piece and tissue section. 
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A comparison of the spectra of the rat skin tissue section with the spectra obtained from rat 
skin after formalin fixation, paraffin preservation and dewaxing in different solvents is 
presented in Figure 3.10. The dishwashing liquid results in the inefficient removal of wax 
and Raman spectra have paraffin bands at 1061, 1131, 1293 cm-1 and 1439 cm-1. In the case 
of cyclohexane, the bands present at 787 and 802 cm-1 in the Raman spectra can be 
assigned to cyclohexane itself and thus overall spectral quality was compromised due to 
these bands. The use of ether did not appear to be suitable as a dewaxing agent as it 
interfered with the proteins in the tissue section and resulted in the deformation of amide I 
band. The Raman bands of the amide I and phenylalanine were not as sharp when 
compared with the spectra obtained after dewaxing in hexane or xylene. The xylene and 
hexane were determined to be good dewaxing solvents. Histolene did not show any better 
dewaxing than xylene, most probably because Histolene is 80% xylene in composition. 
From these observations, it can be concluded that xylene can be adopted as solvent of 
choice to keep the protocol consistent with the one used in the hospital histopathology 
laboratory. 
It should be noted that in the previously reported protocol (O Faolain et al., 2005), which 
included 18 hour soaking in the dewaxing solvent in addition to the normal protocol, was 
followed for the initial studies (all experiments presented in this chapter) to select a solvent 
of choice. For the final protocol to be adopted for the further experiments, chapter 4, 
xylene is selected as solvent of choice after the initial experiments reported above. The 
soaking for 18 hours has not been used, for consistency with the protocol used in the 
hospitals. 
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Figure 3.10 Raman spectra of the fresh rat skin after dewaxing in different solvents. 
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3.3 Laser line selection 
3.3.1 Introduction 
The choice of laser wavelength is of critical importance for the observation of the spectra of 
biomaterials without the related fluorescence emission. Raman and Rayleigh scattering 
depend on the inverse of wavelength of incident light to the power of λin-4, suggesting that 
the choice of source should be that of shortest wavelength. However, if the sample of 
interest is resonant with the incident wavelength, fluorescent emission may arise, which can 
dominate the Raman signal on the Stokes side. Similarly, photo degradation can occur at 
shorter wavelengths when there is absorption (Byrne et al., 2011). Notably, in biological 
tissue, in the absence of melanin, there is significantly less fluorescence at wavelengths 
higher than ~600 nm (Kollias et al., 1998, Na et al., 2001). The large background observed 
at wavelengths higher than this has been proposed to arise from stray light due to scattering 
(Bonnier et al., 2010a). For a given sample, the applied laser power and time allowed for 
signal collection are the main factors responsible for high signal to noise ratio (S/N) of a 
Raman spectrum. An increase in laser power will improve the S/N ratio in a given interval 
of time but may also increase the risk of sample photodegradation. Therefore, it is essential 
to explore the stability of the sample in relation to the intensity of the laser source and to 
assess the possibility of sample damage (Gremlich and Yan, 2001). Different groups have 
investigated biochemical changes caused by different cancers using Raman spectroscopy 
with different laser lines. Different studies include, analysis of the normal and diseased 
human breast tissue samples (Frank et al., 1995), differentiation between the normal and 
transformed (Jurkat and Raji) human lymphocytes using a 633nm laser line (Chan et al., 
2006), lung tissue of normal and infant patient using a 785 laser line (Krafft et al., 2008a) 
differentiation between the cultured normal and malignant cervical and breast cells (Yazdi 
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et al., 1999) and diagnosis of cancer in human cervical tissue using 514nm (Lyng et al., 
2007), and 785 nm (Kanter et al., 2009a, Krishna et al., 2006). 
For the present study, longer wavelengths such as 532nm, 660nm and 785 nm were 
investigated to allow mapping to be carried out without photodegradation of the tissue. 
3.3.2 Methods 
Cervical tissue sections of 5µm thickness were mounted on Mirr-IR slides and dewaxed in 
hexane for 18 hours. A HORIBA Jobin Yvon HR 800 UV confocal Raman microscope 
equipped with lasers of wavelength 532, 660 and 785nm was used to acquire the spectra. 
Other parameters include a grating of 300gr/mm, a 100µm confocal hole, 100% filter and 
X50 objective lens with numerical aperture of 0.75. The acquisition time was varied from 5, 
10, and 30 seconds with 2 acquisitions per spectrum for 532, 660 and 785nm laser lines 
respectively. The laser power measured at source was found to be ~80 mW for 532 nm, ~90 
mW for 660 nm and ~300 mW for 785 nm. The acquisition time varied from one laser to 
another. Changing from stronger laser power to weaker did not allow the same acquisition 
time for the three laser lines as prolonged irradiation with stronger laser power resulted in 
photodegradation of the tissue section. 
3.3.3 Results and Discussion 
Figure 3.11 represents the Raman spectra obtained from a dewaxed cervical tissue section 
using three different laser lines. The background at 532 nm and 660 nm laser lines were 
high but low background was observed using 785 nm. This could be indicative of 
fluorescence. The background has been removed in Figure 3.6, but the spectra are offset for 
clarity. The spectrum acquired using the 532 nm laser line (red) has high signal to noise 
ratio as compared to the 660 nm laser line spectrum (green). This spectrum has normal 
biological peaks at 620, 642 cm-1 (C-C twisting of proteins), 763 cm-1  (O-P-O DNA), 850, 
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940 cm-1 (collagen) 1002 cm-1 (phenylalanine), 1318 cm-1 (thymine), 1340 cm-1 (adenine), 
1451 cm-1 (CH deformation of lipids or proteins) and 1665 cm-1 (amide I). 
 
 
Figure 3.11 Raman spectra of the cervical tissue section acquired with different laser lines. 
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In Figure 3.11, the Raman spectrum acquired from the cervical tissue samples by the use of 
785 nm laser line (blue), has more prominent bands as compared with the spectrum 
obtained with the 532 nm laser line, including 620, 642 cm-1 (C-C twisting of proteins) 849 
cm-1, 938 cm-1 (collagen), 1002 cm-1  (phenylalanine) amide III and amide I. The shift of the 
excitation source from shorter wavelength towards longer wavelength resulted in the 
minimization of background from tissues as demonstrated in literature and experimentally 
(Carter and Edward, 2001). It is important to mention that there is no contribution of the 
two bands of quartz, 457 cm-1  and 487 cm-1  (dotted lines), in the biological spectra 
acquired with the 532 laser line as compared to those recorded using 785nm. 
 
The Raman spectrum acquired with the 660nm laser line appears to have a low signal to 
noise ratio. This may be due to the fact that the Raman signal depends on 1/λ4 of the laser 
used and the intensity of the laser. This means the Raman signal will decrease significantly 
with increasing wavelength i.e. moving from 532, 660, to 785nm. However, in the 
experimental set up used in these studies, the intensity increases with increasing 
wavelength. As a result of these two effects, a good Raman signal is expected from 532 nm 
(~80mW) and 785 nm (~130mW) laser lines and poor signal from 660 nm (~90mW) laser 
line. Thus with the 660 nm laser line, no meaningful information could be obtained even 
after the normalization and baseline correction of the spectra. 
 
On comparing the results of the three laser lines 532 nm, 660 nm and 785 nm, the Raman 
bands are better defined for the 785 nm laser line as compared to the 532nm laser line. All 
these Raman bands are not clear for 660 nm laser line indicating that it is the least suitable 
of the three for the current study. Although, the 532 nm laser line also produced reasonably 
good Raman spectra of the tissue sample, the major concern in the use of this laser line was 
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photodamage of the tissue section during mapping and was observed experimentally during 
the point spectra acquisition using the 660 nm and 532 nm laser lines. It can be concluded 
that the 785 nm laser line is most appropriate for Raman mapping of cervical tissue 
samples. 
 
3.4 Substrate Optimisation 
3.4.1 Introduction 
The next issue was the selection of an appropriate substrate for mounting the tissue section 
in order to carry out Raman spectroscopy. Figure 3.12 represents the Raman spectra of the 
cervical tissue on CaF2 and quartz along with the spectra of the substrates at the 785 nm 
laser line. The Mirr IR substrate is also shown for comparison. 
The broad background from the Mirr IR slide under 785nm laser line dominates the Raman 
spectrum and no spectral features from the tissue sample could be discerned and thus it is 
not shown in Figure 3.12. On the other hand, the spectra of tissue on the quartz substrate 
contain the peaks at 426 and 790 cm-1 and the Raman spectra of the tissue contains a broad 
band at about 1358cm-1 with the 785 nm laser line. 
 
The Mirr-IR substrate gives rise to a large background under 785nm laser illumination and 
as such was not considered suitable. The quartz and calcium fluoride (CaF2) substrates do 
not produce a significant background with the 785nm laser line. Furthermore, both of these 
can also be used with FTIR and Raman spectroscopy. The CaF2 contribution in the 
biological spectrum is negligible as compared to a large band from quartz. Thus, CaF2 was 
selected as substrate for further experiments with Raman micro spectroscopy. 
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Figure 3.12 Spectra from cervical tissue on quartz and CaF2 slides and substrates using 785 
nm laser line. 
 
 
 101 
3.5 Objective Optimisation  
3.5.1 Introduction 
Once the tissue processing protocol, laser wavelength and substrate for the mounting of the 
tissue section was optimized, the next target was to decide on the objective lens used to 
focus on the tissue section. The option of objective lenses of various magnification and 
numerical aperture was available i.e. X50, X100 dry, X60 and X100 water immersion 
objectives with numerical aperture 0.75, 0.90, 1.0 and 1.0 respectively. They are used to 
focus the laser on the sample to be analysed and to collect the back scattered light. The aim 
of the study was to evaluate the potential of Raman mapping using objectives of different 
magnification to differentiate between the layers of normal cervical epithelium on the basis 
of spectral differences obtained from the respective layers.  
3.5.2 Methods 
Three parallel tissue sections of 10 µm thicknesses were cut using a microtome, one for 
H&E staining and two unstained for Raman spectroscopy. The latter two samples were 
mounted on CaF2 slides. The tissue sections were dewaxed using the protocol already 
mentioned in section 3.2.5. 
 
The point spectra and maps were acquired from the normal region of CIN II cervical tissue 
sections using lenses of different magnification. The tissue sections mounted on CaF2 slides 
were fixed to a normal glass slide with blue-tack for Raman spectral acquisition using the 
X50 and X100 dry objective and to a plastic Petri dish for spectral acquisition with the 
X100 water immersion objective. Deionised water was used as an immersing medium for 
the water immersion objective. Raman spectra from the CaF2 slide lying above the Petri 
dish and glass slide were also recorded. 
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3.5.3 Results and Discussion 
3.5.3.1 Point spectral acquisition 
Figure 3.13 shows the Raman spectra acquired from cervical tissue sections using different 
objectives. The decrease in spectral background noise is evident from the observation of the 
bands labelled with solid lines assigned to DNA bands in the spectra, from dry objective 
lens to water immersion objective lens and lens of lower magnification to higher 
magnification because there is a shift in numerical aperture from 0.75, 0.90 for dry or air 
objectives to 1.00 for immersion objectives. The higher the numerical aperture, the more 
signal will be collected from the area of interest. 
 
NA (numerical aperture) = nsinθ                                                     (Equation 3.1) 
 
 
As indicated by the equation 3.1, this depends on refractive index and intake angle of the 
lens, so the greater the NA the more the signal collected from the sample. 
Immersion of the tissue section in water makes the tissue surface less scattering, resulting in 
better defined peaks, as shown by (Bonnier et al., 2010b). The comparison of spectral bands 
at 1665 cm-1 for amide I and other structural proteins such as for collagen 856 and 938 cm-1 
shows an improvement in spectral quality from X50 dry (green spectra) to X100 dry (sky 
blue spectra) and to X60 and X100 immersion objective (purple and red spectra). 
On the basis of these findings, both the X100 dry and X100 immersion objectives were 
found to be most suitable for the tissue samples for point spectral acquisition. Moreover, for 
X100 immersion, the Raman spectra are clearer as compared to X100 dry, even without the 
baseline correction and normalization, as shown in Figure 3.14. 
It should be noted that from these two objective lenses, the X100 dry objective lens was  
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selected for further experiments, Raman mapping, in the current study. This was due to the 
reason that the tissue samples, if needed, could be used again and again for mapping and 
the dry lens would avoid the problem of immersing the tissue sections in the water 
repeatedly. Furthermore, it was found that the sample positioning was less stable in the 
immersed state, and thus it was less suitable for prolonged mapping times. 
 
 
Figure 3.13 Raman Spectra from cervical epithelium using different objective lenses green 
(X50 NA 0.75) mid blue (X100 NA 0.90) magenta (X60 immersion, NA 1.00) red (X100 
immersion, NA 1.00. 
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Figure 3.14 Raman Spectra from cervical epithelium tissue section using X100 dry and 
X100 immersion objectives. 
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3.5.3.2 Raman spectral mapping 
The same procedure was tried for mapping of the cervical epithelium from superficial cells 
to stroma. The aim of acquiring these maps was to get an initial understanding of the layer 
separation of cervical epithelium on the basis of collagen, deoxyribonucleic acid (DNA) 
and glycogen. Also, in order to choose the objective lens that could best reveal the layer 
separation. 
 
The normal cervical epithelium along with the stroma from an area distant to the CIN II 
area, as marked by the pathologist, was analysed by Raman micro spectroscopy. Figure 
3.15 presents the results of a preliminary map with a step size of 5µm and acquisition time 
of 15 seconds x2 per spectrum using X50 magnification objective. Figure 3.15 A and 
Figure 3.15 B show images of the H&E stained tissue section taken with a X10 objective 
and an extended video image of the unstained tissue section with X50 objective. The red 
box corresponds to the area scanned by the Raman microscope. KMCA was used to classify 
the spectral data set obtained from the Raman map. 
 
A Raman map of the tissue layers was generated by the use of KMCA, as shown in Figure 
3.15 C. The Raman map is clustered into five clusters with a different colour being 
assigned to each cluster. Average Raman spectra representing the respective colour 
cluster/group are shown in the Figure 3.16. The comparison between the KMCA of the 
Raman map and average spectra obtained as a result of this KMCA shows that the average 
plot of the mid blue cluster corresponds to the spectrum of the substrate obtained 
experimentally. Based on literature, (Jess et al., 2007, Notingher, 2007, Notingher et al., 
2003, Lyng et al., 2007) the Raman bands in the green plot can be assigned to thymine 
(480cm-1), adenine (722cm-1), collagen (850, 940cm-1) and phenylalanine (1002cm-1). This 
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indicates that this cluster might be from connective tissue or the basal and parabasal layer. 
The predominant bands (480, 849 and 938 cm-1) in the blue, orange and brown average 
Raman spectra of the respective clusters are assigned to glycogen, suggesting different 
layers of epithelium. The peaks from all spectra at 1061 cm-1, 1133 cm-1, 1294 cm-1, 1339 
cm-1 correspond to peaks of the Raman spectra of paraffin wax obtained experimentally. 
This Raman map was able to differentiate between basal, parabasal and squamous 
epithelium with varying concentration of glycogen. 
 
 
 
 
Figure 3.15 H&E stained de-waxed cervical epithelium (A) Unstained cervical epithelium 
under Raman micro spectroscope with selection showing the area for mapping with X50 
dry  objective (B). Five cluster K-means analysis of Raman map (C). 
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Figure 3.16 Mean spectra of K-means cluster analysis, green representing stroma, orange 
to basal, brown & blue to superficial layer and mid blue to substrate of the Raman map with 
X50 dry objective. 
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Figures 3.17 A & B show the extended video image of the unstained tissue section of the 
same sample, as in Figure 3.15 B, with X100 dry objective, the red box corresponding to 
the area scanned and the Raman map of tissue layers obtained as a result of the KMCA. 
The Raman map is clustered into five clusters with a different colour being assigned to each 
cluster. 
 
Mean Raman spectra representing the respective colour cluster/group are shown in Figure 
3.18. The KMCA of the Raman map generated five well separated clusters. There exists a 
very good correspondence between the KMCA of the Raman map and the unstained section 
presented in the Figure 3.17 B. The predominant Raman bands in the sky blue plot (850, 
940 cm-1), the green plot (729 cm-1), the orange and brown plots (480, 849 and 938 cm-1) 
can be assigned to collagen, DNA base adenine, and glycogen respectively. The Raman 
plot of the blue cluster corresponds to the spectrum of the substrate. This Raman map 
divides the cervical tissue into connective, basal or parabasal and epithelial layers of 
different maturity. A contribution of the paraffin wax at 1061, 1133, 1294, 1339 cm-1 is also 
seen in the Raman spectra. 
 
The experiments of objective optimisation were conducted by employing X50 dry, X100 
dry and X60, X100 water immersion objectives for the Raman spectral acquisition. Raman 
spectral features become clearer in the spectra acquired with X100 dry and X100 
immersion objectives as compared to X50 dry objective as shown in Figure 3.13. 
Moreover, similar spectral features were obtained with both X100 dry and X100 immersion 
objectives but the spectra acquired by the use of the X100 immersion had lower 
background as compared to the X100 dry. This is due to the reason that immersion of the 
tissue section in the water makes the tissue surface less scattering and results in better 
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defined peaks. It should be noted that the immersion lens did not allow to repeat the 
experiment if needed for further investigations, however. Use of the dry lens would avoid 
the problem of immersing the tissue sections in the water repeatedly. So, from these two 
objective lenses, the X100 dry objective lens was selected for further experiments of 
Raman mapping, in the current study. 
 
 
 
Figure 3.17 Unstained cervical epithelium under Raman micro spectroscope with selection 
showing the area for mapping with X100 dry objective (A). Five cluster K-means analysis 
of Raman map, mid blue representing stroma, green to basal, brown & orange to superficial 
layer and blue to substrate (B). 
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Figure 3.18 Mean spectra of K-means cluster analysis of the Raman map, mid blue 
representing stroma, green to basal, brown & orange to superficial layer and blue to 
substrate, acquired with X100 dry objective. 
 
 111 
3.5 Conclusion 
 
FTIR and Raman micro spectroscopy have been employed in the initial experiments to 
acquire spectral maps from the cervical tissue sections. This is done to compare the results 
of both the techniques and choose one for the further studies based on the biochemical 
information attained. 
 
The results presented and discussed so far for FTIR and Raman micro spectroscopy and 
their comparison points towards the greater suitability of the latter technique for the current 
study. In each sample studied, parallel analysis of the spectral data revealed more 
biochemical changes in the Raman spectra. Particularly, more DNA related bands are 
detected in the case of the Raman spectral data. The higher content Raman spectral 
information achieved is due to the higher spatial and spectral resolution of Raman micro 
spectroscopy compared to FTIR spectroscopy. 
 
Optimisation of the sample preparation procedures (dewaxing and section thickness) and 
the recording parameters (laser line, substrate, and objective lens) for Raman micro 
spectroscopy was carried out. 
 
Different dewaxing agents including hexane, cyclohexane, xylene, histolene, ether and dish 
washing liquid were utilised to determine their ability to remove the wax from the rat skin 
tissue samples. On the basis of the spectral quality obtained with dewaxed rat skin, xylene 
and hexane were found to be equally good and thus these two agents were considered to be 
almost equally good for the removal of the wax. The dishwashing liquid results in the 
inefficient removal of wax and Raman spectra exhibited the paraffin bands even after the 
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application of the agent. Cyclohexane itself contributed to the Raman spectra as indicated 
by the bands present at 787 and 802 cm-1. The use of ether did not appear to be suitable as a 
dewaxing agent due to its interference with the proteins in the tissue section as indicated by 
the observation of deformation of the amide I band. Xylene and hexane were found to be 
the best dewaxing solvents followed by histolene as compared to the other dewaxing agents 
employed in current study. Xylene was adopted as solvent of choice to keep the protocol 
consistent with the one used in the hospital histopathology laboratory. 
The selection of the most suitable laser line was made from three laser lines including 532 
nm, 660 nm and 785 nm. The Raman bands were better defined for 785nm laser line as 
compared to the 532nm laser line but not observed at all for 660 nm laser line, which 
showed that it is the least suitable of the three for the current study. The 785nm laser line 
was preferred over 532nm laser line due to the major concern of photo degradation of the 
tissue section. 
For the selection of the most suitable substrate, three different substrates including Mirr-IR, 
quartz and calcium fluoride were used and results were compared. The Mirr-IR substrate 
gives rise to broad background under 785nm laser illumination and as such was not 
considered suitable. The quartz and CaF2 substrates do not cause fluorescence with the 
785nm laser line. The CaF2 contribution in the biological spectrum is negligible as 
compared to a prominent band from quartz. This led to the conclusion that the CaF2 
substrate should be used for the further experiments with Raman micro spectroscopy. 
The optimization of the objective lens was done by employing X50 dry, X100 dry and X60, 
X100 water immersion objectives for the Raman spectral acquisition. Similar spectral 
features were obtained with X50 dry, X100 dry and X100 immersion objectives but the 
spectra acquired by the use of the X100 immersion were cleaner as compared to the X50 
and X100 dry and thus less preprocessing was required for this objective. This is due to the 
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reason that immersion of the tissue section in the water makes the tissue surface less 
scattering and results in better defined peaks. But tissue immersion does not readily allow 
for the repeat of the experiment if needed for further investigations. Use of the dry 
objective would avoid the problem of immersing the tissue sections in the water repeatedly. 
So, from these two objective lenses, the X100 dry objective lens was selected for further 
experiments of Raman mapping, in the current study. 
 
 
 
 
 
 
 114 
Chapter 4 
Raman micro spectroscopy of cervical tissue samples 
4.1 Introduction 
This chapter will describe the use of Raman micro spectroscopy, initially for the 
differentiation between different layers of normal cervical epithelium on the basis of the 
Raman spectral signatures of these layers, and then to explore the changes to these spectral 
signatures, representative of the biochemical content, associated with pathologically 
defined diseased states. 
The samples used in this study were obtained from the Histopathology Department, 
Coombe Women and Infants University Hospital. Tissue sections from cervical tissue 
biopsies clinically characterised as normal, low grade squamous intraepithelial lesion 
(LSIL) or CIN I, high grade squamous intraepithelial lesion (HSIL) or CIN II, CIN III and 
carcinoma, were analysed. Raman spectral maps from cervical tissue samples of seventeen 
different patients, including, two true normal, two CIN I, five CIN II, five CIN III and three 
carcinoma samples were acquired. Raman spectral mapping of regions identified by the 
pathologist as normal and diseased was carried out. For each sample, two parallel tissue 
sections of 10µm thickness were cut from the FFPP cervical epithelial tissue block using a 
microtome. One section was mounted on a calcium fluoride slide and used for the Raman 
spectroscopy analysis and the other section was mounted on a glass slide for H&E staining. 
The tissue sections were dewaxed and stained according to the protocol described in 
chapter 3, section 3.2.5.  
Tissue sections from cervical tissue biopsies were mapped with Raman spectroscopy from 
the regions that were identified as normal and as high grade squamous lesions by the 
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pathologist to elucidate the layer differentiation within the normal tissue and how this 
differentiation is affected by the cervical intraepithelial neoplasia, based on the 
spectroscopic signatures of the biochemical composition. The analysis of the Raman maps 
from the cervical epithelium of different tissue sections revealed a serial change associated 
with the progression of disease. 
4.2 Raman spectral data acquisition  
The details of the Raman spectral acquisition were as described in chapter 3, section 3.1.2. 
However, it should be noted that all the results presented in this chapter were acquired by 
using X100 dry objective and the 785 nm laser. 
4.3 Data pre-processing 
The details of the data pre-processing are same as described in chapter 3, section 3.1.3. 
4.4 Results 
The main goal of the current study is to demonstrate the capability of Raman micro 
spectroscopy to classify different stages of progression of normal cervical epithelium to 
carcinoma in situ on the basis of biochemical changes observed. To achieve this 
classification solely on the basis of Raman spectroscopy, results are presented in the 
following sections in a sequence which is based on the Raman analysis, independent of the 
clinical classification of the samples. 
4.4.1 Normal Stages 
4.4.1.1 Normal sample 
Figure 4.1 a, shows the H&E stained tissue section and Figure 4.1b shows the extended 
video image of the unstained tissue section with a X100 objective acquired using the 
Raman micro spectrometer. The sample was diagnosed as normal as there was no evidence 
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of the metaplasia, and was mapped and analysed, as indicated by the red box. KMCA of the 
Raman map is shown in Figure 4.1 c. The analysis employs 5 clusters which divide the 
cervical epithelium into three distinct layers. The comparison of the unstained tissue section 
with the result of the K- means cluster analysis for this map suggests that the blue cluster 
represents the stroma, the red cluster the basal and parabasal layers, the green cluster the 
superficial layer and the black cluster the substrate, while the yellow cluster represents the 
presence of residual wax in the tissue section.  
 
 
 
Figure 4.1 H&E stained normal diagnosed tissue with scale bar of 200µm (a) unstained 
tissue under Raman spectroscope with scale bar of 50µm  (b) Five cluster K means cluster 
map generated from the Raman map (c). 
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Mean Raman spectra representing the respective colour cluster/group are shown in Figure 
4.2, except the clusters describing the substrate and residual wax.  
It should be noted that two important Raman markers of collagen and glycogen can be used 
to differentiate the Raman spectra of the layers of squamous epithelium and stroma. Based 
on the analyses of (Jess et al., 2007, Notingher, 2007, Notingher et al., 2003, Lyng et al., 
2007), the Raman bands at 853, 921, 938 and 1245 cm-1 are indicative of collagen and those 
at 480, 849 and 938 cm-1 can be assigned to glycogen. It should be noted that the two bands 
at 853 cm-1 (collagen) and 849 cm-1 (glycogen) overlap and are not well differentiated by 
Raman spectroscopy. By considering the pattern of the collagen and glycogen bands in the 
current study, it is observed that 921 cm-1 and 938 cm-1 are normally co-incident in spectra 
of collagen and the 480 cm-1 and 853 cm-1 bands are normally present in the spectra of 
glycogen. The Raman spectra of the pure collagen and glycogen used for reference are 
described by (Lyng et al., 2007). These Raman bands are therefore good differentiating 
bands between collagen and glycogen. Another differentiating marker can be that at 1245 
cm-1, which is observed as a very sharp band if associated with the presence of collagen, 
while otherwise it is very much diminished and broad. 
The most prominent Raman bands in the blue spectrum of Figure 4.2, indicative of the blue 
cluster of Figure 4.1c, can be assigned to collagen (853, 921, 938 and 1245 cm-1) and 
phenylalanine (1002cm-1). Collagen is a structural protein and is a major component of the 
connective tissue layer.  
The predominant bands in the red spectrum, corresponding to the red cluster, are of DNA 
bases, thymine (755 cm-1), adenine (722 cm-1) and cytosine (782 cm-1). On the basis of this 
information, it can be concluded that the red cluster represents the basal and parabasal 
layers. The bands present at 480, 849 and 938 cm-1 in the Raman spectrum suggest that 
accumulation of glycogen starts in the basal and parabasal layers, which are also rich in 
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DNA. The major Raman features observed in the mean representative spectrum of the 
green cluster can be assigned to glycogen (480, 849 and 938 cm-1), and are Raman  
 
 
Figure 4.2 K-means cluster spectra, blue representing stroma (collagen), red representing 
basal layer (DNA) and green representing superficial layer (glycogen), for the Raman map 
of the marked region in figure 4.1 c. 
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signatures of the squamous epithelium of the cervix, as cervical epithelium cells accumulate 
glycogen with maturity (Lyng et al., 2007, Salzer and Siesler, 2009).  
It has been observed that the basal layer shares some features with the stromal layer, such 
as that at 1318 cm-1, assigned to guanine, and the superficial layer, such as that at 1084 cm-
1
, assigned to the O-P-O stretching of DNA, but these Raman bands are not differentiating 
bands between these layers. The Raman band at 1339 cm-1 is assigned to tryptophan and is 
present in the Raman spectra of all the layers. 
The comparison between the H&E stained tissue section, the unstained tissue section and 
the KMCA of the Raman map suggests that Raman spectroscopy is able to differentiate 
normal cervical epithelium into three layers including connective, basal, and squamous 
epithelium on the basis of the Raman signatures of collagen in the connective tissue, DNA 
bases in the basal and parabasal layer and glycogen in the superficial layer. The prominence 
of glycogen bands in the mean spectrum of the basal layer may indicate that cells are 
dividing and gradually maturing to accumulate glycogen. 
4.4.1.2 Normal region of CIN II sample 
For the purpose of the study, the normal side of another sample which was CIN II 
diagnosed, as indicated by the red box in Figure 4.3a, was mapped and analysed. KMCA 
of the Raman map is shown in Figure 4.3 c. Figure 4.3 a, shows the H&E stained tissue 
section and Figure 4.3b shows the extended video image of the unstained tissue section 
with a X100 objective acquired using the Raman micro spectrometer. The analysis employs 
5 clusters which divide the cervical epithelium into three distinct layers. The comparison of 
the unstained tissue section with the result of the K- means cluster analysis for this map 
suggests that the blue cluster represents the stroma, the red cluster the basal and parabasal 
layers, the green cluster the superficial layer and the black cluster the substrate, while the 
yellow cluster represents the presence of residual wax in the tissue section. 
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Figure 4.3 H&E stained normal region of CIN II diagnosed tissue with scale bar of 200µm 
(a) unstained tissue under Raman spectroscope with scale bar of 50µm (b) Five cluster K 
means cluster map generated from the Raman map (c). 
 
 
The representative Raman spectra are presented in Figure 4.4. As discussed above, in case 
of the true normal cervical tissue sample, all the information associated with biological 
spectra of the corresponding layers were the same. The yellow spectrum is presented here, 
to highlight the peaks related to the residual wax. The peaks present in the yellow spectrum 
at 1061 cm-1, 1133 cm-1, 1294 cm-1, 1339 cm-1 are identical to those of the Raman spectrum 
of paraffin wax, chapter 3, Figure 3.6, indicating that the dewaxing procedure was not 
completely effective in removing the wax from the cervical tissue sections under study. 
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Figure 4.4 K-means cluster spectra, blue representing stroma (collagen), red representing 
basal (DNA), green representing superficial (glycogen) and yellow representing residual 
wax, for the Raman map of marked region in figure 4.1 c. 
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4.4.2 Abnormal Stages 
4.4.2.1 Abnormal sample I 
Figure 4.5a, b and c shows the H&E stained tissue section, unstained tissue section and 
KMCA Raman maps of a CIN III diagnosed cervical tissue section, respectively. It can be 
seen (Figure 4.5 a) that one side is more intensely stained compared to the other, indicative 
of a higher degree of abnormality, and this region, indicated by the red box, was analysed 
by Raman spectroscopy.  
 
 
 
Figure 4.5 H&E stained diseased side of CIN III marked tissue with scale bar of 200µm  
(a) unstained tissue under Raman spectroscope with scale bar of 20µm (b) Five cluster 
KMCA map generated from the Raman map (c). 
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The mean Raman spectra of the KMCA are presented in Figure 4.6. The KMCA of the 
Raman map shows a two layer separation, as indicated by two prominent clusters. The red 
cluster corresponds to the basal layer as indicated by the characteristic Raman markers in 
the mean spectrum (the Raman bands of the DNA bases including Raman spectral features 
of thymine (755 cm-1), adenine (722 cm-1) and cytosine (782 cm-1), characteristic of the 
basal layer). The green cluster corresponds to cervical epithelium. The mean Raman 
spectrum of the yellow cluster has prominent Raman features of glycogen. 
Comparison with the KMCA map of the normal region, shown in Figure 4.1c, shows that 
the squamous epithelial layer seems to have some features similar to the basal layer as 
observed and discussed in section 4.4.1. Notably, there is no distinct representation of the 
stromal layer in the KMCA of this tissue section, the clustering resulting in only two layers, 
one with distinct Raman features of DNA and the other with those of glycogen. The 
absence of the Raman spectral features of collagen may indicate some biochemical changes 
in the stroma due to the progression of disease and need to be further evaluated to 
understand the basis of these changes. 
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Figure 4.6 Mean Raman spectra of, basal (red), and squamous epithelial (green & yellow) 
layers from KMCA of Raman map in Figure 4.5 c. 
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4.4.2.2 Abnormal sample II 
Another example of a Raman classified abnormal region is presented in Figure 4.7 and 
Figure 4.8. Figure 4.7 shows the KMCA of tissue section from a CIN III region which 
gives three prominent clusters. 
 
 
 
 
Figure 4.7 H&E stained disease side of CIN III marked tissue with scale bar of 200µm (a) 
unstained tissue under Raman spectroscope with scale bar of 40µm  (b) Five cluster KMCA 
map generated from the Raman map (c). 
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Analysis of the mean spectrum of the yellow cluster (Figure 4.8) correlates it with the 
marking ink already presented in chapter 3, Figure 3.7. In the KMCA map, the green 
cluster corresponds to stroma as well as some portion of the epithelial layer, while the red 
cluster corresponds to the basal layer only. On the other hand, the mean Raman spectrum of 
the red and green clusters (Figure 4.8) can both be correlated with the basal layer, but the 
differentiating factor between the two clusters is the absence of the bands for 
glycogen/collagen in the red spectrum and the presence of these bands in the green 
spectrum. It should be noted that the substrate is divided into two types of clusters in this 
map, represented by the black cluster which is due to substrate only while the yellow 
cluster is due to a combination of marking ink and substrate. 
 
The results of this Raman map, once again, show the presence of DNA related Raman 
bands and the absence of collagen Raman spectral bands. This, again, may have some 
biochemical relation to the progression of disease before the morphological changes take 
place. The absence of glycogen bands in the green spectrum may indicate the abundance of 
rapidly growing abnormal cells which are unable to accumulate glycogen due to the rapid 
cell division and lack of maturity.  
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Figure 4.8 Mean representative Raman spectra, red and green spectra correspond to basal 
(DNA) and yellow spectrum corresponds to marking ink, from KMCA of Raman map in 
Figure 4.7 c. 
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4.4.2.3 Abnormal sample III 
Another example of a Raman classified abnormal region is presented in Figure 4.9 and 
Figure 4.10. Figure 4.9 shows the KMCA of a carcinoma in situ tissue section which does 
not give any separation of the prominent clusters. All the three representative Raman 
spectra, red, green and yellow contain the features related to DNA, although the yellow 
spectra also show some features of the residual wax. 
 
 
 
Figure 4.9 H&E stained carcinoma in situ marked tissue with scale bar of 200µm  (a) 
unstained tissue under Raman spectroscope with scale bar of 40µm  (b) Five cluster KMCA 
map generated from the Raman map (c). 
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Figure 4.10 Mean representative Raman spectra, red and green spectra show features of the 
basal layer (DNA) and yellow spectrum shows features of DNA and marking ink, from 
KMCA of Raman map in Figure 4.9 c. 
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4.4.3 Intermediate Stages 
In this section, Raman spectral results of four different cervical tissue samples are presented 
to show an increase in the degree of the abnormality in the form of biochemical changes 
observed by Raman micro spectroscopy. 
 
4.4.3.1 Intermediate sample I 
Figure 4.11 a shows the H&E stained normal region of a CIN III diagnosed tissue section 
taken with a X10 objective which exhibits the normal pattern of the stroma, basal, 
parabasal, intermediate and superficial epithelium. 
Figure 4.11 b shows the extended video image of the same unstained tissue section with a 
X100 objective, acquired using the Raman micro spectrometer and the red box indicates the 
area analysed. KMCA of the Raman map is shown in Figure 4.11 c.  
 
 
Figure 4.11 H&E stained normal region of CIN III diagnosed tissue with scale bar of 
500µm  (a) unstained tissue under Raman spectroscope, with scale bar of 100µm (b) Five 
cluster KMCA map generated from the Raman map (c). 
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It shows intact stroma, separated from the basal layer, as indicated by the Raman bands of 
the collagen, including 849 cm-1, 921 cm-1, 938 cm-1 and 1245 cm-1, of the blue mean 
spectrum in Figure 4.12. The separation of the stroma and basal layer is very clear, but at 
the same time, the squamous epithelium has three types of clusters, two with strong Raman 
spectral features of glycogen (green and yellow clusters) and one with the characteristic 
Raman spectral features of the basal layer (red cluster), indicating characteristics of basal 
cells in this layer. This information indicates that the squamous layer shows evidence of 
disease, based on strong DNA features throughout this layer, indicating rapidly 
proliferating cells. 
 
4.4.3.2 Intermediate sample II 
The other interesting observation concerned with the normal region of the CIN III marked 
tissue sections. Figure 4.13 a, 4.13 b represent H&E stained and parallel unstained tissue 
section of a normal region of a CIN III marked tissue section. The KMCA pseudo colour 
map and mean Raman spectra are presented in Figure 4.13c and Figure 4.14, respectively.  
The mean Raman spectra are presented in Figure 4.14, the green spectrum represents the 
superficial layer (glycogen) while the red spectrum represents the basal and stromal layers 
as indicated by the presence of characteristic Raman features of both DNA and collagen in 
the mean Raman spectrum of the red cluster. It is observed that, although the histological 
appearance of these tissue samples is normal, as indicated by the pathologist, the KMCA 
divides the Raman spectral data of these “normal regions” into just two clusters. 
The Raman spectral features of these two clusters suggest that there are two types of layers, 
one prominent, the basal layer with strong DNA bands, and the other diminished, the 
superficial layer as characterised by strong glycogen bands. No features of the stromal layer 
are evident in these clusters. This trend of the absence of collagen related Raman bands and 
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presence of DNA related Raman bands in the stromal layer, where collagen related Raman 
bands are normally prominent, has been observed in the normal region of the four CIN III 
marked tissue sections examined. These observations lead to the conclusion that Raman 
spectroscopy can detect the biochemical changes occurring before the morphological 
manifestation of the disease. 
 
Figure 4.12 K-means cluster spectra, representing blue to stroma (collagen), red to basal 
(DNA), green & yellow to superficial (glycogen) layers, for the Raman map of marked 
region in figure 4.11 c.  
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Figure 4.13 H&E stained normal side of CIN III marked tissue with scale bar of 200µm (a) 
unstained tissue under Raman spectroscope with scale bar of 40µm (b) Five cluster K mean 
map generated from the Raman map (c). 
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Figure 4.14 Mean representative spectrum, red spectrum representing  basal layer (DNA 
bases) and green spectrum indicating superficial layer (glycogen) from KMCA of Raman 
map of Figure 4.13 c. 
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4.4.3.3 Intermediate sample III 
The CIN II marked cervical tissue sample, classified by Raman spectroscopy as 
intermediate between normal and abnormal is presented here. Figure 4.15 a shows the 
H&E stained tissue section of a formalin fixed paraffin preserved tissue section which has 
only abnormal regions. Figure 4.15 b shows the optical images of the parallel unstained 
section as viewed by the Raman micro spectroscope. Figure 4.15 c shows the five cluster 
KMCA of the Raman map. 
 
KMCA of Raman micro spectral mapping of this sample divides the tissue section into 
three layers, stroma (blue cluster), basal (red cluster) and superficial layer (green cluster). 
The yellow cluster shows residual wax in the tissue and the black cluster corresponds to 
substrate. Careful analysis of the KMCA pseudo image reveals that the superficial layer 
exhibits regions with spectral characteristics of the basal layer. In the pseudo image of this 
sample, it appears as though the basal layer invades into the superficial layer in such a way 
that the typical characteristics of the latter are hugely reduced and are represented only by a 
few pixels. The stromal layer (blue cluster) also shows characteristic spectral features of the 
basal cell layer. 
 
Figure 4.16, elucidates the discriminating Raman marker bands between the layers. Raman 
bands assigned to the stromal layer are from collagen (853, 921, 938 and 1245 cm-1), those 
assigned to the basal layer are DNA related bands including thymine (755 cm-1), adenine 
(722cm-1) and cytosine (782 cm-1) and the bands at 480, 849 and 938 cm-1 suggest 
accumulation of glycogen in the superficial layer. 
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Figure 4.15 H&E stained disease side of CIN II marked tissue with scale bar of 200µm (a) 
unstained tissue under Raman spectroscope, 40µm (b) Five cluster KMCA map generated 
from the FTIR map (c). 
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Figure 4.16 Representative mean Raman spectra from KMCA map in Figure 4.15 c where 
blue spectrum representing stromal layer (collagen), red spectrum representing basal layer 
(DNA) and green representing superficial layer (glycogen). 
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4.4.3.4 Intermediate sample IV 
Raman spectral results of a CIN II marked cervical tissue sample which was classified as 
intermediate between normal and abnormal by Raman micro spectroscopy, are presented in 
Figure 4.17 and Figure 4.18. Figure 4.17 a shows a H&E stained tissue section which has 
diseased and normal tissue areas adjacent to each other. These regions are ideal to 
investigate how the layer differentiation is affected by the proliferation of disease. Figure 
4.17 b shows the optical image of the parallel unstained tissue section as viewed by the 
Raman micro spectrometer. KMCA of the Raman map of the same sample is shown in 
Figure 4.17 c.  
 
 
 
Figure 4.17 H&E stained normal & disease region of CIN II diagnosed tissue with scale 
bar of 200µm  (a) unstained tissue under Raman spectroscope with scale bar of 40µm (b) 
Five cluster KMCA map generated from the Raman map (c). 
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The KMCA of the Raman map (Figure 4.17c) clearly shows the separation of the normal 
and abnormal regions. The normal region is separated into three layers, including stroma 
(indicated by the yellow and blue colour clusters with a mean spectrum having 
characteristic bands of collagen, Figure 4.18), basal layer (indicated by the red colour 
cluster with mean spectrum having characteristic bands of DNA bases) and squamous 
epithelium (indicated by the green colour cluster, with mean spectrum having characteristic 
bands of glycogen). The reason for the two clusters (yellow and blue) in stromal layer is the 
difference in the intensity of the collagen related bands. The abnormal region is separated 
into only two layers representing stromal and basal layers. The KMCA of the Raman map 
of this region indicates the presence in the stromal or connective tissue layer of the 
characteristic features of the basal layer, as characterised by the Raman spectral features of 
thymine (755 cm-1), adenine (722cm-1) and cytosine (782 cm-1). Notably, the existing 
system of classification (CIN system) does not consider the involvement of the stromal 
layer when categorising the degree of abnormality or grading of the cervical intraepithelial 
neoplasia (CIN) (Sellors and Sankaranarayanan, 2003/4). It is clear, however, that cervical 
intraepithelial neoplasia turns the three layer separation into two layers.  
This increase in DNA content and decrease in the collagen content may raise the question 
of whether this increase in DNA content is associated with the interaction of the basal cells 
with stromal cells or is due to some biochemical changes in the stroma cells themselves. 
Notably HPV infection also results in higher DNA content but is normally understood to 
primarily affect the epithelial layer and not the stromal layer. Further elucidation of the 
origin and nature of the biochemical phenomena indicated by spectral analysis requires the 
PCA analysis and the immunohistochemistry of proteins involved in cervical cancer such as 
p16, details of which are presented in Chapter 5 and Chapter 6 respectively. 
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Figure 4.18 Representative mean Raman spectra from KMCA of Raman map, yellow and 
blue clusters corresponding to stroma, red corresponding to basal layer, and green 
corresponding to squamous epithelium from the marked region in figure 4.17 c. 
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4.5 Conclusion 
 
The major purpose of this study is to evaluate the potential of the technique in elucidating 
the biochemical changes occurring during the progression of Cervical Intraepithelial 
Neoplasia (CIN) to cancer. The pathologist, in general, divides the cervical epithelium into 
basal, parabasal, intermediate and superficial layers. The cervical epithelium is supported 
by the underlying connective tissue known as stroma. Raman micro spectroscopy was 
employed to visualize this layer separation and also how this separation is affected due to 
the biochemical changes caused by the progression of the disease. 
 
Raman micro spectroscopy was able to differentiate the normal region of the cervical tissue 
sample into three layers including stroma, basal/parabasal and superficial layers on the 
basis of the spectral features of collagen, DNA bases and glycogen. Raman micro 
spectroscopy reveals more detailed biochemical changes related to the DNA as compared 
to FTIR spectroscopy as already discussed in chapter 2. 
 
The results of the Raman micro spectroscopy presented in this chapter have proven that the 
technique is very useful in the discrimination of the diseased areas from the normal areas 
and particularly to describe the biochemical changes in the diseased samples in detail. The 
Raman spectra contain the signatures of the DNA bases and can be used as a discriminating 
factor for the differentiation between the layers and between normal and abnormal regions.  
On moving from normal to abnormal regions of the cervical tissue sample, the 
characteristic Raman features of the basal layer are first observed in the superficial layer 
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and then in the stromal layer. Notably, the region of the CIN III sample which was 
pathologically classified as normal has been recognised as having biochemical information 
similar to the abnormal region. This has been indicated by the absence of the collagen 
Raman spectral bands in the stromal layer as well as absence or minute presence of the 
glycogen bands in the superficial layer. 
All the results, based on KMCA of Raman spectroscopic maps of different cervical tissue 
samples, presented in this chapter lead to the conclusion that Raman micro spectral 
mapping of the cervical tissue sections has been able to identify the biochemical changes, 
occurring during disease progression. The information and conclusion made on the basis of 
the biochemical changes would not be possible only on the basis of the morphological 
observations/changes occurring in the tissue. 
The presence of the Raman signatures associated with an increase in the DNA content and 
decrease in the collagen content, due to the progression of disease demand further study to 
establish the reasons for these changes and understand whether these are due to an 
interaction of the basal cells with stromal cells or are due to some biochemical changes in 
the stromal cells themselves. This requires further study on normal and tumour samples as 
well as an immunohistochemical study. The PCA of these cervical tissue samples are 
presented in Chapter 5 and an immunohistochemical study for the evaluation of the 
expression of the p16 protein, a well known marker protein for cervical cancer is presented 
in Chapter 6. 
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Chapter 5 
Principal Component Analysis of the Raman spectral data from basal, 
superficial and stromal layers 
5.1 Introduction 
In the previous chapter, Raman spectral data acquired from cervical tissue sections, 
analysed by KMCA, was presented. The process differentiates diseased areas from normal 
areas and particularly helps to elucidate the biochemical changes in the diseased samples. 
Raman signatures of different representative bio-molecules, including DNA bases, 
collagen, and glycogen were identified and used as discriminating factors between the 
basal, stromal and superficial layers of the cells in the cervical tissue samples classified 
with normal and abnormal areas. 
 
KMCA of the Raman spectral data from the normal and abnormal regions of the cervical 
tissue samples can lead to the conclusion that, as the disease progresses, the characteristic 
Raman features of the basal layer initially progress to the superficial layer and then to the 
stromal layer, based on an increased contribution of DNA features and reduction of the 
characteristic collagen Raman spectral bands in the stromal layer as well as the glycogen 
bands in the superficial layer. This information is helpful in the elucidation of the 
biochemistry of the progression of cervical cancer from normal to abnormal stages and 
indicates that the decisions made about the stage of the cervical cancer, only on the basis of 
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the morphological changes occurring in the tissue, is not the most appropriate and for this 
purpose the biochemical changes can be more accurate. 
 
However, the results of the KMCA of the Raman maps pose many further questions. (i) 
Are the normal regions of a diseased sample biochemically similar to the true normal 
samples? (ii) Can signatures of HPV infection be observed in early stage diseased samples? 
(ii) Why does KMCA classify regions of the superficial layer as basal in character? (iii) 
Why does KMCA classify regions of the stroma as basal in character? While the 
proliferation of basal-like cells into the superficial layer may be expected in diseased 
samples, the presence of the Raman signatures associated with an increase in the DNA 
content and decrease in the collagen content, due to the progression of disease, demands 
further study to establish the reasons for these changes and to understand whether these are 
due to an interaction of the basal cells with stromal cells or are due to some biochemical 
changes in the stromal cells themselves. 
 
KMCA provides a separation of the different layers of the cervical epithelium on the basis 
of the similarities of the Raman spectral profiles and the clustered data is represented by an 
average of all the spectra of one layer. In order to further elucidate the biochemical basis of 
this, and to attempt to address the questions above, principal components analysis (PCA) 
will be performed on the Raman spectral data and interpreted and presented in this chapter. 
To demonstrate the process, the Raman spectral maps of true normal tissue will initially be 
analysed. A pair wise PCA of different regions of tissue, in normal and diseased samples, 
as identified by KMCA, can highlight the specific biochemical differences (Bonnier and 
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Byrne, 2012). In terms of the changes occurring in the basal layer, an obvious candidate is 
infection by the HPV virus. In an attempt to identify spectral signatures of HPV infection, 
cervical cell lines with different degrees of HPV infection will be compared (Ostrowska et 
al., 2010). 
5.2 Data preprocessing 
In order to undertake a detailed analysis of the biochemical differences underlying disease 
progression, data were preprocessed to remove any contributions of substrate, paraffin or 
marking ink. All spectra, including calibration and substrate backgrounds, were vector 
normalized and smoothed using a Savitzky Golay smoothing algorithm of order 5. A 
rubber band correction for baseline removal for all the spectra was carried out and the 
substrate spectrum was subtracted from each spectrum (Knief, 2010a). The contribution of 
the wax was modelled and removed by using Classical Least Square analysis (CLS) (Zhou 
et al., 2011). All spectral processing and analysis was performed in the Matlab 7.2 (The 
Mathworks Inc.) environment and the algorithms were developed in-house (Knief, 2010b). 
5.3 Data Analysis 
Regions of the original Raman data maps clustered by KMCA, and presented in chapter 4, 
were separated by picking the related Raman spectra from that specified area, as indicated 
by the KMCA in the pseudo colour map. Where identified regions were subdivided, the 
details are provided in the relevant sections. 
5.3.1 Principal component analysis 
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PCA has been explained in detail in chapter 3 and in the following sections, it is firstly 
demonstrated to confirm the differentiation of superficial/basal and basal/stromal Raman 
spectra from normal tissue, as indicated by KMCA in the previous chapter, but also to 
confirm the biochemical origin of that separation in a multivariate approach rather than that 
of identifying individual peaks.  
Having established the validity of the PCA, it is then used to explore any biochemical 
differences between samples classified similarly by KMCA in the previous chapters, and 
indeed within regions which are clustered. For example, biochemical differences between 
the basal layers of the normal, intermediate and abnormal samples, as identified in chapter 
4, are compared to address the question that was raised by the KMCA; whether the basal 
layer proliferates into the stromal and superficial layers or whether the cells of these layers 
undergo some biochemical changes during the disease development and progression. It is 
hoped that this analysis can shed further light on the progression of cervical cancer and 
may help identify markers of the disease progression associated with each stage of the 
disease. 
5.4 Results: Normal tissue 
The KMCA pseudo colour map of the sample of the normal diagnosed tissue section, as 
well as the visual images of the stained and unstained sections are presented in Figure 5.1. 
This figure is reproduced here to use as a reference for the ability of Raman micro 
spectroscopy to differentiate between the three layers of the cervical tissue sample, namely 
the basal, superficial and stromal layers. This layer differentiation was achieved by using 
KMCA of the Raman spectral data, presented in chapter 4 (Figure 4.2). 
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Figure 5.1 H&E stained normal diagnosed tissue with scale bar of 200µm (a) unstained 
tissue under Raman spectroscope with scale bar of 50µm  (b) Five cluster K means cluster 
map generated from the Raman map (c). 
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In order to elucidate the biochemical features responsible for this layer differentiation in 
addition to those which were identified by the KMCA, PCA was performed on the Raman 
spectral data associated with each cluster, by comparing the basal layer with the stroma and 
superficial layers, separately. 
 
5.4.1 PCA of basal-normal vs stroma-normal 
Figure 5.2 represents the scatter plot of the PCA for basal vs stroma. These two layers are 
well differentiated by PC1, which accounts for 67.4 % of the variance. The loading of PC1 
is presented in Figure 5.3. 
 
Notably, in the PCA scatter plot, the cluster of the Raman spectra of the basal layer is 
distributed negatively with respect to PC1 and the Raman spectra of the stroma are 
clustered on the positive side. This is translated to the loadings of PC1 (Figure 5.3), as all 
the negative loadings are associated to the characteristic Raman features of DNA bases and 
are clearly indicative of the characteristics of the basal layer as it is richer in DNA as 
compared to the stromal layer. The features associated with DNA, contributed by the basal 
layer, include those at 728 cm-1 (A), 827 cm-1 (O-P-O of DNA), 898 cm-1 (deoxiribose ring 
breathing) ,1276 cm-1and 1340 cm-1 (G). Only a few features related to proteins are 
observed, including those at 509 cm-1 (S-S stretching), 642 cm-1 (C-C stretching), 1129 cm-
1
 (C-N stretching) and 1449 cm-1 (CH deformation). On the other hand, the positive 
loadings can be assigned to the characteristic Raman features of the stromal layer. These 
loadings are assigned to collagen and differentiate this layer from the basal layer. The 
features contributed by the stroma include 853 cm-1, 921 cm-1, 972 cm-1 and 1242 cm-1, 
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assigned to the collagen of the stromal layer and 1165 cm-1, 1195 cm-1 (C-N stretching) and 
1655 cm-1 (amide-I). 
 
 
 
Figure 5.2 PCA scatter plot for basal-normal vs stroma-normal. 
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Figure 5.3 PCA loading (PC-1) for basal-normal vs stroma-normal. 
 
 
 151 
5.4.2 PCA of basal-normal vs superficial-normal 
 
Figure 5.4 and Figure 5.5 represent the PCA scatter plot and loadings of the PCA for the 
basal-normal versus superficial-normal, respectively. A good separation of the two layers is 
observed as two well distinguished clusters of the spectra in the PCA scatter plot in the 
Figure 5.4. In the PCA scatter plot, the cluster of the Raman spectra of the basal-normal 
layer is observed in the negative axis and Raman spectra of the superficial layer are 
clustered in the positive axis which is consistent with the loadings of the PCA (Figure 5.5), 
as the negative loadings are related to the characteristic Raman features of DNA bases 
which are characteristic of the basal layer. The clustering of the Raman spectra of the 
superficial layer is observed in the positive axis, which is consistent with the loadings of 
the PCA, because the positive loadings are assigned to the characteristic Raman features of 
glycogen, a specific marker of this layer. 
The loadings (PC1) show the Raman features which can be related to the basal layer 
include the DNA related Raman bands and glycogen related Raman bands which can be 
attributed to the superficial layer. Specifically, the loadings of PC1 show features including 
755 cm-1 (T), 728 cm-1, 1338 cm-1 (A), 775 cm-1 (C), 1182 cm-1, 1313 cm-1 (G) and 1080 
cm-1 (O-P-O of DNA). Other features observed including 480 cm-1, 853 cm-1 and 938 cm-1 
are assigned to glycogen of the superficial layer. 
The PCA of the basal layer of the two normal samples designated “true normal-1” and 
“true normal-2” is presented in the Appendix, A1.1 and A1.2, as scatter plot and loadings 
respectively. The scatter plot shows some differentiation of the two clusters of the Raman 
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spectra which are attributed to some degree of inter-patient variability, largely based on 
intensity variations of peaks associated with proteins and lipids. 
5.4.3 Summary 
These results of the PCA of the normal basal layer versus the normal stromal and 
superficial layers demonstrate the ability of the PCA to highlight the spectral features 
which lead to the differentiation of these layers on the basis of the Raman spectral features 
characteristic for each layer. A similar analysis will now be employed to investigate 
whether the “normal” regions of diseased samples are biochemically similar to samples 
classified as “true normal”. 
 
Figure 5.4 PCA scatter plot for basal-normal vs superficial-normal. 
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Figure 5.5 PCA loading (PC-1) for basal-normal versus superficial-normal. 
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5.5 Results: True normal versus diseased samples 
5.5.1 PCA for Raman spectra of the basal-true normal vs CIN II normal 
The basal layer of the “true-normal” of Figure 4.1 in chapter 4 and here in the section 
5.4.1 (Figure 5.1) was compared to a region of a CIN II sample of Figure 4.3 in chapter 4 
(Figure 5.6), characterized by the pathologist as “normal” in order to establish whether 
Raman spectral signatures associated with disease are identifiable outside of the diseased 
region. The results are presented as PCA scatter plot and the loadings in Figure 5.7 and 
Figure 5.8 respectively. The two layers are well differentiated by PC1, which accounts for 
74.5 % of the variance. Notably, in the PCA scatter plot, the cluster of the Raman spectra 
of the basal layer from the true normal sample (basal-true normal) is distributed positively 
with respect to PC1 and the Raman spectra of the basal layer of the CIN II normal sample 
(basal-1) are clustered on the negative side. This is translated to the loadings of PC1 
(Figure 5.8) as all the positive loadings are associated with the characteristic Raman 
features of DNA bases and are clearly indicative of the characteristics of the basal layer. 
The loadings contributed by the true normal basal layer include 728 cm-1 (A), 795 cm-1 (C), 
828 cm-1 and 1088 cm-1 (O-P-O, DNA), 881 cm-1 (deoxiribose ring breathing), 849 cm-1 
(glycogen) and 1449 cm-1 (CH deformation). 
On the other hand, in the negative loadings, contributed by the basal-1 (CIN II normal basal 
layer), the major difference as compared to the true normal basal is the one assigned to 
amide-III beta sheets of the proteins at 1222 cm-1. Notably, this feature is not observed in 
the loadings of the PCA of the basal layers of the two normal samples including “true 
normal-1” and “true normal-2” (Appendix, A1.1 and A1.2). Moreover, PCA of the basal-1 
(CIN II normal basal layer) with the second true normal sample “true normal-2” was also 
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done and presented in the appendix (A1.3 and A1.4) as scatter plot and loadings 
respectively. Notably, the loadings are the same and 1222 cm-1 feature is also observed 
there which further confirms the above findings. 
Other loadings can be assigned to the characteristic Raman features of the DNA, including 
1095 cm-1 (O-P-O, DNA), 1318 cm-1, 1585 cm-1 (G). One band related to glycogen at 482 
cm-1 is also observed. These results of 
the PCA show that the normal side of the diseased sample (basal-1) is not the same as the 
“true normal”.  
 
 
Figure 5.6 H&E stained normal region of the CIN II diagnosed tissue with scale bar of 
200µm (a) unstained tissue under Raman spectroscope with scale bar of 50µm  (b) Five 
cluster K means cluster map generated from the Raman map (c). 
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Figure 5.7 PCA scatter plot of basal true normal vs CIN II normal (basal-1). 
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Figure 5.8 PCA loadings of basal true normal vs CIN II normal (basal-1). 
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5.5.2 PCA of Normal versus Intermediate 
It has been observed in chapter 4 that in the CIN II diagnosed tissue sample which has 
been identified as Intermediate by KMCA, the relative strengths of the DNA bands 
(including those at 728cm-1 and 856cm-1) increase in the superficial layer as the disease 
moves from the basal layer to the superficial layer. In addition, some bands of glycogen 
were also observed in the superficial layer. KMCA showed the presence of the DNA 
related bands and clustered regions of the superficial layer with the basal layer further 
supporting this. PCA of the normal tissue region gives a more complete picture of the 
spectral differences between the two layers, however, and thus may be more precise in 
elucidating the biochemical differences associated with this early stage of disease 
progression. Moreover, it is of interest to establish whether the characteristics of the basal 
layer itself remain the same or not from one stage of the disease to another. 
The KMCA classified basal layer (basal-2, Figure 4.13) of the diseased region of the CIN 
II diagnosed tissue, presented here as Figure 5.9, was divided into two parts; (i) basal 2a 
(ii) basal 2b, which are histologically less diseased and more diseased respectively and thus 
PCA was applied to determine any biochemical differences between the two parts of the 
basal layer. The basal 2b region was further subdivided into two sub-regions (basal 2b-i 
and basal 2b-ii, according to the line of separation of basal-2a and the superficial layer, as 
indicated in Figure 5.9, and PCA was performed on this data to explore whether these two 
groups are similar or different in their biochemical composition, affected by the 
progression of the disease. Basal-2b-i is expected to be closer in biochemical composition 
to basal-2a and indeed that of the normal region characterised in the previous section 
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(basal-1) and basal-2b-ii may be expected to resemble the normal superficial layer. These 
results are presented in the following sections. 
 
 
 
 
Figure 5.9 H&E stained normal & disease region of CIN II diagnosed tissue with scale bar 
of 200µm  (a) unstained tissue under Raman spectroscope with scale bar of 40µm (b) Five 
cluster KMCA map generated from the Raman map (c). 
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5.5.3 PCA results of basal true normal vs basal 2a 
 
PCA of the basal layer of the true normal vs the normal side of the basal layer of an 
intermediate sample (basal-2a) is presented in Figure 5.10 and Figure 5.11 as scatter plot 
and loadings of the PCA, respectively. It was expected that the basal-true normal would be 
differentiated from the basal-2a in a similar way as basal 1 of the normal-CIN II section. 
Moreover, these differentiating Raman spectral features may be taken as the markers of the 
early stage of the disease or a pre-disease stage.  
As expected, the PCA scatter plot differentiates the two regions. The Raman spectra of the 
basal-true normal are clustered in the negative axis and spectra of the basal-2a in the 
positive axis of the scatter plot. This indicates that the loadings of the PCA which are 
negative, including those at 480 cm-1, 849 cm-1 and 939 cm-1 (glycogen), and some 
loadings related to DNA, including the feature at 718 cm-1 (Adenine), are contributed by 
the basal-true normal layer. The positive loadings associated with the DNA, including 1088 
cm-1 (O-P-O of DNA) and 1346 cm-1 (Guanine) and 1202 cm-1, 1222 cm-1 (amide-III beta 
sheet) and 1675 (amide-I) are contributed by the basal-2a. This can lead us to conclude that 
PCA helps to differentiate the basal-2a from the basal-true normal and confirms that basal-
2a is similar to the basal-1 in biochemical composition, as both layers of the cells are 
closely related to normal but not identical. This is further supported by the observation of 
the similar loadings contributed by the basal-2a region (Figure 5.11) as contributed by the 
basal-1 region, when compared to the basal-true normal by using PCA (Figure 5.8). 
 161 
 
Figure 5.10 PCA Scatter plot for basal-true normal vs basal-2a.  
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Figure 5.11 PCA loading (PC-1) for basal-true normal vs basal-2a.  
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5.5.4 PCA results of CIN II normal (basal-1) vs basal 2a 
To further confirm the PCA results presented in the previous section, PCA of the basal-2a 
and basal-1 was carried out. As both the basal-1 and basal-2a are the normal sides of an 
intermediate cervical tissue sample, it was expected that there will be no proper 
differentiation between their Raman spectral data. 
PCA of these Raman spectral data sets show that PC1, which accounts for 54% of the 
observed variance, does not differentiate them as indicated by the PCA results of the basal-
1 vs the basal-2a (normal side of the basal layer of an intermediate sample) presented in 
Figure 5.12 and Figure 5.13 as scatter plot and loadings of the PCA, respectively. 
Although, PC2 does differentiates the, as indicated by the PCA scatter plot, it explains only 
26 % of the variance in the Raman spectra. Notably, in the PC2 loadings, the major features 
are associated with glycogen, including those at 480, 849, 939cm-1, which may indicate that 
there is difference of the glycogen level in basal-1 compared to basal-2a. As the Raman 
spectra related to basal-1 are clustered in the positive axis and those of the basal-2a in the 
negative (Figure 5.13), the loadings associated with the glycogen in the positive, are 
contributed by the basal-1 region. 
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Figure 5.12 PCA scatter plot for CIN II normal (basal-1) vs basal-2a. 
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Figure 5.13 PCA loadings for CIN II normal (basal-1) vs basal-2a.  
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5.5.5 PCA for Raman spectra of the cervical cancer cell lines 
HPV infection is accepted as a significant factor associated with cervical cancer, and thus, 
in an attempt to guide the interpretation of spectral differences associated with biochemical 
changes in early stage diseased tissue, the Raman profiles of model cell lines were further 
analyzed in an attempt to establish spectroscopic markers for HPV infection. Raman 
spectral data from different HPV-infected human cervical cancer cell lines having different 
numbers of the integrated copies of HPV per cell including HPV 16-positive SiHa (1-2 
copies of HPV per cell) and CaSki (60-600 copies), and HPV 18-positive HeLa cells (20-
50 copies) along with the HPV negative C33A cells (Choi et al., 2005), from a previous 
study conducted in DIT (Ostrowska et al., 2010) was used. This was done to find the 
Raman spectral differences between these model cell lines as a potential spectral marker of 
HPV infection and to compare with the Raman spectral changes/PCA results of the true 
normal cervical tissue vs CIN II normal cervical tissue samples, to establish whether the 
observed differences can be associated with HPV infection in the normal region of the 
diseased sample. The comparison of the HPV negative cell line C33A with the cell line 
with the highest HPV content, CaSki, is presented here, although similar and consistent 
results were seen for the other cell lines. 
The scatter plot for the PCA of the C33A vs CaSki cell lines is presented in Figure 5.14. As 
expected, the cell lines are well differentiated by the first principle component (PC1) which 
accounts for 71.2 % of the variance. The cell lines are not differentiated by PC2, indicating 
that the associated variance is independent of cell line and most likely has origin in point to 
point measurement variations. Figure 5.15 shows the loading of PC1, which indicates the 
spectral features which contribute most to the differentiation. Negative loadings are 
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stronger in the negatively scattered data (CaSki), whereas positive loadings are stronger in 
the positively scattered data (C33A). The features related to the DNA bases, including 
those at 828 cm-1, 1418 cm-1 (O-P-O, DNA), 1181 cm-1, 1318 cm-1 (G), 1344 cm-1, 1491 
cm-1 (A) and 1375 cm-1 (T) are contributed by the CaSki cells, while those at 718 cm-1 (A), 
786 cm-1 (C), 1587 cm-1 (guanine) are contributed by the C33A cells. Features related to 
proteins are also observed, including those at 1661 and 1675 cm-1 (amide-I) are contributed 
by the spectra of the C33A cells.  
The comparison of the PCA loadings of the cell lines, Figure 5.15, with the PCA loadings 
of the basal-true normal versus basal-CIN II normal, Figure 5.8, indicates that there are no 
strongly matching Raman signatures which could lead us to identify the signatures of HPV 
infection in the cervical cancer tissue samples. The loading at 1222 cm-1 (amide-III beta 
sheet) in the basal-true normal versus basal-CIN-II normal may be of interest as it is the 
major difference between the two tissue data sets, but it is not prominent in the loadings 
which differentiates the cell lines.  
Notably, the most prominent bands in Figure 5.8 are protein related and are related to the 
physiological effects of HPV infection in cells, rather than the DNA bands associated with 
the virus itself. Due to the very small genome size of the HPV as compared to the human 
genome, it has been argued that it is unlikely that the signatures of the virus itself can be 
identified (Diem et al., 2012). Notably, the physiological effects of HPV infection in tissue, 
in vivo, may be very different from those in cells, in vitro. Moreover, the Raman spectra 
from the cell lines have been acquired by culturing the cells in vitro and focusing on the 
nucleus of the cells, whereas in the case of the tissue samples, the samples have been 
dewaxed prior to the acquisition of the spectra and data was taken from random points on 
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the tissue rather than specifically cell nuclei. The strong feature at 1222cm-1 in Figure 5.8 
is also present in the intermediate and abnormal samples and maybe considered as an early 
marker of the disease progression and potentially has origin in HPV infection. To further 
confirm this observation, the PCA of the basal layer of the two normal samples including 
“true normal-1” and “true normal-2” is presented in the Appendix, A1.1 and A1.2 as scatter 
plot and loadings respectively. In the loadings, the 1222 cm-1 is not observed which further 
can lead to the conclusion that the amide-III beta sheet (1222 cm-1) may be taken as Raman 
spectral marker of the early progression of the disease. 
 
 
Figure 5.14 PCA scatter plot of C33A vs CaSki cells: C33 A (HPV negative) and CaSki 
(60-600 copies of HPV 16). 
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However, although it can be concluded that Raman spectroscopy certainly has potential for 
detecting the biochemical changes associated with the HPV infection in vitro, for tissue in 
vivo or ex vivo, further controls to establish signatures of infection are required. 
 
 
Figure 5.15 PCA loadings of C33A vs CaSki cells; C33 A is HPV negative and CaSki 
having 60-600 copies of HPV 16.  
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5.6 Results: Diseased basal and superficial layers 
 
5.6.1 PCA of basal-true normal vs basal-2b-i 
PCA analysis of basal-true normal versus basal-2b-i is performed to explore biochemical 
differences between these layers, as basal-2b-i is expected to be closer in biochemical 
composition to basal-true normal as compared to basal-2b-ii. 
PCA results of the basal-true normal vs basal 2b-i, are presented in Figure 5.16 and Figure 
5.17 as scatter plot and loadings of the PCA, respectively. It can be seen in the PCA scatter 
plot that the two groups are different from each other and the Raman spectra of the basal-
true normal are clustered in the negative axis and spectra of the basal-2b-i in the positive 
axis. Notably, the major difference which can be identified at first glance is the presence of 
glycogen related bands at 482 cm-1, 849 cm-1 and 938 cm-1 in the negative sense, solely 
contributed by the Raman spectra of the basal-true normal . This indicates that the basal-
true normal layer, as expected, has more glycogen in the cells as compared to the basal-2b-
i. Moreover, this also means that the cells of the basal-2b-i are more proliferative in nature 
as compared to the basal-true normal and hence the glycogen content is reduced due to its 
consumption by the cells during the process of the cell growth or proliferation. Another 
important loading is that at 1222 cm-1 (amide-III beta sheet) which is contributed by basal-
2b-i and differentiates the Raman spectra of this layer from those of the true normal. It 
should be noted that this band has been observed throughout the PCA results in this 
chapter, normal versus abnormal regions, apart from the PCA of the cell lines, and remains 
the exclusive contribution by the diseased parts of the cervical tissue samples but not by the 
Raman spectra of the true normal sample. This again suggests that this signature could be 
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associated with HPV infection in the cervical tissue samples. Other negative loadings of the 
PCA including 524 cm-1 (S-S stretching), 718 cm-1  (Adenine) and 1348 cm-1 (tryptophan 
ring breathing) are contributed by the basal true normal and the positive loadings including 
669 cm-1 (thymine), 788 cm-1, 1088 cm-1 (O-P-O of DNA) 1062 cm-1 (C-N stretching) 
correspond to the basal-2b-i. This can lead us to the conclusion that basal-2b-i does not 
seem normal or seems to have more dividing /DNA rich cells as compared to the cells of 
the basal-true normal layer (true normal case). 
 
 
Figure 5.16 Scatter plot of PCA for basal-true normal vs basal-2bi. 
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Figure 5.17 Loadings of PCA for basal-true normal vs basal-2bi. 
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5.6.2 PCA for basal-2a versus basal-2b 
Figure 5.18 and Figure 5.19 represent the PCA scatter plot and loadings of the PCA for 
basal-2a vs basal-2b, respectively. The basal-2a and basal-2b, are the less diseased part and 
the more diseased part of the cervical tissue section presented in the stained tissue section, 
Figure 5.9. On the basis of the fact that DNA related Raman features are dominantly 
observed in the more diseased part as compared to the less diseased/normal part of the 
tissue, the basal-2b region is expected to give more DNA related features as compared to 
the basal-2a. 
 
A good separation of the two layers was observed, as indicated by two well distinguished 
clusters of the spectra in the PCA scatter plot. In the PCA scatter plot, the cluster of the 
Raman spectra of the basal-2a layer is observed on the negative side of PC1 and Raman 
spectra of the basal-2b layer in the positive. 
 
It is very interesting and important to mention that the loadings of the PCA give very useful 
further information here regarding the state of the disease and are consistent with the 
different degree of disease of the different regions of the cervical tissue section. All the 
loadings related to the characteristic Raman features of DNA bases, including those at 669 
cm-1 (T), 718 cm-1 (A), 782 cm-1 (C), 826 cm-1 (O-P-O, DNA) and 888 cm-1 (deoxyribose 
ring breathing) are present on the positive side and hence are associated with the basal-2b 
part (more diseased) of this cervical tissue section. The negative loadings include 482 cm-1 
(glycogen), 1158 cm-1 (C-N stretching), 1172 cm-1 (tyrosine), 1449 cm-1 (CH deformation) 
and 1675 cm-1(amide-I) and are associated with the basal-2a, which is the less diseased side 
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of the basal-2 layer. Thus, although they are grouped by KMCA, basal-2a resembles more a 
normal tissue state, whereas basal-2b is more characteristic of the diseased state. 
 
Figure 5.18 Scatter plot of PCA for basal-2a vs basal-2b. 
 
 
 175 
 
 
Figure 5.19 Loadings of PCA for basal-2a vs basal-2b. 
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5.6.3 PCA for basal-2bi vs basal-2bii 
 
PCA results of the basal 2b-i and basal 2b-ii, two subdivisions of the basal 2b, intermediate 
IV, which is the more diseased part of an intermediate sample, are presented here in Figure 
5.20 and Figure 5.21 as scatter plot and loadings of the PCA, respectively. The purpose of 
this analysis was to establish whether these two groups are similar or different in their 
biochemical composition affected by the progression of the disease, and on what basis the 
KMCA of the Raman data clustered them. 
It is clear from the PCA scatter plot that the two groups are not very different from each 
other as, although they are partially differentiated, they overlap to some extent. The Raman 
spectra of basal-2bi are largely clustered in the negative axis and spectra of the basal-2bii in 
the positive axis. This means that the loadings of the PCA which are negative, including 
669 cm-1 (thymine), 782 cm-1 (cytosine) and 1062 cm-1 (O-P-O of DNA), correspond to the 
basal-2b-i and the positive ones including 718 cm-1, 1238 cm-1 (adenine), 1260 cm-1 
(thymine) and 1278 cm-1 (cytosine), correspond to the basal-2b-ii region.  
Notably, the results of the KMCA of the intermediate IV sample, presented in chapter 4, 
Figure 4.17C & 4.18 as a KMCA pseudo colour map and representative spectra 
respectively, showed the presence of the characteristic features of the basal layer in the 
superficial layer, which raised the question of whether these features are developed in the 
superficial layer itself or are due to the possibility of the invasion of the basal cells into this 
layer. It should be noted that the loadings of the PCA between basal-2bi and basal-2bii, 
Figure 5.21, are very different than those of the basal versus superficial (Figure 5.5) as 
there are no representations of glycogen in the former as compared to the latter. The 
 177 
differentiating features are rather associated with DNA, characteristic of rapidly 
proliferating cells. Moreover, under normal conditions, the basal layer provides cells to the 
superficial layer, but those cells are under controlled growth and have the ability to store 
glycogen during the process of the maturation, and only matured cells having stored 
glycogen move into the superficial layer. This may lead to the conclusion that during the 
progression of the cervical cancer, rapidly proliferating basal cells, rich in DNA and 
lacking in glycogen, invade the superficial layer due to the progression of the disease. The 
KMCA clustering of the basal 2bii layer with the basal 2bi layer is a representation of this 
process. 
 
Figure 5.20 Scatter plot of PCA for basal-2bi vs basal-2bii. 
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Figure 5.21 Loadings of PCA for basal-2bi vs basal-2bii.  
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5.6.4 PCA of basal-true normal vs basal-2b-ii 
 
PCA analysis of basal-true normal versus basal-2b-ii was carried out to explore 
biochemical differences between these layers, as basal-2b-ii was expected to be different 
from the basal-true normal and resemble the superficial layer of the true normal sample. It 
should be noted that the basal-2b-ii derives from the superficial layer and has been named 
basal due to the classification of KMCA on the basis of the observation of the DNA related 
bands, in chapter 4. 
PCA results of the basal-true normal vs basal 2b-ii are presented in Figure 5.22 and Figure 
5.23 as scatter plot and loadings of the PCA, respectively. It can be seen in the PCA scatter 
plot that the two groups are different from each other and the Raman spectra of the basal-
true normal are clustered in the negative axis and spectra of the basal-2b-ii in the positive 
axis. Once again, the major difference between the two groups of the Raman spectra 
appearing in the form of the loadings is the presence of the glycogen related bands at 482 
cm-1, 849 cm-1 and 938 cm-1, which are solely contributed by the Raman spectra of the 
basal-true normal (in the negative). This confirms, as described earlier, that the basal-true 
normal layer of the cells is rich in glycogen as compared to the basal-2b-ii. In addition, the 
cells of the basal-2b-ii appear to be more proliferative in nature as compared to the basal-
true normal and hence glycogen content is reduced due to its consumption by the cells 
during the process of the cell growth or proliferation. The loading observed at 1222 cm-1 
(amide-III beta sheet), contributed by basal-2bii, is again the predominant difference 
between these two groups of spectra and is consistent with the previous PCA results, 
further indicating that it may be associated with HPV infection, making the tissue abnormal 
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and differentiating it from the Raman spectra of the basal layer of the true normal sample. 
Other positive loadings contributed by the basal-2b-ii include those at 669 cm-1 , 759 cm-1 
(thymine), 1062 cm-1 (C-N stretching) and by the basal true normal include 644 cm-1and 
1108 cm-1 (C-C stretching) and 1348 cm-1 (tryptophan ring breathing). 
 
 
Figure 5.22 Scatter plot of PCA for basal-true normal vs basal-2b-ii.  
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Thus the basal-2b-ii is well differentiated from the true normal basal layer and seems to 
have more dividing /DNA rich cells as compared to the cells of the basal-normal layer 
(normal case). In addition, no positive loadings associated with glycogen are seen, which 
are normally contributed by the superficial layer. It can be concluded that basal-2b-ii is not 
similar or close to the biochemical composition of the superficial layer. To further confirm 
this, PCA of basal-2b-ii vs superficial is performed and presented in the following section. 
 
 
Figure 5.23 Loadings of PCA for basal-true normal vs basal-2b-ii.  
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5.6.5 PCA of basal-2b-ii versus superficial 
 
To elucidate the expected similarities between the basal-2b-ii layer and the superficial layer 
of the true normal (superficial-true normal) cervical tissue section, PCA is performed on 
these groups of Raman spectra. Notably, the basal-2b-ii layer was originally superficial 
layer and has been named basal due to the presence of DNA bands (shown by KMCA in 
previous chapter). 
 
It can be seen in the PCA scatter plot, presented in Figure 5.24, that the two groups are 
differentiated from each other and the Raman spectra of the superficial layer are clustered 
in the positive axis and spectra of the basal-2b-ii layer in the negative axis. This means that 
the loadings of the PCA, shown in Figure 5.25, which are positive, including those at 480 
cm-1, 853 cm-1 and 938 cm-1 (glycogen), 1136 cm-1 (C-C skeletal stretching), 1355 cm-1 
(tryptophan ring breathing), 1386 cm-1 (CH3 bending), derive from the superficial layer. 
The negative loadings contributed by basal-2b-ii, including those at 669 cm-1, 749 cm-1, 
1235 cm-1 (thymine) 728 cm-1, 1208 cm-1 (adenine), 783 cm-1 (cytosine), and 1182 cm-1, 
1313 cm-1 (guanine) are related to DNA and at 1044 cm-1 (CH bending), 1228 cm-1 (amide-
III beta sheet), 1449 cm-1 (CH deformation) and 1675 cm-1 (amide-I) are attributed to the 
proteins. 
It can be concluded that the cells of the superficial and basal-2b-ii are not similar, as shown 
by the scatter plot and translated into the loadings of the PCA. Moreover, the loadings 
contributed by the Raman spectra of the basal-2b-ii are attributed to DNA and no glycogen 
related loadings are contributed by the cells in this layer. These changes, including the 
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absence of the glycogen contents in the cells of the basa-2b-ii layer as compared to the 
superficial-true normal, differentiate the samples and lead to the conclusion that the 
hypothesis made in the chapter 4 on the basis of the KMCA results of “invasion of the 
basal cells into the superficial layer during the progression of the disease” is true and in fact 
the changes are not occurring in the superficial layer itself. 
 
 
Figure 5.24 PCA scatter plot for basal-2b-ii versus superficial. 
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Figure 5.25 PCA loadings for basal-2b-ii versus superficial. 
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5.6.6 PCA of basal-true normal vs basal-3 
 
PCA of the basal layer of the normal cervical tissue sample (basal-true normal) versus the 
basal layer of an intermediate sample (basal-3) is presented in Figure 5.26 and Figure 5.27 
as scatter plot and loadings of the PCA, respectively. The PCA scatter plot shows a good 
separation of the clusters of the spectra and indicates that the two groups are significantly 
different from each other. The Raman spectra of the basal-true normal layer are clustered in 
the negative axis and the spectra of the basal-3 layer are clustered in the positive axis. The 
basal-true normal layer contributes the negative loading of the PCA at 480 cm-1, 849 cm-1, 
939 cm-1 (glycogen), related to the glycogen and some other loadings including those at 
644 cm-1 (C-C stretching), 718 cm-1  (adenine), 831 cm-1 (tyrosine), 1056 cm-1  and 1088 
cm-1 (O-P-O, DNA). The positive loadings include those at 1102 cm-1 (C-C stretching), 
1202 cm-1 and 1222 cm-1 (amide-III beta sheet), 1346 cm-1 (guanine) and are contributed by 
the basal-3 layer. These features, particularly related to amide-III beta sheets of proteins, 
are consistent with the results of the basal-true normal versus basal-2 and its sub-regions, 
discussed in section 5.7 and maybe indicative of the .HPV infection as these are 
consistently observed in the PCA loadings of the basal true normal versus the diseased 
samples but require further investigation. 
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Figure 5.26 PCA Scatter plot for basal-true normal vs basal-3. 
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Figure 5.27 PCA loading (PC-1) for basal-true normal vs basal-3. 
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5.6.7 PCA results of basal-3-i vs basal-3-ii 
 
PCA results of the two parts of  the, basal layer (basal-3) of an intermediate sample III, 
presented in chapter 4 in Figure 4.15, which are called basal 3b-i and basal 3b-ii as 
explained in Figure 5.28, are presented here in Figure 5.29 and Figure 5.30 as scatter plot 
and loadings of the PCA, respectively. The purpose of this analysis was to establish 
whether these two groups are similar or different in their biochemical composition affected 
by the progression of the disease and to confirm the findings of the PCA of basal-2bi-vs-
basal-2bii (Figure 5.19) where it was concluded that during the progression of the cervical 
cancer, rapidly proliferating basal cells, rich in DNA and lacking in glycogen, invade the 
superficial layer due to the progression of the disease. 
 
The basal-3b-i layer was expected to be similar in biochemical composition to the basal-
true normal layer (normal case) while the basal-3b-ii layer was expected to be different 
from the basal-true normal layer and to resemble the superficial layer of the true normal 
sample. It should be noted that basal-3b-ii was originally superficial layer and has been 
called basal due to the observation of the DNA bands (shown by KMCA in previous 
chapter) which can be associated with the progression of the cervical cancer into the 
superficial layer from the basal layer of the intermediate tissue section. 
 
The PCA scatter plot shows that the two groups are different from each other but some 
overlap is observed. The Raman spectra of the basal-3b-i layer are clustered in the positive 
axis and spectra of the basal-3b-ii layer in the negative axis. This indicates that the positive 
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loadings of the PCA, including 669 cm-1, 755 cm-1 (thymine), 577 cm-1, 783 cm-1 (cytosine) 
correspond to the basal-3b-i layer and the negative loadings, including those at 1248 cm-1, 
1340 cm-1 (adenine), 1375 cm-1 (thymine) and 1092 cm-1 (O-P-O of DNA) are contributed 
by the basal-3-ii layer. Notably, the 480 cm-1 (glycogen) loading is negative, contributed by 
basal-3ii but other glycogen related loadings including 849 cm-1, 938 cm-1 are contributed 
by the basal-3i and not by the basal-3ii. This indicates that there is depletion of the 
glycogen in the basal-3ii, although not completely depleted as indicated by observation of 
only one feature of the glycogen at 480 cm-1 only, and increase in the DNA related 
features. These  
 
 
Figure 5.28 H&E stained disease side of CIN II marked tissue with scale bar of 200µm (a) 
unstained tissue under Raman spectroscope, 40µm (b) Five cluster KMCA map generated 
from the FTIR map (c). 
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Figure 5.29 Scatter plot of PCA for basal-3i vs basal-3ii. 
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Figure 5.30 Loadings of PCA for basal-3i vs basal-3ii. 
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5.6.8 PCA results of basal-true normal vs basal-carcinoma 
 
Figure 5.32 and Figure 5.33 represent the scatter plot and loadings of the PCA 
respectively, for the Raman spectra from the basal layer of the normal case (basal-true 
normal) against the basal layer of an abnormal sample called basal-carcinoma (carcinoma 
in situ) presented in Figure 5.31 has been rproduced here from chapter 4 (Figure 4.9). The 
differentiation of the two groups can be seen as the clustering of the Raman spectra of the 
basal-true normal in the negative axis and those of the basal-carcinoma in the positive axis 
of the scatter plot. 
 
The loadings of the PCA contributed by the basal-true normal include 482 cm-1, 849 cm-1 
and 938 cm-1 (glycogen), 718 cm-1 (Adenine) and 644 cm-1, 1144 cm-1 (C-C stretching). 
The basal-carcinoma contributes the loadings including 669 (thymine), 782 (cytosine), 781 
(cytosine) and 1062 (C-N stretching) and 1116 (C-C stretching). This shows that there are 
more DNA related loadings contributed by the abnormal case as compared to the true 
normal case which is due to the presence of more dividing cells and in turn more DNA 
content in the abnormal sample. The features associated with the amide-III including 1222 
is very much reduced in their intensity. Notably, this is the most diseased sample (abnormal 
most) and similar reduction in the intensity of these bands is observed in the PCA of the 
basal-true normal against the basal-7 sample as presented in the respective loadings in the 
Appendix (Figure A1.12). The reduction of the amide-III related features may indicate the 
integration of the HPV virus into the host genome instead of its present with the protein 
coat independently in the host cell. 
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Figure 5.31 H&E stained carcinoma in situ marked tissue with scale bar of 200µm  (a) 
unstained tissue under Raman spectroscope with scale bar of 40µm  (b) Five cluster KMCA 
map generated from the Raman map (c). 
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Figure 5.32 PCA scatter plot for basal-true normal versus basal-carcinoma. 
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Figure 5.33 PCA loading (PC-1) for basal-true normal versus basal-carcinoma. 
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5.6.9 Summary 
 
The major goals of the above described analyses were to evaluate the ability of Raman 
micro spectroscopy to determine the biochemical changes occurring in the different parts of 
the tissue structure, to establish the signatures of HPV infection in the cervical tissue 
samples by comparing them with the cell line data, and to elucidate the biochemical 
changes which lead to the results of the KMCA which indicate invasion of the basal 
layer/characteristics of the basal layer into the superficial layer. 
The PCA results presented so far in this chapter, including comparison of different basal 
layers of the true normal, CIN II normal, sub-regions of the basal-2 and basal-3 layers 
along with the cell lines representative of cervical cancer, have led to different conclusions. 
The comparison of the PCA loadings of the cell lines, Figure 5.15 with the PCA loadings 
of the true normal basal versus CIN II normal basal, Figure 5.8, have indicated that there 
are no strongly matching Raman signatures which could lead us to identify the signatures 
of HPV infection in the cervical cancer tissue samples. The loading at 1222 cm-1 (amide-III 
beta sheet) in the basal-true normal versus basal-CIN-II normal may be of interest as it is 
the only major difference between the two data sets reflected in the form of loading of the 
differentiating PC1, but it is absent in the loadings of the cell lines. The amide-III feature 
(1222 cm-1) is consistently present in the loadings of the PCA contributed by the basal 
layers of the intermediate and abnormal samples in the PCA with the basal-true normal. 
Thus this feature may be considered as an early marker of disease progression and could 
potentially indicate HPV infection. Notably, this loading is much reduced in intensity in the 
carcinoma in situ sample shown in Figure 5.33 (Figure 4.8 in chapter 4 called abnormal 
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III) and most extreme abnormal sample (Figure 4.7 in chapter 4 called abnormal II) 
presented in the Appendix, Figure A1.XII. As, these are the most diseased samples and 
the reduction of the intensity of amide-III related feature may indicate that at this stage of 
the disease, integration of the HPV virus into the host genome has taken place instead of its 
presence with the protein coat independently in the host cell. 
 
PCA of the basal-true normal against the basal layers of the intermediate and abnormal 
samples (basal 4-7) has also been carried out to differentiate the biochemical changes 
which take place due to the progression of the disease from the normal case to the 
intermediate and abnormal stages and the results are presented in the Appendix. 
 
The following conclusions can be made from the PCA results: 
a) The basal layer of the CIN II normal is different to the basal layer of the true 
normal. 
b) The CIN II normal basal region, far from the diseased area, is similar in 
biochemical content to the basal region close to the diseased area. 
c) The basal region in the diseased section is already low in glycogen and rapidly 
proliferating. 
d) The changes in the superficial layer are due to rapidly proliferating cells invading 
into this layer. 
e) The amide-III feature (1222 cm-1) which is consistently observed in the loadings of 
the PCA contributed by the basal layers of the intermediate and abnormal samples 
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in the PCA with the basal-true normal may be considered as an early marker of 
disease progression and may be indicative of the HPV infection. 
 
5.7 Results: Diseased basal and stroma layers 
 
5.7.1 PCA of stroma-true normal versus sub-regions of the stroma-3 
One of the indications from chapter 4 was that cervical cancer progression from the basal 
layer into the stromal layer is shown by the results of the KMCA, based on the observation 
of more DNA bands/basal like characteristics in the stromal layer of the intermediate or 
abnormal cervical tissue samples as compared to that of the normal sample. The question is 
therefore raised as to whether this progression takes place due to the invasion of the basal 
cells into the stroma or whether there are some biochemical changes which have taken 
place in the cells of the stroma layer itself, due to the changes in the biochemistry of the 
basal layer. For this purpose, the stromal layer (stroma-3) of the sample called intermediate 
III (Figure 4.15) in chapter 4, has been compared with the stroma-true normal, Figure 4.1 
in chapter 4 by using PCA. Moreover, stroma-3 has been divided into two sub-regions, 
stroma-3i and stroma-3ii, as identified by the KMCA in chapter 4. These subgroups of 
stroma-3 are made on the basis of the DNA bands/basal like characteristics in some parts, 
stroma-3i, and other parts having typical characteristics of the stroma (collagen related 
bands), stroma-3ii, as indicated in Figure 5.34. The red and blue clusters in the stromal 
layer correspond to stroma-3i and stroma-3ii, respectively. The PCA of the Raman spectra, 
comparing these sub-regions, as well as stroma-true normal, is presented in the following 
sections. 
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Figure 5.34 H&E stained disease side of CIN II marked tissue with scale bar of 200µm (a) 
unstained tissue under Raman spectroscope, 40µm (b) Five cluster KMCA map generated 
from the FTIR map (c). 
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5.7.2 PCA of stroma-true normal versus stroma-3i 
The PCA results of the stroma-true normal versus stroma-3i are presented in Figure 5.35 
and Figure 5.36 as PCA scatter plot and loadings, respectively. The differentiation of the 
two groups can be seen, although not very distinctively, as the clustering of the Raman 
spectra of the stroma-true normal in a negative sense with respect to PC1 and the stroma-3i 
in the positive sense. This means that the loadings appearing in the negative are contributed 
by the stroma-true normal and those in the positive are contributed by the stroma-3i. 
The major differentiating factors between the two groups of Raman spectra reflected in the 
form of the loadings are the features associated with collagen, including those at 853 cm-1, 
877 cm-1, 920 cm-1 and 939 cm-1, which are contributed by the stroma-true normal and are 
completely absent in the stroma-3i. This indicates a depletion of the collagen content of the 
identified regions of the stroma-3i layer due to the development and progression of the 
cervical cancer. The other differentiating factor between the two groups is the features 
related to the DNA, which are mainly contributed by the stroma-3i, and include those at 
1218 cm-1 (T), 1245 cm-1 (A), 1272 cm-1 (C) and 1308 cm-1, 1340 cm-1 and 1360 cm-1 (G), 
apart from the two bands at 765 cm-1 (T) and 815 cm-1 (O-P-O, DNA) which are 
contributed by the stroma-true normal. 
 
There are some features associated with proteins, including those at 570 cm-1 (S-S 
stretching), 902 cm-1 (C-C stretching), 1031 cm-1 (C-N stretching), 1449 cm-1 (CH 
deformation) and 1665 cm-1 (amide-I), contributed by the stroma-true normal and those 
contributed by the stroma-3i include 1118 cm-1 (C-C stretching) and 1145 cm-1 (C-N 
stretching). 
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Notably, the two observations of significant depletion of the collagen content and increase 
in the DNA content in the stroma-3i as compared to the stroma-true normal layer, may lead 
to the conclusion that due to the depletion of the collagen during disease progression, 
relative to the DNA, collagen has a diminished contribution at some points in the Raman 
map of the stroma, and KMCA in chapter 4 recognises the greater similarities with the 
DNA rich cells of the basal layer. This depletion of the collagen and increase in the DNA 
features may be the result of changes to the stromal cells themselves or associated with the 
invasion of the basal cells into the stroma and requires further analysis including PCA of 
the stroma and basal layers of the abnormal and intermediate samples consisting of stroma-
4 versus basal-4 and stroma-6 versus basal-6, presented in this section.  
 
Figure 5.35 PCA scatter plot for stroma-true normal vs stroma 3-i. 
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Figure 5.36 PCA loadings for stroma-true normal vs stroma 3-i. 
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5.7.3 PCA of stroma-true normal versus stroma-3ii 
The PCA results of the stroma-true normal versus stroma-3ii are presented in Figure 5.37 
and Figure 5.38 as PCA scatter plot and loadings, respectively. The spectra of the stroma-
true normal are clustered in the negative axis with respect to PC1 and the stroma-3ii in the 
positive axis, showing the differentiation of the two groups. This indicates that the loadings 
in the negative sense are contributed by the stroma-true normal and those in the positive are 
contributed by the stroma-3ii dataset. The differentiation between the two groups of the 
spectra seems to be due to collagen and DNA related features, reflected in the form of the 
loadings. The features associated with collagen, including those at 853 cm-1, 877 cm-1, 920 
cm-1 and 939 cm-1, are contributed by the stroma-true normal and are completely absent in 
the stroma-3ii. The other differentiating factor between the two groups is the features 
related to DNA, which are predominantly contributed by the stroma-3ii, including those at 
1218 cm-1 (T), 1245 cm-1 (A), 1272 cm-1 (C) and 1320 cm-1, 1340 cm-1 and 1360 cm-1 (G), 
although two bands including 765 cm-1 (T) and 815 cm-1 (O-P-O, DNA) are contributed by 
the stroma-true normal. 
Some features associated with proteins are observed, including those at 902 cm-1 (C-C 
stretching), 1031 cm-1 (C-N stretching), 1449 cm-1 (CH deformation) and 1665 cm-1 
(amide-I), contributed by the stroma-true normal and those contributed by the stroma-3ii 
include 1118 cm-1 (C-C stretching) and 1145 cm-1 (C-N stretching). 
As mentioned in the case of the PCA loadings of the stroma-true normal versus stroma-3i, 
the two observations, including significant depletion of the collagen content and the 
increase in the DNA content in the stroma-3ii as compared to the stroma-true normal layer 
may indicate that the depletion of the collagen during the disease progression and increased 
 204 
levels of DNA maybe the results of changes to the stromal cells themselves or associated 
with the invasion of the basal cells into the stroma. 
 
 
 
Figure 5.37 PCA scatter plot for stroma-true normal vs stroma 3-ii. 
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Figure 5.38 PCA loadings for stroma-true normal vs stroma 3-ii. 
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5.7.4 PCA of stroma-3i versus stroma-3ii 
As discussed in the previous sections, the two types of the stromal layers, namely the 
stromal 3-i and stromal-3ii regions, are differentiated from the stroma-true normal, by 
PCA. Notably, KMCA showed that the stroma-3i corresponds to the pixels which do not 
show any features associated with collagen and was considered to be due to the 
development of the biochemical changes in the stroma consisting of the basal like 
characteristics. The stromal-3ii region was categorised by KMCA to be the diseased 
stromal layer, indicated by the presence of some collagen related bands. However, in the 
previous section, PCA loadings contributed by the stroma-3ii, did not show any features 
associated with collagen. In order to establish whether these two sub-regions/groups of the 
spectra are biochemically different from each other and the origin of that difference, PCA 
of these two groups of spectra was performed and the results are presented in Figure 5.39 
and Figure 5.40 as PCA scatter plot and loadings, respectively. 
The PCA scatter plot does not show any differentiation of the two groups with respect to 
PC1 (78.2%) and only a slight differentiation according to PC2 (10.4%). According to PC2, 
the stroma-3i spectra are clustered in the positive and stroma-3ii in the negative sense. The 
loadings contributed by the stroma-3i include those at 509 cm-1 (S-S stretching), 642 cm-1 
(C-C stretching), 783 cm-1 (C), 1218 cm-1 (T) and 1340 cm-1 (G) while stroma-3ii 
contributes the features associated with collagen including 853 cm-1, 877 cm-1, 920 cm-1 
and 939 cm-1. Notably, there are no features of collagen contributed by the stroma-3i data, 
which can lead to the conclusion that the pixels identified by the KMCA as separate 
clusters in the stromal layer of the intermediate-III sample in chapter 4 (Figure 4.15), are 
actually associated with the biochemical changes in the cells of the stromal layer.During 
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cervical cancer progression, collagen can have a diminished contribution, relative to the 
DNA contribution, at some points in the Raman map of the stroma of the above mentioned 
sample, and KMCA recognises the greater similarities with the DNA rich cells of the basal 
layer. Moreover, the presence of the collagen related bands in the loadings contributed by 
stroma-3ii confirms the findings of the KMCA, whereby this sub-region was shown to have 
some collagen content, albeit diminished, as indicated by PC1 of the PCA of the stroma-
true normal versus stroma-3ii (Figure 5.35). 
 
 
Figure 5.39 PCA scatter plot for stroma-3i vs stroma 3-ii.  
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Figure 5.40 PCA loadings (PC1 & PC2) for stroma-3i vs stroma 3-ii.  
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5.7.5 PCA results of the stroma versus basal layers of abnormal and intermediate 
cervical samples 
PCA of the Raman spectral data of the stromal layers of abnormal and intermediate 
samples (stroma-4 and stroma-6) versus their respective basal layers (basal-4 and basal-6) 
is presented in the following sections. PCA of (a) stroma of the abnormal (stroma-4) versus 
basal-5 and (b) stroma of the intermediate (stroma-6) versus basal-6 as well as their 
comparison may lead to the elucidation of the biochemical changes occurring in the stromal 
layers of these samples and also how these changes can bring them close in their 
biochemical composition to their respective basal layer. 
 
5.7.5.1 PCA of Stroma vs Basal of the abnormal sample/ Stroma-4 vs basal-4 
As confirmed in the previous sections the finding of the KMCA indicates that the increased 
basal layer-like characteristics in the stromal layer are associated with disease progression 
and biochemical changes in the stromal layer itself. To further confirm these findings, PCA 
of stroma-4, the stromal layer of the abnormal-I sample in chapter 4, Figure 4.5, with the 
basal-4 data set, which belongs to the same sample, was carried out.  
Figure 5.41 and Figure 5.42 represent the scatter plot and loadings of the PCA for the 
Raman spectra from stroma-4, the stromal layer of the abnormal-I characterised sample in 
chapter 4, Figure 4.5, with the basal-4 data set, which belongs to the same sample. The 
differentiation of the two groups can be seen as the clustering of the Raman spectra of the 
stroma-4 in a positive sense with respect to PC1 and the basal-4 in the negative sense. 
Figure 5.42 indicates collagen related loadings of PC1, including those at 853 cm-1, 874 
cm-1, 921 cm-1 and 939 cm-1, which are associated with the stromal layer. The presence of 
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these collagen related features indicates that here, collagen has not been depleted 
completely. Other positive loadings associated with the stroma-4 layer are associated with 
DNA and include those at 429 cm-1, 751 cm-1 (thymine), 721 cm-1 (adenine), 775 cm-1, 781 
cm-1 (cytosine), 827 cm-1 (O-P-O of DNA) and 898 cm-1 (deoxyribose ring breathing). 
DNA related loadings are in fact seen in both negative and positive senses, indicating the 
presence of the features of the DNA in the basal layer and the stromal layer. Negative 
loadings associated with DNA which are contributed by the basal-4 layer include those at 
1220 cm-1 (adenine) and 1318 cm-1, 1340 cm-1 (guanine). Notably, these findings can be 
confirmed from the PCA loadings of the basal-true normal versus stroma-normal presented 
in the Figure 5.3, where the features contributed by the stroma-normal were only related to 
collagen including those at 853 cm-1, 921 cm-1, 939 cm-1 and 1242 cm-1, along with some 
protein related features at 1165 cm-1, 1195 cm-1 (C-N stretching) and 1655 cm-1 (amide-I) 
and there were no DNA features observed. The loadings associated with proteins, including 
those at 1003 cm-1 (phenyl alanine), 1129 cm-1 (C-N stretching), 1449 cm-1 (CH 
deformation) and 1655 cm-1 (amide-I) are contributed only by the basal-4 layer (in 
negative) and differentiate this layer from the stromal layer. 
The observation of the collagen related bands contributed by stroma-4 indicates that there 
is still some collagen present, although the DNA features are increased as compared to the 
normal stroma. This confirms the observations of the previous section that, due to the 
depletion of the collagen during disease progression, the cells of the stromal layer exhibit a 
more DNA rich Raman spectrum. This can explain why the KMCA in chapter 4 clusters 
the basal and stromal groups as one cluster, as relative to the DNA, collagen has a 
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diminished contribution at some points in the Raman map of the stroma, and KMCA 
recognises greater similarities with the DNA rich cells of the basal layer. 
 
 
Figure 5.41 PCA scatter plot for stroma-4 vs basal-4. 
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Figure 5.42 PCA loading (PC-1) for stroma-4 vs basal-4. 
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5.7.5.2 PCA of Stroma vs Basal of the Intermediate sample/ Stroma-6 vs basal-6 
 
Figure 5.43 and Figure 5.44 represent the scatter plot and loadings of the PCA for the 
Raman spectra from the stromal layer of the intermediate sample and its basal layer, termed 
basal-6. The differentiation of the two groups can be seen as the clustering of the Raman 
spectra of the stroma of the intermediate sample (stroma-6) in the positive sense of PC1 
and those from the respective basal layer (basal-6) in the negative sense. The positive 
loadings correspond to the stroma and the negative loadings correspond to the basal layer. 
Collagen related loadings including those at 853 cm-1 and 939 cm-1 are contributed only by 
the stromal layer in the positive and are characteristic features of this layer and differentiate 
it from the basal-6 layer. Other loadings contributed by the stromal layer are associated 
with DNA and include those at 815 cm-1 (O-P-O of DNA), 898 cm-1 (deoxyribose ring 
breathing), 1243 cm-1 (thymine) and 1272 cm-1 (guanine). The loadings associated with 
DNA which are contributed by the basal-6 layer include those at 1218 cm-1 (adenine) and 
1340 cm-1 (guanine). The negative loadings associated with proteins, including those at 
1003 cm-1 (phenyl alanine), 1449 cm-1 (CH deformation) and 1655 cm-1 (amide-I), are 
contributed by the basal-6 layer and differentiate this layer from the stromal layer. 
 
The observation of the collagen related bands contributed by stroma-6 indicates that there 
is still some collagen, although the DNA features are increased as compared to the normal 
stroma. This supports the conclusion that the biochemical changes observed are associated 
with the cells of the stromal layer themselves.  
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Figure 5.43 PCA scatter plot for stroma-6 vs basal-6. 
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Figure 5.44 PCA loading (PC-1) for stroma-6 vs basal-6. 
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5.7.5.3 Comparison of the PCA results of stroma of abnormal (stroma-4) vs basal-4 
and stroma of intermediate (stroma-6) vs basal-6  
 
Comparison of the PCA scatter plots and loadings for (a) stroma of abnormal (stroma-4) vs 
basal-4 and (b) stroma of intermediate (stroma-6) vs basal-6 was made. The PCA scatter 
plot of stroma-4 vs basal-4 shows that the cluster of the Raman spectra of the stromal layer 
of this sample is closer to the cluster of the basal layer of the same sample (Figure 5.41) as 
compared to the clusters of the stroma-6 and basal-6 shown in the scatter plot (Figure 
5.43). 
The collagen loadings contributed by stroma-4 (stroma-abnormal), shown in Figure 5.42, 
including those at 853 cm-1 and 939 cm-1, are weaker as compared to those contributed by 
stroma-6 (stroma-intermediate) shown in Figure 5.44. 
The comparison of the 400-1000 cm-1 region of the PCA loadings for both types of the 
PCA analysis clearly shows that the major difference in this part is based on increased 
DNA related loadings in stroma-4 as compared to stroma-6, in which the major loadings 
observed derive from collagen. 
Consideration of the 1000-1800 cm-1 region shows that, in the loadings of stroma-4, there 
are no protein related features but in the stroma of the intermediate there are two strong 
loadings which are related to proteins at 1108 cm-1 and 1141 cm-1. 
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5.8 Conclusion 
 
In this chapter, Raman micro spectroscopy, with the aid of PCA, has been employed to 
determine the biochemical changes occurring in the different layers of the cervical tissue 
samples, namely the basal, stromal and superficial layers. PCA has been found to be very 
useful to further interpret the results of the KMCA and to elucidate the differentiation of 
the basal-true normal and basal-CIN II normal (far from diseased), both of which have been 
found different than the basal layers of the diseased samples. This means that in order to 
predict the presence of the disease it is not required to essentially go for the region of 
disease and suggests that Raman micro spectroscopy can identify onset of disease before 
the morphological changes.  
The comparison of the PCA loadings of the HPV negative and positive cell lines (C33A 
and CaSki), with the PCA loadings of the basal-true normal versus basal-CIN II normal 
indicated that there are no strongly matching Raman signatures which could lead us to 
identify the signatures of the HPV infection in the cervical cancer tissue samples. However, 
there is a feature associated with the amide-III beta sheet (1222 cm-1) observed in the PCA 
of the basal-true normal versus basal-CIN-II normal which may be of interest, as it is the 
major difference between the two data sets reflected in the form of loading by PCA but it is 
absent in the loadings of the cell lines. The amide-III feature (1222 cm-1) is consistently 
present in the loadings of the PCA contributed by the basal layers of the intermediate and 
abnormal samples in the PCA with the basal-true normal. Thus this feature may be 
considered as an early marker of disease progression and could potentially indicate HPV 
infection. In this regard, interestingly, this band is much reduced in intensity of the PCA 
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loadings of their basal layers with the basal-true normal presented in the carcinoma in situ 
sample shown in Figure 5.33 (Figure 4.8 in chapter 4 called abnormal III) and most 
extreme abnormal sample (Figure 4.7 in chapter 4 called abnormal II) presented in the 
Appendix, Figure A1.XII. Notably, these are the most diseased samples and the reduction 
of the amide-III related feature may indicate that at this stage of the disease, integration of 
the HPV virus into the host genome has taken place instead of its presence with the protein 
coat independently in the host cell. The PCA of the basal layer of the two normal samples 
including “true normal-1” and “true normal-2” is presented in the Appendix, A1.1 and 
A1.2 as scatter plot and loadings respectively. The scatter plot shows some differentiation 
of the two clusters of the Raman spectra which is attributed to the inter-sample variability 
but the Raman spectral features which has been the differentiating features, particularly the 
band at 1222 cm-1, between the true-normal and diseased samples are not observed here in 
the loadings which further support the conclusion that the amide-III beta sheet (1222 cm-1) 
may be taken as Raman spectral marker of the early progression of the disease. 
It can be concluded that Raman spectroscopy certainly has potential for detecting the 
biochemical changes associated with HPV infection but as there are no strongly matching 
Raman signature loadings of the HPV negative and positive cell lines (C33A and CaSki), 
with the PCA loadings of the basal- true normal versus CIN II normal basal, further studies 
of spectral markers of HPV in tissue samples rather than cell lines maybe helpful in this 
regard. 
Regarding the evaluation of the KMCA observation on the invasion of the basal 
cells/characteristics of the basal layer into the superficial layer, Raman spectroscopy along 
with PCA have led to the conclusion that, during the progression of cervical cancer, there 
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are the cells of the basal layer which are not normal indicated by their rapidly proliferating 
behaviour (DNA rich content) and lack of glycogen content,. These cells are progressing to 
the superficial layer due to the progression of the disease. The PCA confirms these findings 
made on the basis of the KMCA in the chapter 4. 
For the evaluation of the KMCA observation on the appearance of the basal 
cells/characteristics of the basal layer in the stromal layer, Raman spectroscopy along with 
the PCA have led to the conclusion that these are actually associated with the biochemical 
changes in the cells of the stromal layer and there is no migration of the basal cells into the 
stroma. In addition, during cervical cancer progression, relative to the DNA, collagen has a 
diminished contribution at some points in the Raman map of the stroma and KMCA 
recognises the greater similarities with the DNA rich cells of the basal layer. This has been 
supported by the observation of the collagen related loadings contributed by the stroma-4 
and stroma-6 indicating that there is still some collagen present, although the DNA features 
are increased as compared to the normal stroma. Raman spectroscopy has identified 
significant changes in the stroma which may be useful for diagnostics and also can be 
important for disease progression and understanding mechanisms for treatment of medium 
stage progression. 
 
In order to further confirm the findings from this chapter, including progression of the basal 
cells into the superficial layer but not into the stroma, immunohistochemical staining for 
the evaluation of the expression of p16 protein is performed and presented in chapter 6. 
The expression of p16 is a biomarker for the presence of HPV and is expected to be 
enhanced in the basal and superficial cells/layers rather than in the stroma/stromal cells.  
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Chapter 6 
Immmunohistochemical staining of cervical tissue samples 
6.1 Immunohistochemistry 
Immunohistochemistry is a method of detecting specific macromolecules (e.g. proteins) 
in cells and tissues due to their specific interactions. The techniques can be used to 
detect, for example, target proteins by using antigen-antibody interactions, nucleic acids 
by using hybridization of the complementary segments of the nucleic acid and 
carbohydrate moieties by using lectin binding (Junqueira, 1992). 
6.2 Background 
6.2.1 Marker proteins associated with HPV infection 
In 99.7% cases of cervical intraepithelial neoplasia, infection with human 
papillomavirus (HPV) is considered to be a key factor. HPVs are non-enveloped viruses 
with an icosahedral protein coat and double stranded circular DNA of genome size 
approximately 8kb (Longworth and Laimins, 2004). 
The life cycle of HPV has two stages or phases; the first is the productive phase which 
involves the replication of viral DNA in the basal cells of the host to maintain a copy 
number of 50-100 genomes per cell. Viruses achieve this with the help of early 
expression of genes/proteins including E1, E2, E4, E5, E6 and E7.  
The E6 and E7 genes/proteins affect the functioning of tumour suppressor protein p16 
and pRB (Jedpiyawongse et al., 2008). The p16 protein is only expressed when the 
hypophosphorylated retinoblastoma (Rb) protein (pRb), which controls it negatively, is 
made dysfunctional. The oncoproteins encoded by the E6 and E7 genes have the ability 
to bind host cell regulatory proteins, especially the tumor suppressor gene products p53 
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and pRb. These changes may lead to functional inactivation of Rb protein through 
binding to the E7 gene product (Dyson et al., 1989, Werness et al., 1990). In several 
studies of cancer, the p16 protein is over-expressed when the Rb gene is mutated, 
deleted or inactivated and, conversely, p16 protein is markedly reduced or absent in cell 
lines and clinical specimens that contain an intact Rb gene. As p16 is controlled or 
regulated by pRb, which is regulated by the E7 gene product from the HPV infection, 
the expression analysis of p16 in cervical tissue samples may help to identify the HPV 
infection level during the progression of cervical cancer. 
In eukaryotic cells, a complex pattern of controlled expression and post-translational 
modifications (e.g. phosphorylation) of the cell-cycle regulating proteins affects the 
progression of the cell cycle. The p16INK4a protein plays a crucial role in the 
regulation of the mechanism of the cell cycle. It is an important part of the 
retinoblastoma protein (pRB)-mediated control of the G1-S-phase, and triggers the cell 
cycle arrest in the course of cellular differentiation processes. In terminally 
differentiated epithelial cells, p16INK4a expression is reduced to the levels which are 
not detectable by immunohistochemistry. In various tumor samples, the tumor 
suppressor gene p16INK4a has been found to be functionally inactivated by gene 
mutation or promoter hypermethylation. In replication competent cervical epithelial 
cells, however, where high risk type HPV (HR-HPV) oncoproteins have initiated the 
cellular transformation process, p16INK4a has been shown to be highly up-regulated 
and thus strongly over expressed. 
In the current study, immunohistochemical staining of the cervical tissue samples for 
p16 protein is performed to be used as a marker of the presence of the cervical cancer 
and its progression. The objective of this study is to identify the severity of the cervical 
cancer by evaluating the expression profile of the p16 protein, which is considered as a 
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marker protein for cervical cancer progression. This is also done to confirm and 
compare the findings including the migration of the basal cells/characteristics of the 
basal layer into the superficial and stromal layer which has been made on the basis of 
the results of Raman micro spectroscopy, described in chapters 4 & 5. The p16 
expression is expected to be enhanced in the basal and superficial cells/layers as this 
protein is expressed only in these layers as a result of the onset of the disease and 
notably, not in the stroma/stromal cells.  
In addition, chapter 4 & 5 also led to the conclusion that there is no migration of the 
basal cells into the stroma. In addition, during cervical cancer progression, relative to 
the DNA, collagen has a diminished contribution at some points in the Raman map of 
the stroma and KMCA recognises the greater similarities with the DNA rich cells of the 
basal layer. If invasion of the basal cells into the stroma is occuring, one would expect 
the expression of the p16 protein to be detectable in those cells, originating from the 
basal layer, which have migrated into the stroma. 
 
6.3 Methodology 
 
The staining of formalin-fixed, paraffin-embedded tissue sections was done using the 
CINtec® p16INK4a Histology kit (Roche), which uses the DAB (3, 3-diaminobenzidine) 
detection system. As the samples in use for the current study are obtained as formalin-
fixed and paraffin-embedded sections, in order to undertake immunohistochemical 
staining on them, they are required to be dewaxed. The tissue processing and detection 
of the p16 protein in these samples was done by using following protocol: 
 
 223 
6.3.1 Deparaffinization and Rehydration 
Prior to deparaffinization, slides were placed in a drying oven at a temperature of 60 °C 
for at least 20 minutes to remove water, thereby improving adherence of the tissue 
section to the slide (“baking”), as well as to melt the paraffin. Tissue slides were 
deparaffinized to remove embedding medium and then rehydrated before the staining 
procedure. The slides were processed at ambient temperature (20-25 °C) according to 
the following steps: 
a) Immersion for 5 minutes in a xylene bath; this step was repeated, once with a 
fresh bath. 
b) Excess liquid was removed. 
c) Immersion for 3 minutes in 95% ethanol. 
d) This step was repeated once with a fresh bath. 
e) Excess liquid was removed. 
f) Immersion for 3 minutes in 70% ethanol. 
g) This step was repeated once with a fresh bath. 
h) Excess liquid was removed. 
i) Slides were rinsed for 30 seconds in deionized water. 
 
6.3.2 Staining Protocol 
6.3.2.1 Epitope Retrieval 
Plastic Coplin staining jars were filled with the diluted Epitope retrieval solution 
(provided with the kit) and placed in the heated water bath (95-99 °C) to heat the 
Epitope Retrieval Solution. At this step, it was important to adjust the level of the water 
in the water bath to make sure that the jar was immersed in the water to a level of 80%. 
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To stabilize the temperature and avoid evaporation, the jars were covered. Further 
details of the epitope retrieval step are: 
a) The deparaffinised sections were immersed in the preheated epitope retrieval 
solution in the staining jars; this step lowered the temperature in the jars to less 
than 90°C. The temperature of the water bath and the Epitope Retrieval Solution 
was brought to 95-99 °C. 
b) The sections were kept for 10 minutes at 95-99 °C. 
c) The entire jar with slides was removed from the water bath. 
d) The slides were left to cool in the Epitope Retrieval Solution for 20 minutes at 
room temperature. 
e) The Epitope Retrieval Solution was removed and the sections were rinsed in 
diluted wash buffer (provided with the kit) for 5 minutes. 
 
6.3.2.2 Peroxidase-Blocking Reagent 
a) 200 µL Peroxidase-blocking reagent was applied to cover the samples. 
b) The sections were incubated for 5 minutes; 
c) The excess liquid was tapped off and slides were placed in a fresh wash buffer 
bath for 5 minutes. 
 
6.3.2.3 Antibody or Negative Reagent Control 
The excess buffer was removed and tissue sections were covered with 200 µl of the 
antibody (Mouse Anti-Human p16INK4a). For negative controls to confirm the 
specificity of the staining, tissue sections were not incubated with the primary antibody 
but instead were incubated with the Negative Reagent Control which includes 
monoclonal mouse anti-Rat oxytocin-related neurophysin antibody, supplied in 50 
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mmol/L Tris buffer pH 7.2, containing 15 mmol/L sodium azide (NaN3) and stabilizing 
protein. Rat oxytocin-related neurophysin is not present in human tissues and thus no 
staining would be expected in these negative control samples. After this step, the 
samples were incubated for 30 minutes. This was followed by the removal of the excess 
liquid and the slides were placed in a fresh wash buffer bath for 5 minutes. 
6.3.2.4 Visualization Reagent 
a) Excess buffer was removed. 
b) The sections were covered with 200 µl of the visualisation reagent (DAB 
Chromogen added to 2 mL of DAB Buffered Substrate) which is provided with 
the kit. 
c) The sections were incubated for 30 minutes. 
d) Excess liquid was decanted and the slides were placed in a fresh wash buffer 
bath for 5 minutes. 
e) This step was repeated twice with a fresh wash buffer bath. 
 
6.3.2.5 Substrate-Chromogen Solution (DAB) 
a) The sections were covered with 200 µl of Substrate-chromogen solution (DAB). 
b) They were then incubated for 10 minutes. 
c) Excess liquid was decanted and the sections were rinsed gently with deionized 
water. 
d) The substrate-chromogen solution (DAB) waste was collected in a hazardous 
materials container for safe disposal. 
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6.3.2.6 Counterstain with Hematoxylin 
a) The slides were immersed in a bath of hematoxylin and incubated for 5 minutes. 
b) They were then placed in a tap water bath and rinsed gently with running tap 
water until all the residual hematoxylin was cleared. This gave a blue colour. 
6.3.2.7 Mounting 
a) The sections were immersed for 3 min in 70% Ethanol. 
b) They were then immersed for 3 min 99% Ethanol. 
c) The sections were mounted with a glass coverslip using DPX. 
d) The slides were protected from light and stored at room temperature. 
 
6.4 Results of Immunohistochemical staining of cervical tissue samples 
 
The immunohistochemical staining for p16 causes the development of a brown colour 
in the nucleus and cytoplasm of the epithelial cells of cervical tissue (Hoshikawa et al., 
2010). To confirm the specificity of the staining, expression evaluation of p16 protein, 
the immunostaining of p16 of a CIN II diagnosed cervical tissue section recorded with 
X10 and X40 objective lenses, has been shown in Figure 6.1 A & B respectively. This 
sample was used as a negative control for immuno histochemical staining of p16 
protein. It was not incubated with the primary antibody and hence it did not show any 
expression detection or brown colour due to antibody-antigen attachment. 
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Figure 6.1 A Micrograph with X10 objective showing negative immunohistochemical 
staining for p16 protein in CIN II cervical tissue section with normal and diseased sides, 
used as a negative control (no antibody). 
 
 
 
Figure 6.1 B Micrograph with X40 objective showing negative immunohistochemical 
staining for p16 protein in CIN II cervical tissue section with diseased side, used as a 
negative control (no primary antibody). 
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Figure 6.2 A Micrograph with X10 objective showing negative immunohistochemical 
staining for p16 protein in normal cervical tissue section (chapter 4 reference: Figure 
4.3). 
 
 
 
Figure 6.2 B Micrograph recorded with X40 objective showing negative 
immunohistochemical staining for p16 protein in normal cervical tissue section (chapter 
4 reference: Figure 4.3). 
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In Figure 6.3 A & B the p16 staining of the CIN III cervical tissue section recorded 
with X10 and X40 objective lenses respectively, is shown, revealing extensive staining 
of the cervical epithelial cells. In chapter 4, the Raman analysis of this sample is shown 
in Figure 4.7. The Raman analysis characterised it as the most abnormal sample, as 
KMCA indicated no discrimination of the basal, stroma and superficial layers. This 
analysis is confirmed by immunohistochemical staining of the p16 protein. Notably, 
however, there is no evidence of p16 expression in the stromal layer, supporting the 
information acquired from chapter 5 regarding the absence of the invasion of the basal 
cells into the stroma and that changes in the Raman features associated with the 
progression of the disease are related to the cells of the stroma themselves. 
 
 
 
Figure 6.3 A Micrograph recorded with X10 objective showing positive 
immunohistochemical staining for p16 protein in CIN-III cervical tissue section 
(chapter 4 reference: Figure 4.7). 
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Figure 6.3 B Micrograph recorded with X40 objective showing positive 
immunohistochemical staining for p16 protein in CIN-III cervical tissue section 
(chapter 4 reference: Figure 4.7). 
. 
Figure 6.4 A & B shows the p16 staining of a CIN II cervical tissue section recorded 
with X10 and X40 objective lenses respectively, indicating no staining of the cervical 
epithelial cells. In chapter 4, this sample corresponds to Figure 4.15, and Raman 
characterised it as an intermediate sample as indicated by the KMCA map where 
discrimination of the basal, stroma and superficial was observed, but the latter two 
layers were observed to have some characteristics of the basal layer. The negative 
immunohistochemical staining for p16 protein found here indicates that the expression 
of this protein is not detectable. However, Raman micro spectroscopy could detect the 
biochemical changes taking place in this sample due to the progression of the cervical 
cancer independent of the expression of p16 protein. 
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Figure 6.4 A Micrograph recorded with X10 objective showing negative 
immunohistochemical staining for p16 protein in CIN II marked tissue (in Figure 4.15) 
cervical tissue section. 
 
 
 
Figure 6.4 B Micrograph recorded with X40 objective showing negative 
immunohistochemical staining for p16 protein in CIN II marked tissue (in Figure 4.15) 
cervical tissue section.  
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Figure 6.5 A & B shows the immunohistochemical staining for p16 protein in a CIN II 
cervical tissue section recorded with X10 and X40 objective lenses respectively. The 
staining/brown colour is evident in some parts of the cervical epithelium. Here the 
results of the immunohistochemical staining for p16 protein are consistent with the 
Raman micro spectral mapping of the CIN II sample as Raman micro spectroscopy 
characterised it as intermediate sample indicated by the KMCA colour map, presented 
in chapter 4, Figure 4.17. 
 
 
 
Figure 6.5 A Micrograph recorded with X10 objective showing positive 
immunohistochemical staining for p16 protein in CIN II marked tissue (chapter 4 
reference;  Figure 4.17) cervical tissue section. 
 
 233 
 
 
Figure 6.5 B Micrograph recorded with X40 objective showing positive 
immunohistochemical staining for p16 protein in CIN II marked (chapter 4 reference; 
Figure 4.17) cervical tissue section. 
 
Figure 6.6 A & B shows the immunohistochemical staining for p16 protein in the 
normal side of the CIN III cervical tissue section recorded with X10 and X40 objective 
lenses respectively. No positive staining/brown colour was seen in the cervical 
epithelium. Here, the results of the immunohistochemical staining for p16 protein are 
not consistent with the Raman micro spectral mapping of the same sample as Raman 
micro spectroscopy characterised it as intermediate sample indicated by the KMCA 
colour map, presented in chapter 4, Figure 4.13. The Raman spectral mapping indicated 
that the separation of the stroma and basal layer is very clear but the superficial layer 
showed evidence of disease based on strong DNA features throughout this layer, 
indicating rapidly proliferating cells. 
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Figure 6.6 A Micrograph recorded with X10 objective showing negative 
immunohistochemical staining for p16 protein in normal side of the CIN III cervical 
tissue section ( chapter 4 reference: fig 4.13). 
 
 
 
Figure 6.6 B Micrograph recorded with X40 objective showing negative 
immunohistochemical staining for p16 protein in normal side of the CIN III cervical 
tissue section (chapter 4 reference: Figure 4.13). 
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6.5 Conclusion 
 
The immunohistochemical staining for p16 causes the development of a brown colour 
in the nucleus and cytoplasm of the epithelial cells of cervical tissue. In the current 
study, control samples including a negative control, CIN II diagnosed cervical tissue 
section which was not incubated with the primary antibody, did not show any 
expression detection or brown colour due to antibody-antigen attachment. This 
confirmed the specificity of the staining for the expression evaluation of p16 protein. 
 
The CIN III cervical tissue section (chapter 4, Figure 4.7) , which was shown by the 
Raman analysis as the most abnormal sample where KMCA indicated no discrimination 
of the basal, stroma and superficial layers, has shown extensive staining of the cervical 
epithelial cells. Notably, however, there is no evidence of p16 expression in the stromal 
layer, consistent with the PCA analysis from chapter 5 indicating that basal cells do not 
migrate into the stroma and changes in the Raman features associated with the 
progression of the disease are related to the cells of the stroma themselves. 
The p16 staining of a CIN II cervical tissue section indicated no staining of the cervical 
epithelial cells. This sample corresponds to Figure 4.15 chapter 4, whereby Raman 
characterised it as an intermediate sample as indicated by the KMCA map where 
discrimination of the basal, stroma and superficial layers was observed but the latter 
two layers were observed to have some characteristics of the basal layer. The negative 
immunohistochemical staining for p16 protein found here leads to the conclusion that 
the expression of this protein is not detectable. However, Raman micro spectroscopy 
could detect the biochemical changes taking place in this sample due to the progression 
of the cervical cancer at an earlier stage than the expression of p16 protein. 
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In another CIN II sample (chapter 4, Figure 4.17) which was also characterised as an 
intermediate sample by Raman micro spectroscopy as indicated by the KMCA colour 
map, the staining/brown colour is evident in some parts of the cervical epithelium and 
the results of the immunohistochemical staining for p16 protein are consistent with the 
Raman micro spectral mapping. 
 
The staining for p16 protein in the normal side of the CIN III cervical tissue section 
(chapter 4, Figure 4.13) is found to be negative. Again, the results of the 
immunohistochemical staining for p16 protein are consistent with the Raman micro 
spectral mapping of the same sample as Raman micro spectroscopy characterised it as 
intermediate sample indicated by the KMCA colour map. The Raman spectral mapping 
indicated that the separation of the stroma and basal layer is very clear, but the 
superficial layer showed evidence of disease based on strong DNA features throughout 
this layer, indicating rapidly proliferating cells and early detection of the disease by 
Raman spectroscopy as compared to the immunostaining method. 
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Chapter 7 
Summary and Conclusions 
 
The major purpose of this study is to evaluate the potential of the technique of 
vibrational micro spectroscopy in elucidating the biochemical changes occurring during 
the progression of Cervical Intraepithelial Neoplasia (CIN) to cancer. The pathologist, 
in general, divides the cervical epithelium into basal, parabasal, intermediate and 
superficial layers. The cervical epithelium is supported by the underlying connective 
tissue known as the stroma. Common currently employed diagnostic techniques rely on 
morphological changes to the tissue of cellular structures, rather than the underlying 
biochemical changes. Microspectroscopy promises a rapid, label free, automated 
technique for disease diagnostics based on these underlying biochemical changes. 
 
FTIR and Raman micro spectroscopy were employed to visualize the layer separation in 
cervical tissue sections and also how this separation is affected due to the biochemical 
changes caused by the progression of the disease. The comparison of the results of both 
the techniques was made to choose one for the further studies based on the biochemical 
information attained. Although, both Raman micro spectroscopy and FTIR 
spectroscopy were able to differentiate the normal region of the cervical tissue sample 
into three layers, including stroma, basal/para-basal and superficial layers, on the basis 
of the spectral features of the collagen, DNA bases and glycogen respectively, Raman 
spectroscopy due to its higher spatial and spectral resolution compared to FTIR 
spectroscopy revealed more detailed biochemical changes related to the DNA. 
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Before further exploring the chosen technique, Raman micro spectroscopy, for the 
analysis of the cervical tissue samples, different dewaxing agents including hexane, 
cyclohexane, xylene, histolene, ether and dish washing liquid were utilised to determine 
their ability to remove wax from rat skin tissue samples in order to optimize sample 
processing protocols for the cervical tissue samples. On the basis of the spectral quality 
obtained with dewaxed rat skin, xylene and hexane were found to be equally good for 
the removal of the wax. The dishwashing liquid resulted in the inefficient removal of 
wax and Raman spectra exhibited the paraffin bands even after the application of the 
dewaxing agent. Cyclohexane itself contributed to the Raman spectra as indicated by 
the bands present at 787 and 802 cm-1. The use of ether did not appear to be suitable as 
a dewaxing agent due to its interference with the proteins in the tissue section as 
indicated by the observation of deformation of the amide I band. Xylene and hexane 
were found to be the best dewaxing solvents, followed by histolene, as compared to the 
other dewaxing agents employed in the current study. Xylene was adopted as solvent of 
choice to keep the protocol consistent with the one used in the hospital histopathology 
laboratory. 
 
The selection of the most suitable laser line was made from three laser lines, including 
532 nm, 660 nm and 785 nm. The Raman bands were better defined for the 785nm laser 
line as compared to the 532nm laser line, and a poorly defined spectrum was obtained 
for 660 nm laser line, which showed it to be the least suitable of the three for the current 
study. The 785nm laser line was preferred over the 532nm laser line due to the major 
concern of photo degradation of the tissue section. 
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For the selection of the most suitable substrate, three different substrates including 
Mirr-IR, quartz and calcium fluoride were used and results were compared. The Mirr-
IR substrate gave rise to a broad background under 785nm laser illumination and as 
such was not considered suitable. The quartz and CaF2 substrates did not cause 
fluorescence with the 785nm laser line. The CaF2 contribution in the biological 
spectrum was negligible as compared to a prominent band from quartz which led to the 
selection of the CaF2 as the most substrate to be used for the further experiments with 
Raman micro spectroscopy. 
 
The optimization of the objective lens was done by employing X50 dry, X100 dry and 
X60, X100 water immersion objectives for the Raman spectral acquisition. Similar 
spectral features were obtained with X50 dry, X100 dry and X100 immersion objectives 
but the spectra acquired by the use of the X100 immersion objective were cleaner as 
compared to the X50 and X100 dry objectives and thus less spectral preprocessing was 
required for this objective. This is due to the reason that the immersion of the tissue 
section in the water makes the tissue surface less scattering and results in better defined 
peaks. However, tissue immersion does not readily allow for repetition of the 
experiment if needed for further investigations. Use of the dry objective avoids the 
problem of immersing the tissue sections in water repeatedly. So, from these two 
objective lenses, the X100 dry objective lens was selected for further experiments of 
Raman mapping. 
 
After optimization of the above mentioned parameters for Raman micro spectroscopy, 
the technique was employed for spectral mapping of the cervical tissue sections. The 
results of the Raman micro spectroscopy have proven that the technique, in combination 
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with K-Means Clustering Analysis, is very useful in the discrimination of the diseased 
areas from the normal areas and particularly in the detailed identification of the 
biochemical changes in the diseased samples. The differentiated clusters of Raman 
spectra contain the signatures of the DNA bases and can be used as a discriminating 
factor for the differentiation between the layers and between normal and abnormal 
regions. On moving from normal to abnormal regions of the cervical tissue sample, the 
characteristic Raman features of the basal layer were observed in the superficial layer 
and in the stromal layer. Notably, the region of the CIN III sample, which was 
pathologically classified as normal, has been recognised as having biochemical 
information similar to the abnormal region. This has been indicated by the diminution 
of the collagen Raman spectral bands in the stromal layer as well as absence or minute 
presence of the glycogen bands in the superficial layer.  
 
The results, based on KMCA of Raman spectroscopic maps of different cervical tissue 
samples, led to the conclusion that Raman micro spectral mapping of the cervical tissue 
sections has been able to identify the biochemical changes occurring during disease 
progression. The information and conclusion made on the basis of the biochemical 
changes would not be possible only on the basis of the morphological 
observations/changes occurring in the tissue. 
 
PCA of the Raman spectral data was performed and was found to be very useful to 
further interpret the results of the KMCA and to elucidate the basis of differentiation of 
the basal-true normal and basal-CIN II normal (far from diseased region), both of which 
have been found to be different to the basal layers of the diseased samples. This means 
that, in order to predict the presence of the disease, it is not necessary to investigate the 
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region of disease directly and suggests that Raman micro spectroscopy can identify the 
onset of disease before the morphological changes to the tissue structure are observable. 
 
The comparison of the PCA loadings of the HPV negative and positive cell lines (C33A 
and CaSki), with the PCA loadings of the basal-true normal versus basal-CIN II normal 
indicated that there were no strongly matching Raman signatures which could lead to 
the  identification of signatures of HPV infection in the cervical cancer tissue samples. 
However, a feature associated with the amide-III beta sheet (1222 cm-1) has been 
consistently observed in the PCA of the basal-true normal versus basal-CIN II normal 
which might be of interest, as it is the major difference between the two data sets 
reflected in the form of a loading by PCA, although it is not prominent in the loadings 
of the cell lines. This amide-III protein feature (1222 cm-1) is also consistently present 
in the loadings of the PCA contributed by the basal layers of the intermediate and 
abnormal samples in the PCA with the basal-true normal. Thus, this feature may be 
considered as an early marker of disease progression and could potentially indicate 
HPV infection. Notably, this band is much reduced in intensity in the loadings 
contributed by the most extreme abnormal sample and the carcinoma in situ samples 
which are the most diseased samples. Referring to Figure 1.5 (Woodman et al., 2007), 
this feature may therefore be a signature of episomal HPV, in which the virus is present 
in the cytoplasm, surrounded by proteins and the reduction of the amide-III related 
feature as the disease progresses may be an indicator for integration of the HPV virus 
into the host genome. It is also notable that the HPV infected cervical cell lines are 
derived from cancer patients, and thus the HPV should exist in its full integrated form, 
and thus, if it is a marker for episomal HPV, the absence of the strong protein band at 
1222cm-1 is to be expected. Further investigation is needed however to confirm this 
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suggestion. It can be concluded that Raman spectroscopy certainly has potential for 
detecting the biochemical changes associated with HPV infection but as there are no 
strongly matching Raman signature loadings of the HPV negative and positive cell lines 
(C33A and CaSki), with the PCA loadings of the basal- true normal versus CIN II 
normal basal, further studies of spectral markers of HPV in tissue samples rather than 
cell lines are required. 
 
As the KMCA (in chapter 4) suggested the migration of the characteristics of the basal 
layer into the superficial layer, Raman spectroscopy along with PCA have led to the 
conclusion that, during the progression of cervical cancer, cells of the basal layer are 
characterised by high DNA content and lack of glycogen content. These cells progress 
to the superficial layer during the progression of the disease. PCA confirms these 
findings made on the basis of the KMCA. 
 
For the evaluation of the KMCA observation on the appearance of the basal 
cells/characteristics of the basal layer in the stromal layer, Raman spectroscopy along 
with the PCA, have led to the conclusion that these characteristics are actually 
associated with the biochemical changes in the cells of the stromal layer and there is no 
migration of the basal cells into the stroma. In addition, during cervical cancer 
progression, relative to the DNA, collagen has a diminished contribution at some points 
in the Raman map of the stroma and KMCA recognises the greater similarities with the 
DNA rich cells of the basal layer. This has been supported by the observation of the 
collagen related loadings contributed by the stroma-4 and stroma-6 (chapter 5) 
indicating that there is still some collagen present, although the DNA features are 
increased as compared to the normal stroma. Raman spectroscopy has identified 
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significant changes in the stroma which may be useful for diagnostics and also can be 
important for tracking disease progression and understanding mechanisms for treatment 
of medium stage progression. 
 
In order to further confirm the findings from chapter 5, including the classification of 
the cervical tissue samples and the progression of the basal cells into the superficial 
layer but not into the stroma, immunohistochemical staining for the evaluation of the 
expression of p16 protein was performed. The expression of p16 is a biomarker for the 
presence of HPV and is expected to be enhanced in the basal and superficial cells/layers 
rather than in the stroma/stromal cells. The immunohistochemical staining for p16 
causes the development of a brown colour in the nucleus and cytoplasm of the epithelial 
cells of cervical tissue. For this purpose, control samples, including a negative control, 
CIN II diagnosed cervical tissue section which was not incubated with the primary 
antibody, did not show any expression or brown colour due to antibody-antigen 
attachment. This confirmed the specificity of the staining for the expression evaluation 
of p16 protein. 
The CIN III cervical tissue section (chapter 4, Figure 4.7), which was shown by the 
Raman analysis as the most abnormal sample, whereby KMCA indicated no 
discrimination of the basal, stroma and superficial layers, showed extensive staining of 
the cervical epithelial cells. Notably, however, there is no evidence of p16 expression in 
the stromal layer, consistent with the PCA analysis from chapter 5, indicating that 
basal cells do not migrate into the stroma and changes in the Raman features associated 
with the progression of the disease are related to the cells of the stroma themselves. 
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The p16 staining of a CIN II cervical tissue section indicated no staining of the cervical 
epithelial cells. This sample corresponds to Figure 4.15 in chapter 4, whereby Raman 
analysis characterised it as an intermediate sample as indicated by the KMCA map 
where discrimination of the basal, stroma and superficial layers was observed, but the 
latter two layers were observed to have some characteristics of the basal layer. The 
negative immunohistochemical staining for p16 protein found here leads to the 
conclusion that the expression of this protein, if present, is not detectable. However, 
Raman micro spectroscopy could detect the biochemical changes taking place in this 
sample due to the progression of the cervical cancer at an earlier stage than the 
expression of p16 protein. 
 
In another CIN II sample (chapter 4, Figure 4.17) which was also characterised as an 
intermediate sample by Raman micro spectroscopy, as indicated by the KMCA colour 
map, the staining/brown colour is evident in some parts of the cervical epithelium and 
the results of the immunohistochemical staining for p16 protein are consistent with the 
Raman spectral mapping. 
 
The staining for p16 protein in the normal side of the CIN III cervical tissue section 
(chapter 4, Figure 4.13) was found to be negative. The results of the 
immunohistochemical staining for p16 protein are not consistent with the Raman micro 
spectral mapping of the same sample as Raman micro spectroscopy characterised it as 
intermediate sample indicated by the KMCA colour map. The Raman spectral mapping 
indicated that the separation of the stroma and basal layer is very clear, but the 
superficial layer showed evidence of disease based on strong DNA features throughout 
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this layer, indicating rapidly proliferating cells and early detection of the disease by 
Raman spectroscopy as compared to the immunohistochemical method. 
 
Raman spectroscopy has been found to be a powerful technique to investigate the 
biochemical changes associated with progression of cervical cancer from normal to 
abnormal stages and carcinoma in situ and has shown the potential to produce clinically 
important data for the characterisation of the disease. Raman spectral mapping of the 
cervical tissue samples of various stages of the disease along with the multivariate data 
analysis techniques including KMCA and PCA have been shown to be very promising 
for the discrimination of these cervical tissue samples and extracting Raman markers 
associated with the biochemical changes occurring in different regions of the tissue 
including basal, superficial and stromal layers. In addition, different sub-regions of 
these layers of the cervical tissue have also been characterised and differentiated on the 
basis of the changes in the spectral features observed which has proved the diagnostic 
capabilities of the Raman microspectral imaging with respect to cervical cancer and 
early markers of the disease. 
 
The technique promises a “Raman based classification system” which depends on the 
identification of markers associated with early stage biochemical changes rather than 
the morphological ones which appear at a later stage of disease progression. Moreover, 
the technique is objective, no prior labeling is required, it can be cost effective and can 
be automated. To bring the technique to the clinical environment, it is essential to make 
the technique acceptable to the clinicians by making it easy to use for them, affordable 
and adaptable from laboratory to clinic by excluding the requirement of personal trained 
for acquisition of the Raman spectra and implementation of complex algorithms for 
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data analysis. These improvements will enable the technique to produce final results in 
a single visit to the “Raman clinic” and reduce the workload on the clinicians as well as 
the anxiety of the patient in relation to the outcome of the results associated with long 
waits and repeated visits, a particularly significant big problem in third world countries 
where patients are reluctant to follow up initial visits. 
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Appendix 
PCA results of basal layer of normal-1 versus normal-2 
PCA results of the basal-true normal-1 versus basal-true normal-2 are discussed here. The 
purpose of this analysis was to differentiate the inter-patient/inter-sample variability. The 
PCA results are presented in A1.1 and A1.2 as scatter plot and loadings respectively.  
 
 
A1.1 PCA scatter plot of basal true normal-1 vs basal true normal-2. 
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The PCA scatter plot shows some differentiation of the two clusters of the Raman spectra 
which is attributed to the inter-sample variability but the Raman spectral features which has 
been the differentiating features, particularly the band at 1222 cm-1, between the true-
normal and diseased samples are not observed here in the loadings. Moreover, major 
differentiating features include 1298, 1449 and 1655 cm-1 associated with proteins and 
lipids which are not taken, in the current studies discussed in chapter 5, as marker of the 
disease progression and HPV infection. This indicates the differentiation of the two clusters 
is solely on the basis of the intensity difference of these spectral features. 
 
 
A1.2 PCA loadings (PC-1) of basal true normal-1 vs basal true normal-2. 
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PCA results of basal layer of normal-2 versus basal-1 (CIN II normal 
PCA of the basal-1 (CIN II normal basal layer) with the second true normal sample “true 
normal-2” was also done and is presented in the Appendix (A1.3 and A1.4) as scatter plot 
and loadings respectively. Notably, the loadings are the same as observed in case of “basal-
true normal-1” versus “basal-1 (CIN II normal)” presented in chapter 5, Figure 5.7 and 5.8, 
and the 1222 cm-1 feature is also observed in these loadings which further confirms that the 
changes in the amide-III beta sheet (1222 cm-1) may be taken as a Raman spectral marker 
of the early progression of the disease. 
 
 
A1.3 PCA scatter plot of basal true normal-2 vs basal-1(basal-CIN II normal). 
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A1.4 PCA loadings (PC-1) of basal true normal-2 vs basal-1(basal-CIN II normal). 
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PCA results of basal layer of normal case (basal-true normal) vs intermediate, 
abnormal (basal-4 to basal-7) samples 
 
PCA results of the basal-true normal versus other basal layers of different samples of 
different stages of the disease including intermediate and abnormal cases are discussed in 
the following sections. The purpose of this analysis was to differentiate the biochemical 
changes which take place due to the progression of the disease from the normal case to the 
intermediate and abnormal stages. 
 
PCA results of basal-true normal vs basal-4 
PCA of the Raman spectra from the basal layer of the normal case (basal-true normal) 
against the basal layer of an abnormal sample called basal-4, shown in A1.3, are presented 
here in A1.4 and A1.5 as scatter plot and loadings of the PCA, respectively. PCA scatter 
plot shows that two groups are different from each other. The Raman spectra of the basal-
true normal layer are clustered in the negative axis and spectra of the basal-4 layer in the 
positive axis of the scatter plot. The loadings contributed by the basal-true normal include 
those which are associated with glycogen at 849 cm-1, 939 cm-1 (glycogen) and some 
others related to proteins including 644 cm-1 (C-C stretching), 831 cm-1 (tyrosine) and 
some related to the DNA including 487 cm-1 (adenine), 749 cm-1 (thymine) and 1346 cm-
1 (guanine).  
PCA loadings contributed by the basal-4 include those related to DNA at 487 cm-1 
(adenine), 538 (thymine/S-S stretching of proteins, 1056 cm-1, 1088 cm-1 (O-P-O, DNA) 
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and others related to proteins including 1144 cm-1 (C-C stretching of proteins) and 1202 
cm-1 and 1222 cm-1 (amide-III beta sheet). The contribution of these loadings by the basal-4 
layer is consistent with the previously discussed samples and indicates towards the 
biochemical changes related to proteins due to the progression of cervical cancer, from 
basal layer of the true normal case to the abnormal cases. 
 
 
A1.5 H&E stained diseased side of CIN III marked tissue with scale bar of 200µm (a) 
unstained tissue under Raman spectroscope with scale bar of 20µm (b) Five cluster KMCA 
map generated from the Raman map (c). 
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A1.6 PCA Scatter plot for basal-true normal versus basal-4.  
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A1.7 PCA loading (PC-1) for basal-true normal versus basal-4. 
 
 280 
PCA results of basal-true normal vs basal-5 
 
PCA of the Raman spectra from the basal layer of the normal case (basal-true normal) 
against the basal layer of an intermediate sample (basal-5) shown in Figure A1.6, are 
shown in Figure A1.7 and A1.8 as scatter plot and loadings of the PCA, respectively. The 
PCA scatter plot shows clear differentiation of the two groups by clustering the Raman 
spectra of the basal-true normal layer in the negative axis and the spectra of the basal-5 
layer in the positive axis of the scatter plot and hence negative and positive loadings are 
associated with them respectively. 
 
A1.8 H&E stained normal region of CIN III diagnosed tissue with scale bar of 500µm  (a) 
unstained tissue under Raman spectroscope, with scale bar of 100µm (b) Five cluster 
KMCA map generated from the Raman map (c). 
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The loadings of the PCA associated with glycogen at 939 cm-1 and 849 cm-1 (glycogen) are 
positive but are not very sharp and dominant and hence do not seem to differentiate these 
layers. The PCA loadings related to DNA including 487 (adenine), 1346 (guanine), 1056, 
1088 cm-1 (O-P-O of DNA) and those associated with the proteins including 831 cm-1 
(tyrosine), 1202, 1222 and 1273 cm-1 (amide-III beta sheet) are contributed by the basal-5 
layer. 
 
 
A1.9 PCA Scatter plot for basal-true normal vs basal-5. 
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The basal-true normal layer contributed the loadings related to DNA including 718 cm-1 
(adenine), 749 (thymine) and those which are related to proteins including 644 (C-C 
stretching), 1449 (CH deformation) and 1675 (amide-I). 
 
A1.10 PCA loading (PC-1) for basal-true normal vs basal-5. 
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PCA results of basal-true normal vs basal-6 
 
PCA of the Raman spectra from the basal layer of the normal case (basal-true normal) 
against the basal layer of an intermediate sample called basal-6 (Figure A1.9), are shown 
in Figure A1.10 and Figure A1.11 as scatter plot and loadings of the PCA, respectively. 
 
 
 
A1.11 H&E stained normal side of CIN III marked tissue with scale bar of 200µm (a) 
unstained tissue under Raman spectroscope with scale bar of 40µm (b) Five cluster K mean 
map generated from the Raman map (c). 
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The PCA scatter plot shows differentiation of the two groups by clustering the Raman 
spectra of the basal-true normal layer in the negative axis and spectra of the basal-6 layer in 
the positive axis of the scatter plot which indicates that negative and positive loadings are 
contributed by the basal-true normal layer and the basal-6 layer respectively. 
The characteristic features of glycogen, 480 cm-1, 849 cm-1 and 939 cm-1 are observed as 
negative loadings contributed by the basal-true normal layer along with other loadings 
including 718 cm-1 (adenine), 1056 cm-1 and 1088 cm-1 (O-P-O, DNA). The basal-6 
contributes the loadings including 1303 (adenine), 1318 and 13456 (guanine) as well as 
1202 cm-1 1222 cm-1 and 1273 cm-1 (amide-III beta sheet). 
 
A1.12 PCA Scatter plot for basal-normal vs basal-6. 
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A1.13 PCA loading (PC-1) for basal-true normal vs basal-6. 
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PCA results of basal-true normal vs basal-7 
Figure A1.13 and Figure A1.14 represent the scatter plot and loadings of the PCA 
respectively, for the Raman spectra from the basal layer of the normal case (basal-true 
normal) against the basal layer of an abnormal sample called basal-7, Figure A1.12. The 
differentiation of the two groups can be seen as the clustering of the Raman spectra of the 
basal-true normal in the negative axis and those of the basal-7 in the positive axis of the 
scatter plot. 
 
 
A1.14 H&E stained disease side of CIN III marked tissue with scale bar of 200µm (a) 
unstained tissue under Raman spectroscope with scale bar of 40µm (b) Five cluster KMCA 
map generated from the Raman map (c). 
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A1.15 PCA Scatter plot for basal-true normal versus basal-7. 
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A1.16 PCA loading (PC-1) for basal-true normal versus basal-7. 
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